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ABSTRACT 
Background 
Human Immunodeficiency Virus (HIV) infection is now a chronic disease. People 
living with HIV (PLHIV) are ageing and at risk of co-morbid conditions. Regardless 
of HIV virological stability, 20% of PLHIV are at risk of a neurological co-morbid 
disease called HIV Associated Neurocognitive Disorder (HAND). HAND has three 
categories, asymptomatic neurocognitive impairment, mild neurocognitive disorder 
and HIV associated dementia each relating to varied levels of disability and affecting 
quality of life. The early identification and diagnosis of HAND is important, as 
HAND is a potentially treatable condition. Despite this, very little is known about 
how this complex condition is experienced by PLHIV or their caregivers and 
communities.  
The diagnosis of HAND is multifactorial and is often achieved by the exclusion of 
other medical conditions which can confound the diagnosis. Additionally, PLHIV 
may experience mild signs and symptoms that they attribute to other causes such as 
morbidity associated with ageing.  
Informal caregivers can make an important contribution to the diagnosis of HAND as 
they are often more attuned to the complexity of identifying subtle changes in 
cognition in PLHIV. For those PLHIV who do not have the support of an informal 
caregiver, professional caregivers may act as alternate observers of cognitive change 
through monitoring PLHIV in their own environment whilst providing care in the 
home.  
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Aim 
The aim of this thesis was to explore the complexities of identifying HAND by people 
living with HIV, and their informal or formal (professional) caregivers. The three 
objectives were to: 
 Explore whether people living with HIV and their informal caregivers can 
identify HAND. 
 Explore the experience of HAND in people living with HIV. 
 Explore whether community-based health care professionals can identify 
HAND. 
Design 
A pragmatic explanatory sequential design used mixed methods to elicit knowledge 
about the identification of HAND by PLHIV, and by their informal and professional 
caregivers.  The thesis explored the complexities of identifying HAND through a 
preliminary pilot study followed by three subsequent study phases. 
 
Method 
A preliminary prospective multi-site observational study was undertaken at three HIV 
health clinics in Sydney, Australia to explore whether cognitive changes were being 
experienced by PLHIV and whether they could identify signs and symptoms of 
HAND. Participants in this study also identified informal caregivers who could 
provide additional information about witnessed changes in their cognition. 
Recruitment was staggered at the three sites with a one-year follow up to review the 
results of medical assessments.  
 
The preliminary pilot study asked the broad initial question “Can people living with 
HIV and their informal caregivers identify HAND?” The results of this study 
informed the development of four further research questions explored through three 
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distinct study phases in this thesis. The Phase 1 study used an online survey with 
PLHIV, focusing on their experience of HAND. The survey was distributed via a peer 
HIV non-government organization to explore the research questions:  
 
1. Are PLHIV aware of and/or concerned about HIV associated 
neurocognitive disorder?   
2. Are PLHIV experiencing signs and symptoms of cognitive change and/or 
observing them in others?  
 
The Phase 2 study used a cross-sectional design to conduct a file audit of patient data 
collected by two interdisciplinary community-based HIV specialist teams. A 
descriptive analysis was undertaken to explore the research question:  
3. What information collected by HIV community-based teams identifies 
patients at risk of HAND?   
Phase 3 used a Modified Delphi method, with a minimum of 80% consensus 
considered as agreement in any round, to answer the final research question: 
4. What assessment criteria are essential to identify those at risk of HAND in 
the community?  
Results 
The preliminary pilot study recruited 165 participants (121 PLHIV and 44 caregivers) 
and found that a wide range of signs and symptoms of cognitive change had been 
experienced by 61% (73) of PLHIV over the previous 12 months.  Fifty-seven per 
cent (25) of informal caregivers had also observed changes in cognition among those 
PLHIV enrolled in the study. Identification of the signs and symptoms of cognitive 
changes by study participants led to 16 being referred for formal testing.  Four of 
these were subsequently diagnosed with HAND.  Sixty-four per cent (77) of PLHIV 
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in the study did not identify the support of an informal caregiver and 41% (49) lived 
alone. The absence of regular observation by informal caregivers may impact on the 
early recognition of HAND through failure to observe changes in cognition in PLHIV 
over time.  
 
In the Phase 1 study, findings from 126 eligible online surveys noted that 75% (94) of 
participants were aware of HAND and 59% (74) of HIV positive respondents had 
either experienced signs or symptoms of cognitive change in themselves or had 
noticed change in others. Of the 94 participants who had heard of HAND, 55% (52) 
responded that they were concerned and 58% (30) of them had spoken to someone 
about their concerns. Of these, 77% (23) stated they had a positive response when 
they had spoken with others (both health professionals and significant others) about 
their concerns, but 21% (11) had not. Importantly, the latter group stated that they 
would not discuss their concerns again. Thirty-nine per cent (49) thought assistance to 
broach the subject of HAND with others would be helpful. The results of the Phase 1 
study led to a partnership with a key HIV peer organization in Sydney, Australia to 
develop and focus test a resource for PLHIV who have HAND and a resource for 
caregivers. 
In Phase 2, a file audit of 262 medical records of PLHIV clearly showed that 
professional caregivers were not collecting and/or not documenting the type of 
information that might be useful for the detection of HAND. Further, incomplete 
patient data were noted in each file.  
These results led to the Phase 3 study which utilized a modified Delphi method to 
gain consensus from experienced clinicians working across four community-based 
services. Expert clinicians with long-term experience of providing support to PLHIV 
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who had been diagnosed with HAND, were asked to agree on essential assessment 
criteria to identify those at risk of HAND in the community. More than 80% 
consensus was achieved by panel members on items to be included in an initial risk 
assessment and follow up annual monitoring tool suitable for use by community-
based health professionals to regularly screen for HAND as a precursor for formal 
medical assessment. 
Conclusion 
The findings of this thesis indicate that the diagnosis of HAND is complex, but the 
observational and other experiences of PLHIV and their caregivers, whether informal 
or formal (professional), can offer unique insights into cognitive changes in PLHIV. 
This form of observational evidence is crucial to enhancing assessment and offers 
additional background information for clinical review, which could facilitate the early 
diagnosis of HAND.  
 
PLHIV may experience social isolation, and as they age, may not have the support of 
an informal caregiver. Some PLHIV may be in same sex relationships where both 
parties may be at risk of developing HAND. For those PLHIV without the support of 
an informal caregiver and/or who live alone, professional caregivers can regularly 
undertake risk assessments to assess and monitor PLHIV who may be at risk of 
HAND. Professional caregivers can therefore act as an alternative to an informal 
caregiver, being well placed to observe changes in cognitive behavior over time.  
 
The personal experience of PLHIV, as well as the experience of their informal and 
professional caregivers, can make essential and important contributions to reducing 
the complexity associated with identifying HAND and instigating early management 
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of this condition. HAND is a potentially treatable condition. Early recognition can 
have a positive impact on health and quality of life of PLHIV as they age.
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Structure of Thesis 
 
This thesis is presented for examination as a thesis containing published work. Of the 
eight chapters presented in this thesis, four contain papers that have been published in 
national and international peer-reviewed, indexed journals. The candidate is the 
principal author of all four papers. Published papers are presented in the format 
required by the journal; therefore, each contains an individual methods section and 
reference list. A complete reference list is also provided at the end of the thesis.  
 
Chapter 1 describes a history of Human Immunodeficiency Virus (HIV) infection and 
offers a rationale for screening for HIV associated neurocognitive disorder (HAND) 
in PLHIV. A parallel history of the development of health services for HIV and HIV 
related cognitive impairment in Sydney, Australia is given from the personal 
perspective of the candidate who has worked with PLHIV throughout this time, and 
as a background to the studies conducted for this thesis. 
 
Chapter 2 reviews published literature to illustrate the significance of support 
provided by informal and professional caregivers to PLHIV. This chapter also 
explores reasons why PLHIV may not have the support of an informal caregiver, and 
how both informal and professional caregivers may be instrumental in identifying 
HAND.  
 
A methodology chapter (Chapter 3) discusses the aims and objectives of the thesis, 
the development of research questions and the rationale for using a mixed method 
approach to conduct the studies. Methods are presented in each of the published 
papers in Chapters 4 -7 (below), supporting the aims of the thesis: 
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Cummins, D., Murray, K., Trotter, G., Batterham, M., Healey, L., O’Connor, C.C. 
(2017). Can patients and their caregivers boost identification of HIV associated 
neurocognitive disorder (HAND)? The Australian Journal of Advanced Nursing, 
34(3), 24-33. 
Cummins, D., Waters, D., Aggar, C., Fethney, J., Crawford, D., O’Connor, CC. 
(2018).  Voices from Australia– concerns about HIV associated Neurocognitive 
Disorder. AIDS Care, 30(5), 609-617. doi: 10.1080/09540121.2018.1426826 
Cummins, D., Waters, D., Aggar, C., O’Connor, CC. (2018). Poor communication 
could have a negative impact on care provided by integrated HIV community teams.  
Journal of Advanced Nursing, 74(6), 1342-1348. doi: 10.1111/jan.13533.  
Cummins, D., Waters, D., Aggar, C., O’Connor, CC. (2018). Assessing risk of HIV 
associated neurocognitive disorder: a modified Delphi study. Nursing Research, Aug 
2. doi: 10.1097/NNR.0000000000000312. [Epub ahead of print] 
 
The final chapter (Chapter 8) presents a summary of findings, discussing conclusions, 
recommendations and suggestions for further research directions for improving the 
diagnosis and treatment of HAND for PLHIV. Chapter 8 also outlines plans for the 
translation of the findings of this thesis into clinical practice – a major inspiration for 
this thesis.  
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ACRONYMS AND ABBREVIATIONS 
 
 
ANI:   Asymptomatic neurocognitive impairment 
cART:  Combined antiretroviral therapy 
CNS:  Central nervous system  
CNS CPE: Central nervous system penetration effectiveness rank 
HAD:  HIV associated dementia 
HAND:  HIV associated neurocognitive disorder 
HIV:   Human immunodeficiency virus 
LGBTI: Lesbian, Gay, Bisexual, Transgender and Intersex  
MND:   Mild neurocognitive disorder 
NSW:   New South Wales 
PLHIV: People/persons living with HIV  
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CHAPTER ONE 
 
HIV associated neurocognitive disorder 
 
Background 
This chapter provides an historical overview of Human Immunodeficiency Virus 
(HIV), the Australian experience of the HIV epidemic from the 1980’s, and the 
clinical presentations and current classification criteria relating to HIV associated 
cognitive impairment. The purpose of this chapter is to illustrate the significance of 
the history of HIV and dementia in relation to the development of services for people 
living with HIV associated neurocognitive disorders (HAND) in Sydney NSW, 
Australia, as experienced by the candidate, a community HIV nurse specialist. This 
chapter will also summarise contemporary literature justifying reasons for screening 
and diagnosing HAND, and define terms used within this thesis in the context of 
Australian healthcare.  
1.1  INTRODUCTION 
The Human immunodeficiency virus (HIV) enters the central nervous system (CNS) 
in the first hours of infection and remains present throughout the infection (Al-Jabri, 
2003). HIV can cause depletion of the immune system leading to acquired immune 
deficiency syndrome (AIDS) (Boasso, Shearer, & Chougnet, 2009). The history of 
HIV and AIDS begins in the early 1980’s when doctors in the United States of 
America became aware of a new illness among a small number of homosexual men 
(CDC, 1981; CDC, 1982).  Since then, more than seventy million people have been 
infected, and the HIV epidemic has been the cause of death for about 35 million 
people globally (WHO, 2017). The burden of the epidemic varies between countries 
and regions, and outcomes are influenced by having access to antiretroviral drugs 
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used to treat HIV since the late 1980s (Gayle & Hill, 2001; Mondal & Shitan, 2013). 
There are currently an estimated 36 million people living with HIV (PLHIV) globally 
(WHO, 2017), with around 26,444 thought to be living in Australia, and 
approximately 11% (2796) of these being unaware of their HIV status (Kirby 
Institute, 2017). For the more than 26,000 PLHIV in Australia in 2016, an estimated 
89% were aware they had contracted the disease and a further estimated 86% had 
been prescribed antiretroviral drugs, with an expected 93% achieving viral 
suppression (Kirby Institute, 2017).  
With HIV antiretroviral therapy having a substantial impact on morbidity and 
mortality, HIV infection is now seen as a chronic manageable disease (Deeks, Levin 
& Havlir, 2013; Degroote et al., 2013). People living with HIV are an ageing 
population with increasing numbers over 50 years of age and at risk of additional co-
morbid conditions (Blaylock & Wortmann, 2015). Cognitive impairment is the most 
common CNS complication for PLHIV (Antinori et al., 2007) as the CNS acts as a 
reservoir for HIV, with neuronal damage occurring from the time of the initial 
infection (Nabha, Duong, & Timpone, 2013). As PLHIV age, they are at risk of 
developing neurocognitive impairment, regardless of immune system recovery and 
suppression of HIV viral load (Coban et al., 2017).  
 
Many PLHIV have mild signs and symptoms of HAND but as they age, may also 
have other co-morbid conditions that can cause cognitive changes. The identification 
and diagnosis of cognitive impairment is complex and multifactorial and 
consequently, the diagnosis of HAND is often by exclusion (Nabha, et al., 2013). 
There are non-HIV related causes of cognitive impairment and other medical 
conditions which can confound a diagnosis of HAND, and these need to be eliminated 
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in clinical assessment whilst additionally managing the person’s health in the wider 
context of their disease (Bloch et al., 2016).  
As PLHIV are at risk of HAND as they age, it is important to recognise the signs and 
symptoms of HAND, to refer to early medical review for diagnosis and treatment 
whilst also treating other conditions that may impact cognition. HAND can 
significantly impact the quality of life of people living with HIV (Tozzi et al., 2004; 
Trepanier et al, 2005), for example, HAND may contribute to less than optimal 
medication adherence whereby non-adherence to antiretroviral drugs can lead to poor 
health (Vivithanaporn et al., 2010). Early intervention is paramount (Parsons, Braaten, 
Hall, & Robertson, 2006) as HAND is a potentially treatable condition by prescribing 
HIV antiretroviral drugs which have enhanced infiltration of the blood brain barrier 
(Letendre et al., 2008; Wright, 2011). 
Informal caregivers may be well placed to notice subtle behavioural or cognitive 
changes whilst providing support to PLHIV who may not themselves notice or 
attribute mild cognitive changes to HAND (Blackstone et al., 2012). For those PLHIV 
who live alone and/or do not have the support of an informal caregiver, a professional 
caregiver may be in the best position to observe changes in cognition whilst providing 
regular clinical care and support. This is especially true for those professional 
caregivers who work in the community setting and are in the unique position to 
observe behaviour changes while the PLHIV undertakes activities of daily living, or if 
there are any changes in the home environment. Therefore, the personal experience of 
PLHIV, as well as the experience of their informal and professional caregivers, could 
make essential and important contributions to reducing the complexity associated 
with identifying HAND and instigating early management of this condition. 
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1.2  HUMAN IMMUNODEFICIENCY VIRUS  
The human immunodeficiency virus (HIV) is a retrovirus which causes immune 
deficiency and leads to acquired immune deficiency syndrome (AIDS), the advanced 
stage of HIV infection (Sharp & Hahn, 2011; Simon, Ho, & Karim, 2006). There is 
no cure for HIV infection.  HIV attacks the body’s immune system, specifically the 
CD4+ T lymphocytes, which help the immune system fight off infections (Simon, et 
al., 2006; Sharp & Hahn, 2011). Over time, HIV can destroy cells in the immune 
system, making the person susceptible to infections and other diseases such as some 
cancers (Moore, 2011; Simon, et al., 2006). Without treatment to maintain the 
immune system and reduce HIV viral load, most PLHIV will eventually become ill 
and die from their HIV infection (Sharp & Hahn, 2011; Simon, et al., 2006). 
 
1.3  HIV INFECTION AND THE CENTRAL NERVOUS SYSTEM  
 The CNS acts as a reservoir for HIV with neuronal damage occurring both at the time 
of initial HIV infection and chronically, as HIV may remain latent in the brain for 
many years (Nabha et al., 2013; Skinner, Adewale, DeBlock, Gill & Power, 2009). 
Neuroimaging studies have observed reduced cortical thickness among PLHIV 
particularly in the premotor cortex, primary sensory, motor cortices and visual cortex 
(Reger, Welsh, Razani, Martin, & Boone, 2002). HIV brain changes are not restricted 
to the cortical areas; global reductions in white matter integrity and basal ganglia 
atrophy are seen. Clinically, this affects motor function, executive function, memory 
and visuospatial function (Reger, et al., 2002). 
 
Dementia has become the leading cause of disability in Australians aged 65 and older 
and is rapidly growing into an area of major disease burden (Australian Institute of 
Health and Welfare, 2016). It has been noted that PLHIV may experience accelerated 
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ageing with dementia prevalence occurring in this population at a younger age when 
compared to the general community (Cohen, Seider & Navia, 2015; Letendre, 2011). 
HIV causes premature cognitive change (Cohen, et al., 2015; Letendre, 2011), 
possibly due to chronic inflammation, immune senescence, metabolic disorders and 
cardiovascular risk factors (Canizares et al., 2014; Soontornniyomkij et al., 2012). 
Additionally there is potential neurotoxicity from antiretroviral drugs (Underwood, 
Robertson, & Winston, 2015; Tedaldi, Minniti, & Fischer, 2015).  
 
1.3.1  Early definitions of HIV related brain disorders 
After the first reports of AIDS in the early days of the HIV epidemic it was observed 
that PLHIV manifested complications affecting the central and/or peripheral nervous 
system. Levy, Bredesen & Rosenblum (1985) reviewed a 5-year period from 1979 to 
1984 and found that 124 of 315 people in their study (39%) had neurological 
symptoms.  In 1983, Snider et al. found from 50 patients with AIDS and nervous 
system disease, 18 had experienced a subacute encephalitis which was attributed to 
cytomegalovirus infection. These authors coined the term ‘subacute encephalitis’ 
whereby there was evidence of progressive encephalopathy in the absence of other 
pathogens resulting from HIV. Around this time, Ho et al. (1985) isolated HIV in 
neurological tissue and cerebrospinal fluid from the autopsies of 24 of 33 patients 
with neurological symptoms.   
 
Navia, Jordan and Price (1986) found that the most frequently recurring neurological 
complication associated with AIDS was subacute encephalitis. Motor symptoms were 
present in 45% of 44 participants in this study; presenting as ataxia, loss of balance, 
increased risk of falls and deterioration in hand writing. Headache was common, and 
seizures also occurred (Navia et al., 1986). Regardless of moderate deficits, such as 
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the presence of neurological symptoms and deficits in at least two areas (behaviour, 
memory and motor), study participants were still able to maintain limited 
independence, capable of performing activities of daily living. Progression of disease 
was often characterised by sudden acceleration and mental decline following a 
systemic illness such as aspiration pneumonia or opportunistic infection (Navia et al., 
1986). With severe deficits, participants developed global cognitive impairment 
associated with dementia, severe disability and incontinence, with a poor prognosis of 
up to six months before death – usually requiring nursing care (Hilton, 1989; Navia et 
al., 1986). Other clinical manifestations observed among PLHIV were vague 
generalised complaints of withdrawal, apathy, depression, irritability and emotional 
lability, with some individuals reportedly losing interest in social activities and 
experiencing loss of emotional responsiveness (Buhrich & Cooper, 1987; Buhrich & 
O’Mullane, 1992).  
 
In 1987, the term ‘AIDS Dementia Complex’ was introduced by Navia and Price 
(1987) to emphasise that AIDS dementia was associated with motor deficits and 
recognising that neurological impairments may be the early and only evidence of HIV 
infection.  A year later the term ‘HIV encephalopathy’ was used to describe what 
Levy & Bresden (1988) determined was the commonest neurological complication of 
AIDS. As many terms were being used interchangeably to describe HIV 
manifestation in the CNS, the American Academy of Neurology AIDS Task Force 
published criteria for HIV associated dementia in 1991 to facilitate a consensus on 
terminology (Jannssen, Cornblad et al., 1991). The current criteria are known as the 
Frascati Classification Criteria and were published in 2007 (Antinori et al, 2007) and 
are described in Section 1.5 below.  
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1.4  HIV ANTIRETROVIRAL DRUGS 
The first antiretroviral drug Zidovudine or AZT became available in 1987 (Fischl et 
al., 1990; Hamilton et al., 1992). At this time, there was limited evidence that AZT 
could reverse some types of neurological disease however, those patients withdrawn 
from therapy showed rapid neurological deterioration (Yarchoan et al., 1988). By the 
early to mid-1990’s other pharmacological agents were being developed and were 
being used in combinations (combined antiretroviral therapy or cART) that led to a 
profound improvement in HIV/AIDS progression and a decrease in morbidity and 
mortality related to HIV infection (Palella et al., 1998). Currently, combined 
formulations containing two or more HIV medications from one or more drug classes 
are offered as a single dose tablet from the time of HIV diagnosis. 
 
There are now more than twenty antiretroviral drugs approved by the US Food and 
Drug Administration and treatment with cART now recommended for everyone with 
HIV. PLHIV take a combination of HIV medicines every day with initial treatment 
regimens generally including three HIV medicines from at least two different drug 
classes. The classes are: nucleoside reverse transcriptase inhibitors (NRTIs); non-
nucleoside reverse transcriptase inhibitors (NNRTIs); protease inhibitors (PIs); fusion 
inhibitors; CCR5 antagonists; integrase inhibitors and pharmacokinetic enhancers 
(used to increase the effectiveness of an HIV medicine included in an HIV regimen) 
(US Department of Health and Human Services, 2017).  
 
Potent antiviral drugs target multiple steps in the HIV lifecycle and inhibit HIV 
enzymes and proteins such as reverse transcriptase and viral protease. Treatment has 
resulted in virological suppression of HIV (as seen in reduced HIV viral load results), 
preserved immune function or restoration of immune function, and decreased risk of 
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opportunistic infections. Although improvements in morbidity and mortality have 
been profound for PLHIV, antiretroviral drugs also have side effect profiles such as 
lipodystrophy, pancreatitis and raised lactic acid (Gebo, 2006); increased risk of heart 
disease (Deeks & Phillips, 2009); metabolic syndrome (Kirk & Goetz, 2009) and; 
liver toxicity (Gebo, 2006). 
 
Pre cART, the neurological prognosis of PLHIV was poor and many developed HIV 
associated dementia, often dying within six months of diagnosis. As more 
sophisticated combinations of antiretroviral drugs became available, survival time 
after a diagnosis of AIDS dementia complex increased from a mean of six months to 
48 months (Navia et al., 1986). Improvements in survival and quality of life continue 
as more antiretroviral drugs are developed and the beneficial effects of these drugs are 
amplified when given in combination (Al-Khindi, Zakzanis, & van Gorp, 2011).   
 
The National Institute of Mental Health and the National Institute of Neurological 
Diseases and Stroke conducted a study called the CNS HIV Antiretroviral Therapy 
Effects Research (CHARTER) study.  This study was the first to explore to examine a 
diverse group of people from several HIV treatment centres to ascertain the frequency 
and severity of HAND in the US (Antinori et al., 2007; Heaton et al., 2011). The 
CHARTER study recruited 1555 HIV-positive people from university-associated 
clinics in Baltimore, New York, San Diego, Galveston, Seattle, and St. Louis.  These 
clients underwent regular medical check-ups and measurement of their CD4+ T cell 
count and HIV viral load in blood. Most CHARTER participants (1205 or 77.5%) 
also agreed to have their HIV viral load measured in spinal fluid. All had extensive 
neuropsychological testing and psychiatric interviews to assess for depression and 
other mental illnesses (Heaton et al., 2011; Kamminga Cysique, Lu, Batchelor, & 
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Brew, 2013). The CHARTER study reported a significant reduction in the prevalence 
of motor impairments since the introduction of cART, possibly attributable to the 
ability of combined therapies to normalise CD4+ T cell count (Heaton et al., 2011). 
The study also reported that for some PLHIV, the integrity of the immune system 
appears to be linked to cognitive outcome, as executive function, motor function and 
visuospatial function was correlated with improved CD4+ T cell count in participants 
(Heaton et al., 2010). 
 
1.4.1 NeuroART and CNS Penetration-Effectiveness (CPE) Rank  
The term neuroART (Wright, 2011) describes a range of antiretroviral drugs which 
also in combination have been shown to have improved penetration in the CNS. 
These drugs have been identified as being more neurologically active as these drugs 
are able to reduce cerebrospinal HIV viral load to an undetectable level.  
 
NeuroART drugs are known to have improved penetration across the blood brain 
barrier and once an individual is diagnosed with HAND they may be prescribed one 
of these agents as part of their medication regimen. Letendre et al. (2008) developed a 
ranking system for the penetration of antiretroviral drugs based on the chemical 
characteristics of HIV drugs, cerebrospinal fluid pharmacology and effectiveness in 
the CNS. Antiretroviral drugs were classified into three categories with each drug 
assigned a rank based on penetration (0 = lowest penetration, 0.5+ = intermediate 
penetration, 1+ = highest penetration) (Letendre et al., 2008). An antiretroviral drug 
was allocated to the lowest penetration category if concentrations of the drug were not 
measurable in the cerebrospinal fluid (Letendre et al., 2008). The CNS Penetration-
Effectiveness (CPE) rank was then determined by summing the individual penetration 
ranks for each antiretroviral drug in a treatment regime. Therefore, a medication 
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regime score can be calculated to ascertain the CPE of all antiretroviral drugs 
prescribed to an individual PLHIV. As a score less than seven is deemed inadequate 
for effective CNS penetration, a person diagnosed with HAND would commonly 
have their medications adjusted to achieve a CPE of seven or greater for optimal CNS 
penetration (Letendre et al., 2008).   
 
However, while some PLHIV will improve once prescribed antiretroviral drugs with 
higher CNS penetration, the condition of others will remain unchanged, or deteriorate 
(Nightingale et al., 2014). CNS neurologic complications can still occur, with 20% of 
PLHIV developing HAND regardless of optimal therapy and virological suppression 
(Coban et al., 2017). The efficacy of antiretroviral drugs in reducing HIV related 
cognitive impairment therefore remains unclear (Tozzi et al., 2007). Consequently, 
evidence for the continued use of the CPE rank in clinical practice is mixed. Some 
clinicians take the CPE score into consideration (particularly in patients with 
symptomatic CNS disease) because higher CPE scores have been associated with 
lower cerebrospinal fluid viral loads. However, the CPE score itself is limited by its 
categorical scoring, unclear weighting of each criterion (pharmacokinetic and 
chemical properties), and lack of consideration of toxic effects or drug interactions 
(Nightingale et al., 2014).   
 
Despite mixed evidence, others have shown successful outcomes among PLHIV if 
signs and symptoms associated with HAND are recognised early and treated. Results 
from the CHARTER study showed that at least 50% of PLHIV with HAND 
prescribed antiretroviral medication with higher CNS penetration experienced 
improvement in neuropsychological performance (Letendre et al., 2004; Smurzynski 
et al., 2011).  This can occur within twelve weeks of treatment and improvements can 
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continue from baseline for up to eighteen months (Gates et al., 2016; Cysique et al., 
2009).   
 
Regardless of what regimen of cART is prescribed, the single most important 
intervention in managing cognitive impairment in the presence of co-morbidities is to 
ensure that the PLHIV remains adherent to treatment in order to maintain viral 
suppression of HIV RNA in the plasma. Monitoring medication adherence and 
management through assistance with procuring prescriptions and arranging 
attendance at medical appointments is just one area that informal and professional 
caregivers can greatly assist those PLHIV experiencing changes in cognition.  
 
1.5  THE FRASCATI CLASSIFICATION CRITERIA  
Following increased access to cART in the 1990’s, diagnoses of neurological 
conditions such as HIV associated dementia started to decrease, however, recognition 
of the milder forms of cognitive impairment increased (Antinori et al., 2007). In 
response, the nomenclature adopted by the American Academy of Neurology Task 
Force on AIDS in 1991 was updated in 2007 to reflect changes in clinical 
presentations and acknowledge the emerging research relating to HIV cognitive 
impairment.  The Frascati Classification Criteria (Antinori et al., 2007) proposes that 
the umbrella term, HIV Associated Neurocognitive Disorder, abbreviated as HAND, 
is now used to describe three categories of changes in cognition in PLHIV:  
1. asymptomatic neurocognitive impairment (ANI); 
2. mild neurocognitive disorder (MND), and;  
3. HIV-associated dementia (HAD).  
 
 
12 
 
Each category has varying degrees of disability related to impact on daily functioning, 
quality of life and experience. 
 
1.6  HIV ASSOCIATED NEUROCOGNITIVE DISORDER (HAND) 
HIV associated neurocognitive disorder (HAND) refers to a spectrum of 
neurocognitive impairment and dysfunction, which can cause varied levels of 
disability in an individual.  As noted above, the Frascati Classification Criteria refers 
to three categories of disability associated with HAND. 
 
HIV associated neurocognitive disorder is diagnosed using neuropsychological 
testing, assessment of functional status and and/or radiology tests (Antinori et al., 
2007). The majority of PLHIV with a diagnosis of HAND in the cART era do not 
present with HAD, and comprehensive neuropsychological assessment is required to 
recognise ANI and MND. These milder forms of HIV related neurological disorder 
can persist over time (milder memory problems and slowness, difficulties in 
concentration, planning and multitasking) and can represent substantial personal, 
societal and economic burden. Some authors have suggested that up to half of the 
participants in their studies may be affected by these milder forms of HAND (Heaton 
et al., 2010; Skinner et al., 2009).  
 
In the CHARTER study described earlier (Antinori et al., 2007; Heaton et al., 2011), 
the prevalence of asymptomatic neurocognitive impairment (ANI) among the 1555 
HIV-positive participants was 30-35% and was characterised by at least mild 
neurocognitive impairment in two domains (at least 1.0 standard deviation (SD) 
below the mean for age-education-appropriate norms).  Individuals exhibited 
impairment in two or more ability domains such as attention, working memory, 
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abstract reasoning, executive function, processing speed or visuospatial processing 
(Antinori et al., 2007). Mild effects on everyday function was not experienced by 
people with a diagnosis of ANI. The CHARTER study also found that the relative risk 
of performance decline in those with ANI was more than five times higher compared 
to those with normal testing. But although those with ANI may be at greater risk of 
cognitive decline, it is unclear how clinically meaningful this will be (Heaton et al., 
2011). 
 
Similarly, the prevalence of mild neurocognitive disorder (MND) for PLHIV 
participating in the CHARTER study was 25-25% and was characterised by 
impairment in at least two domains (at least 1.0 SD below the mean for age-
education- appropriate norms). Those with MND experienced mild negative effects 
on at least two types of everyday functioning (Antinori et al., 2007).  This resulted in 
mild changes to daily function, including the ability to perform activates of daily 
living, work performance and social engagement (Antinori et al., 2007).    
 
The prevalence of HIV associated dementia (HAD) in the CHARTER study was 2-
3%, with moderate to severe impairments in neurocognitive functioning in multiple 
domains (2.0 SD or greater than demographically corrected means) (Heaton et al., 
2010). Participants with HAD were therefore below average in two cognitive domains 
such as memory and executive function, slowed information processing, and defective 
attention and concentration, with marked difficulty in everyday functioning impacting 
on independent living and often requiring full time care (Antinori et al., 2007; Heaton 
et al., 2010). HAD may therefore place an increasing additional burden on resources 
in Australia, especially as PLHIV age. The annual cost for the care of HAD is 
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estimated to increase from about AU$29 million in 2009 to AU$53 Million by 2030 
(Cysique, Bain, Brew & Murray, 2011).  
 
Overall, the prevalence of HAND in HIV infected adults living in the US and based 
on the 2007 Frascati Classification Criteria is approximately 50-60% (Heaton et al., 
2010). If not treated early, milder forms of HAND have been found to be a risk factor 
for developing HAD (Kamminga et al., 2013). There is also a greater chance of 
developing future cognitive difficulties as PLHIV age (Coban et al., 2017). Early 
detection is important to minimise progression of ANI and MND to HAD (Kamminga 
et al., 2013; Heaton et al., 2010; Lu, Brew, Siefried, Draper, & Cysique, 2014). In 
addition, if MND is identified and treated early, outcomes for PLHIV could be 
improved with reduction in symptoms, maintenance of medication adherence and 
independent living, and delayed disease progression (Cysique et al., 2009).  
 
1.6.1  Signs and Symptoms of HAND 
Table 1.1 outlines a range of common signs and symptoms of HAND related to the 
affected area of function. Cognitive changes attributable to HAND such as slowing of 
psychomotor skills, changes in language, memory and concentration (Barber et al., 
2014; Ghate, 2012) can be mild and may be normalized by PLHIV (Antinori et al., 
2007; Gisslen, Price & Nilsson, 2011; Cummins, 2014). In addition, executive 
function can also be affected whereby the person may experience changes in their 
ability to plan, organise and to solve complex or new problems (Antinori et al., 2007; 
Gisslen et al., 2011). Social engagement may also be affected as the person may 
become labile or disinhibited (Corr, personal communication, September 7, 2016). 
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Changes in behaviour may be attributed by the PLHIV and/or their informal caregiver 
to morbidity associated with ageing or other things such as being busy or stressed. 
Caregivers may notice changes in cognition or behaviour that the PLHIV may not, 
such as tiredness and irritability (Murray et al., 2015). These changes may affect the 
person’s ability to perform activities of daily living such as preparing meals, driving, 
managing finances or remembering doctor’s appointments. A person’s social 
relationships and the ability to retain employment, or work at a higher level, can also 
be affected. Negative effects on medication adherence may also impact health, 
wellbeing and quality of life (Osowiecki et al., 2000; Heaton et al., 2004; Letendre et 
al., 2008).  
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Table 1.1: Functional areas affected by HAND  
Area affected Common Signs and Symptoms 
 
Motor skill 
 
Increasing fatigue 
Unsteady gait 
Increased clumsiness 
Fine motor coordination 
Slowed motor speed 
Driving deficits 
Difficulty typing, texting 
 
 
Memory 
Forgetting dates (e.g. birthdays), where placed keys, phone 
Memory affecting cooking and shopping 
Missing appointments and medications 
Forgetting to send emails and issues for meetings 
 
 
Concentration 
How the person becomes receptive to stimuli and how he or she begins to process 
information. Problems include: 
Difficulty taking simple information and following directions 
Difficulty keeping track of conversations 
May have to re-read things 
Difficulty completing activities 
Difficulty following plots of movies and books 
Becoming mentally fatigued easily 
 
 
Behavioural (social) 
change 
The person can experience one of two areas of behaviour change: 
Apathy and listlessness 
    Withdrawal 
    Lack of motivation 
    Impulsivity and disinhibition2: Hypomania 
Change in personality 
Increased agitation, aggression and irritability (e.g. stealing, swearing, over familiarity) 
Emotional lability 
 
 
Executive function 
The person may experience difficulty in: 
Initiation of a task 
Planning 
Problem-solving 
Cognitive flexibility 
Decision-making 
Concept formation and abstraction 
Judgment, feedback utilisation and monitoring behaviour 
 
Source: Cummins, in ASHM, HIV Management in Australasia, 2017. 
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1.6.2  Predictors of HAND 
There are several risk factors which have been shown to predict HAND and influence 
neurocognitive impairment in PLHIV. Non-HIV-related risk factors such as ageing 
and vascular risk factors such as smoking, hypertension, diabetes, 
hypercholesterolaemia and hyperlipidaemia should all be considered, just as they 
would in the non-HIV population (Letendre et.al., 2009; Petoumenos et al., 2017; 
Rodriguez-Penny et al., 2013; Tedaldi et al.,2015; Valcour et al., 2005). Other non-
HIV factors that can affect cognition and may confound the diagnosis of HAND 
include cardiovascular disease (Wright et al., 2010); drug and alcohol use (Fiala et al., 
2005; Letendre, 2011); and hepatitis C co-infection (Schouten et al., 2012). Fewer 
years of education (Heaton et al., 2010) has also been shown to impact cognition. 
 
The CHARTER study reported that cerebrospinal fluid protein concentrations of >45 
mg/dL was predictive of cognitive decline in PLHIV and may be due to a disruption 
in the blood-brain barrier. A lower estimated glomerular filtration rate (eGFR) was 
also identified as a predictor of cognitive decline. The mechanism of this relationship 
is unclear but could reflect the presence of vascular pathology in the kidney and the 
brain (Heaton et al., 2010). Other (HIV-related) predictors of HAND include: past 
history of AIDS defining CNS disease (Fabiani, Pinto, & Bruschi, 2013); other CNS 
disease (Valcour, Shikuma, Watters, & Sackto, 2004); low CD4+ T cell nadir count 
(Ellis et al., 2011; Heaton et al., 2011); and longer duration of HIV infection (Heaton 
et al., 2010). Additionally, the risk of HAND increases as the CD4+ T cell count 
declines below 350cells/uL and with higher plasma viral load (Bhaskaran et al., 
2008).  
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1.7  A HISTORY OF HIV and HIV DEMENTIA IN SYDNEY, AUSTRALIA 
A range of clinical reports from the beginnings of the HIV epidemic in Sydney, 
Australia are published and available, however, there is minimal published 
information relating to the parallel development of health services during this time. 
The candidate has worked as a nurse clinician in HIV for 25 years. The following is 
therefore a personal reflection and historical account of the development of services 
for PLHIV experiencing change in cognition over this time. This personal perspective 
is given both as background and context for studies conducted for this thesis, with 
personal verbal and written communications used to situate service developments 
within the historical frame. 
 
Support services for PLHIV living in Sydney, the largest city in the state of New 
South Wales (NSW), Australia started to observe what was described as “unusual” 
presentations from the late 1980s (Personal Communication G. Cole, November 7, 
2012). Community nurses and inner city mental health teams started reporting 
hypermania in HIV positive clients who in their view, appeared to be behaving 
“weirdly”. Staff were unsure whether this phenomenon was associated to HIV 
infection; mental health issues or; a non-described pathogenesis in the brain. Some 
health professionals hypothesised that presentations could be due to the (then) new 
anti-HIV drug Zidovudine, as little was known about long term side effects at the time 
(Fischl et al., 1990).   
 
Although there was uncertainty about these unusual presentations, many staff thought 
they were seeing a new form of mental illness, as conventional mental health 
treatments did not appear to normalise symptoms in affected individuals.  
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“We were not sure what the future of this group of patients was. 
Some were homeless and the two services (the homeless service 
and community health in Darlinghurst [inner Sydney]) co-jointly 
provided care for patients and many were being admitted to the 
local psychiatric hospital” (Personal Communication G. Cole, 
October 2, 2012).  
 
By the late 1980’s and early 1990’s, the cognitive impairment associated 
with HIV was variously being described in the local Sydney news sources as:  
“… a fear of disfigurement, dread of pain and dementia, fear of 
abandonment by close friends, the ‘double whammy’ of breaking 
the news to friends and family of being gay and having a terminal 
illness and guilt were psychiatric symptoms common among 
those with HIV” (Maede, 1992, p.4). 
 
Following a review of medical notes from a large inner-Sydney hospital specialising 
in the care of people with HIV, Buhrich and O’Mullane (1992) found that one in four 
patients had a psychiatric admission prior to being diagnosed with HIV and there was 
a disproportionate number of patients with AIDS being admitted to the psychiatric 
department. A high proportion of those were admitted for manic episodes 
characterised by disinhibition, loud talking and sexual promiscuity, with over half 
being referred from the community setting (Buhrich & O’Mullane, 1988).   
  
Patients showed a wide range of psychiatric symptoms and differing presentations, 
although the most common symptoms seen in those with HIV/AIDS were anxiety and 
depression, delusions, hallucinations, and hypomania, both with and without evidence 
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of organic cerebral impairment (Buhrich & O’Mullane, 1988). Schizophrenic-like 
psychoses were reported in some patients showing impaired cognition, while others 
had features of classical mania with evidence of overactivity, over spending, 
grandiosity and insomnia (Buhrich & Cooper, 1987). Hypomanic symptoms, with and 
without evidence of cognitive impairment were also common, particularly in the later 
stages of the illness. However, cognitive impairment was often not recognised until 
the hypomania symptoms abated. A substantial number presented with delirium or 
AIDS dementia complex, and in those individuals, behavioural rather than cognitive 
disturbances predominated (Buhrich & O’Mullane, 1988).  
 
Patients were being classified as recommended (at the time) by the United States 
Centre for Disease Control according to dominant psychiatric symptomatology and 
evidence of cognitive impairment (NSW Health, 1993; Buhrich & O’Mullane, 1988). 
But usual management was not appropriate for these patients, and the Diagnostic and 
Statistical Manual of Mental disorders –Revised (DSM3R) criteria for dementia were 
not useful to assess or categorise this group (Buhrich & O’Mullane, 1988). 
 
1.7.1  Admissions to inpatient care 
 
The emergence of HIV related dementia in the late 1980s and early 1990s placed 
enormous pressure on acute care or palliative care beds in Sydney hospitals. 
Furthermore, PLHIV with dementia often maintained physical function so did not ‘fit’ 
within mainstream dementia services tailored to aged persons with dementias, or meet 
age and other admission criteria for nursing home and hostel placements (NSW 
Department of Health, 1994, p.4).  
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The majority of persons with mild to moderate impairment were managed with the 
support of community-based services, volunteers and caregivers in their own home. 
As their physical condition deteriorated, these persons required more intensive 
support. Whilst an inpatient, some required one-on-one or segregated nursing care, 
which was both expensive and contributed to the acute and palliative care inpatient 
bed shortages. Others with moderate to severe AIDS dementia complex were living at 
home, often only partially supervised, and placing volunteer support services such as 
the Community Support Network (a voluntary peer support service which provided 
supports such as shopping, transport and cleaning) under considerable strain (Cotton 
& Whittaker, 1993).   
 
During this period (early 1990s), two large area health services in Sydney were 
experiencing increased admissions of PLHIV with psychiatric symptoms. The Sacred 
Heart Hospice in Darlinghurst (managed by the NSW South Eastern Health Service) 
worked closely with acute care facilities (predominately St Vincent’s Hospital), to 
offer primary care facilities and community services to provide an integrated 
continuum of care for PLHIV. The hospital records note that of 73 consecutive Sacred 
Heart Hospice admissions of PLHIV from October 1991 to April 1992, 51% had 
neuropsychiatric problems ranging from adjustment reactions to active psychosis 
(Sacred Heart Hospice, 1993). Some HIV positive patients had been in long-term 
respite care at the Sacred Heart Hospice for up to a year as no other facility could 
accommodate them at the time as they were too young to be accepted into aged care 
facilities (Sacred Heart Hospice, 1993). Health services in the NSW Central Sydney 
Area Health Service were also affected.  Between 1991 and 1994, Eversleigh Hospital 
in Lewisham admitted 134 people with HIV, and of these, 70 (52%) were diagnosed 
with HIV associated dementia (22 mild, 29 moderate and 12 severe dementia) and 
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seven others had brain disorders (NSW Department of Health, 1994, p4). Blockage of 
acute care beds was becoming a significant problem, with a back-flow of patients 
starting to impact two other large Sydney teaching hospitals, the Royal Prince Alfred 
Hospital and Concord Hospital inpatient and day stay services (NSW Department of 
Health, 1994, p4).  
 
1.7.2  A model of care to reduce inpatient admissions  
The NSW AIDS Bureau Report on Planning for HIV/AIDS Care and Treatment 
Services in New South Wales 1990-1994, recommended that people with AIDS-
related neurological impairment should be managed in the least restrictive 
environment possible, taking into account their level of impairment, available health 
and community resources and the need to ensure the safety of the individual (NSW 
AIDS Bureau, 1990). There was ongoing discussion by the NSW Health department, 
clinicians and HIV positive advocates about the possibility of establishing hostel-type 
unit accommodation within the Sacred Heart Hospice for respite and long term care of 
patients with AIDS dementia complex, as the social and financial cost to the NSW 
health budget was becoming significant. Additionally, poor public knowledge and 
fear of HIV transmission was extensive within the Australian community and 
consequently, many services refused to accept admission of HIV positive patients.  
 
The (then) outgoing Minister of Health, the Honorary Ron Philips who served as a 
Member of Parliament in the NSW Legislative Assembly from 1984 to 1999, 
allocated AU$2 million in one-off funding from the Mark Fitzpatrick Trust to 
establish more appropriate care for those with HIV related dementia. Mark Fitzpatrick 
had medically acquired HIV through treatment for haemophilia and had died when he 
was 10 years old.  Several proposals were submitted to the NSW Department of 
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Health to establish new models of care, with the now experienced Central Sydney and 
South Eastern Area Health Services collaborating to develop a single proposal for a 
state-wide solution to provide care for affected individuals across the state of NSW 
(Eastern Sydney Area Health Service, 1994; NSW Department of Health, 1994).  
 
Two key models of care were proposed: The first was to establish residential 
accommodation to combat the bed blockage situation at several acute inpatient 
facilities; and the second was to establish a community based care model. A house 
was procured in the inner west of Sydney (named “The Bridge”) to accommodate and 
provide 24 hour nursing care to those with AIDS dementia complex.  Following this, 
the AIDS Dementia and Psychiatry HIV Team (ADAPHT) was established as a state-
wide public health service for residents of NSW who had HIV-related cognitive 
impairment and complex needs such as mental illness, drug and alcohol dependence 
and other medical conditions (NSW Health, 2008). In March 1995, a single referral 
path was established for both services to offer an integrated program, with ADAHPT 
providing frontline community outreach with professional consultation, education and 
support throughout NSW, working with local area health services in the development 
of relevant resources and education. Consultation and co-case management was 
provided to assist with diagnosis, engagement plans or the organisation of appropriate 
services. All PLHIV who were referred to the outreach team were allocated a case 
manager. 
 
The focus of support provided by ADAPHT has adapted over time to reflect changes 
in HIV presentation and outcomes for HIV associative cognitive disorder (HAND). 
Currently this service (ADAPHT) offers integrated HIV care including: case 
management for medical and psychosocial issues, neuropsychological assessment and 
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access to HIV supported accommodation. They also connect HIV positive prisoners 
to supports on discharge through the Persons in Custody program, and other HIV 
positive individuals who have alcohol and other drug dependence to the Alcohol and 
Other Drugs (AOD) Integrated Care Program. ADAPHT case managers and 
psychologists travel to visit individuals, regardless of where they live in NSW and 
“The Bridge” facility has moved to a larger property with capacity for 22 residents 
(NSW Health, 2008).  
 
Community based services have also adapted over time. The Central Sydney Area 
Health Service established a Clinical Nurse Consultant (CNC) position for HIV/AIDS 
care in 1990 to reflect the needs of the community and to support generalist 
community nurses who were already caring for people with AIDS dementia complex. 
The candidate is the current CNC and has worked in this service for 21 years.  In 
1996, a community based HIV allied health team was established to work in 
partnership with community nurses to provide holistic community services to PLHIV 
who lived within the Central Sydney Area Health Service boundaries. Social workers 
and dietitians were the first allied health disciplines to be employed and later an 
occupational therapist and physiotherapist joined the team. Later, an additional mental 
health/HIV CNC position was established to reflect the evolving needs of PLHIV in 
the community. Today both CNC positions provide expert HIV information, clinical 
care in the home, liaison with inpatient facilities, and work closely with community 
general practitioners. The South Eastern and Illawarra Area Health Service 
established a similar community HIV outreach Team in 2007. This specialist 
multidisciplinary team is made up of social workers, mental health and primary health 
nurses, a dietitian and an occupational therapist. 
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1.8  THE CASE FOR SCREENING FOR HAND 
In the current era of combined antiretroviral therapy (cART), the majority of PLHIV 
with HAND do not present with HAD but with the earlier stages of cognitive 
impairment (ANI and MND).  Identification is difficult (Elbirt et al., 2015) as these 
milder forms of HAND are subtle and are diagnosed only by neuropsychological 
testing and/or neuroimaging studies (Kamminga et al., 2013). Screening tools may 
therefore assist in determining which PLHIV should undergo formal 
neuropsychological testing, as even mild forms of HAND are associated with 
increased risk of morbidity and mortality in younger PLHIV (Skinner et al., 2009; 
Tozzi et al., 2003). Additionally, early detection is important to minimise progression 
of ANI and MND to HAD (Kamminga et al., 2013). With early recognition of MND 
there are opportunities to treat the person and some evidence that their signs and 
symptoms may improve (Alzheimer’s Australia, 2014; Cysique et al., 2009). For 
some individuals, there is a direct correlation between cognitive improvement and 
enhanced CD4+ T cell counts due to the early administration of antiretroviral drugs 
that cross the blood brain barrier (Heaton et al., 2011; Letendre, Ellis, Ances, & 
McCutchan, 2010). Additionally, lack of knowledge of risk factors, poor 
documentation of discussion during medical and patient consultations (Cummins, 
Trotter & Murray, 2014) and difficulty locating patient information in electronic 
health records (Cummins, Waters, Aggar & O’Connor, 2015) all contribute to 
possible delays in the early identification of risk of HAND in PLHIV.  
 
1.8.1 Diagnostic Biomarkers 
 
There are currently three biomarkers for HAND which may have confirmatory value 
in clinical practice. For PLHIV who are not currently taking cART, the CD4+ T cell 
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count is used. If the person is currently being treated with cART or has failed 
treatment, then the CD4+ T cell nadir can be used and; if the CD4+T cell count is 
above 200/mm3, a diagnosis of HAD is described as doubtful (Brew & Letendre, 
2008; Brew & Chan, 2014). Additionally, cerebral spinal fluid protein and cerebral 
spinal fluid HIV RNA (above 50 copies/ml) are almost always raised in those with 
HAD. Other biomarkers that could be useful for exclusion diagnosis include B12, red 
cell folate and thyroid function (Brew & Letendre, 2008). 
 
Currently however, there is no one clear biomarker to diagnose HIV brain disease 
(Abasi et al., 2016; Atluri, Kurapati, Samikkannu, & Nair, 2014; Gisslen et al., 2011) 
and signs and symptoms, which can be mild, may be normalized by the HIV positive 
individual (Antinori et al., 2007). Development of key biomarkers could be helpful in 
diagnosing HAND as biomarkers could predict the presence and severity of HIV 
brain disease and inform treatment options. Additionally, for those PLHIV who are at 
risk of developing other chronic diseases as they age, specific biomarkers could be 
helpful in separating diagnoses of co-morbid conditions which potentially confound 
the diagnosis of HAND including viral hepatitis and vascular disease. A reliable 
marker to assist in the assessment of response to antiretroviral drugs would also be 
useful, as inactive forms of brain disease related to HIV infection may result in 
PLHIV given medications unnecessarily, with additional risk of toxicity.  
 
1.8.2  Neuropsychological testing – the Gold Standard 
The current definitive test for cognitive impairment in PLHIV is neuropsychological 
assessment. This can confirm diagnosis, monitor the progression of disease and 
functional abilities, and is useful to inform clinical management. In a 
neuropsychological assessment, objective data is obtained via patient review, 
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informant review, record review, behavioural observation and objective tests of 
cognitive, emotional and motor function. Information is also collected on medical and 
social history, including educational level, pre-morbid level of functioning, age, 
ethnicity, and previous and current drug use (Braun et al., 2011). Neuropsychological 
tests include objective manipulation and inspection of responses to pictures, multiple 
choice tests and answers to spoken questions. The tests measure such things as: 
attention and concentration, learning and memory, language and communication, 
visual-spatial cognition and visual-motor praxis, motor and sensory function, adaptive 
behaviour, problem solving and executive function, reasoning and sequencing (Braun 
et al., 2011). Neuropsychological testing is valid and reliable with validity measures 
equalling those reported for neuroimaging (Meyer et al., 2001). Neuropsychological 
examination is the only test currently capable of predicting functional abilities, 
assessing neurocognitive impairment, and measuring cognitive change over time or 
response to treatments (Braun et al., 2011).  
 
1.8.3  Screening tools  
Early neuropsychological screening tests for HAND were designed to focus on sub- 
cortical features targeting information processing, executive function, memory and 
psychomotor speed. This was based on the identification of HIV staining in the 
subcortical and deep grey structures of the brain (Valcour, Paul, Chiao, Wendelken & 
Miller, 2011), possibly explaining the behavioural, motor and predominately 
subcortical features of HIV-related cognitive impairment (Valcour et al., 2011). 
Although memory deficits occur, the pattern of HAND also involves inefficient 
learning and problems with executive function and retrieval of information. These 
features are different to those seen in Alzheimer’s disease where cortical deficits are 
seen more with the encoding of new memories. The motor deficits observed in HIV 
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are not often seen in Alzheimer’s disease but are similar and may be attributed to 
Parkinson’s disease (Valcour et al., 2011).  PLHIV may also need to be assessed for a 
range of other diseases that affect cognition as part of normal ageing (Valcour et al., 
2011; Brew, 2016).  
 
 While several guidelines have made recommendations for screening PLHIV for 
cognitive impairment, recommendations of when and how often to screen are 
inconsistent and consensus has not yet been reached (British HIV Association, 2016; 
European AIDS Clinical Society, 2016). A range of reasons have been proposed for 
clinicians not yet routinely adopting screening (Bloch et al., 2016) including 
competing health issues, limited access to appropriately trained clinicians, limited 
knowledge of the screening tests available and the limitations of the screening tests 
themselves, often only able to identify the most severe form of impairment. The 
American Academy of Neurology recommends increased screening for those with 
mild cognitive impairment (Valcour et al., 2011) and The Mind Exchange Working 
Group (2013) recommends that all PLHIV should be screened for HAND.  In a 
systematic review by Zipursky, et al. (2013), inconsistency of screening was noted, 
with only 16% of studies employing the latest 2007 Frascati HAND classification 
criteria as used in the CHARTER Study.  
 
There are several screening tools currently in use, such as the HIV Dementia Scale, 
International HIV Dementia Scale, and the Cogstate Computerized Battery 
(Kamminga, Lal, Wright, Bloch, Brew, & Cysique, 2017; Muñoz-Moreno et al., 
2013). However, there is currently no single tool that can be used across a full range 
of clinical settings (Chiao et al., 2013). While some tests must be administered by a 
trained clinician, others use computerised technology, requiring further clinical 
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interpretation. Depending on which area of the brain is affected, screening tools may 
be more sensitive to advanced rather than mild signs and symptoms of HAND; have 
limited specificity and sensitivity; or be more appropriate for non-HIV related 
dementias (Kamminga et al., 2017). For example, the Mini Mental State Exam is 
widely used for people with Alzheimer’s disease but should not be used to screen for 
HAND as it is not useful for identifying executive function or motor skills and has 
poor sensitivity to detect the subcortical neuropathology seen in HAND (Valcour et 
al., 2011; Kamminga et al., 2013).  
 
It appears from the literature that the most commonly referenced HIV screening tool 
is the HIV Dementia Scale (HDS) which provides rapid assessment of motor skills, 
simple learning and attention (Kamminga et al., 2013). The HDS was validated in a 
predominately white male population in the pre-cART era and so is useful to assess 
for moderate to severe decline in cognition in this type of population (Zipursky et al., 
2013). Otherwise, the performance characteristics of the HDS are modest, with 
acceptable sensitivity for only the most severe disease and only 70% sensitivity for 
detecting mild impairment (Kamminga et al., 2013; Valcour et al., 2011). Therefore, 
the HDS is not a useful test for screening for ANI and MND due to inadequate 
sensitivity and is inappropriate at a time when ANI is the most prevalent form of 
HAND. The International HIV Dementia Scale (IHDS) was developed for global 
settings after studies had shown the HDS to be less accurate in non-white populations 
or in those PLHIV who had mild cognitive deficits (Robinson-Papp, Elliot, & 
Simpson, 2009).  However, pooled sensitivity of several studies demonstrates that the 
IHDS is only moderately useful in detecting HAND and is also not suitable for the 
detection of mild impairment (Zipursky et al., 2013).  
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The Montreal Cognitive Assessment (MCA) was designed to detect mild cognitive 
impairment in the older, general HIV-negative population (Ciesielska et al., 2016). 
While many clinicians use the MCA, it appears to be insufficiently sensitive to detect 
the mild neurocognitive impairment seen with HAND (Janssen, Bosch, Koopmans & 
Kessels, 2015; Milanini et al., 2016) and is unable to accurately monitor change over 
time. The MCA is therefore not suitable to detect cognitive decline in PLHIV, yet 
Chartier et al. (2015) note that it still has the potential to provide some clinically 
meaningful data. A study by Fazeli et al. (2017) further demonstrated good clinical 
sensitivity, supporting use of the MCA as a brief cognitive screening tool among 
older HIV-positive adults.  
 
Other screening instruments to detect milder levels of neurocognitive decline are 
clearly needed (Lu et al., 2014). A computerized test battery, the CogState, assesses 
five relevant cognitive domains sensitive to the detection of HAND and general 
cognitive impairment. The CogState requires minimal skill for administration and 
scoring, but a neuropsychologist should undertake the final interpretation of scores. 
The CogState has been tested for validity in Australia with 254 PLHIV, age and 
education matched to 72 HIV negative controls (Bloch et al., 2016). Fifty-three 
participants and 22 of the control group underwent neuropsychological testing and 
Cogstate screening. Comparison of both groups resulted in a sensitivity of 76% and 
specificity of 71% for Cogstate screening. In the MND/HAD subgroup, the sensitivity 
and specificity improved dramatically to 100% and 98%, respectively. The 
computerized screening method is suitable for application by non-specialists and may 
assist with detecting patients requiring more in-depth neuropsychological testing, 
hence guiding the best use of resources within under-resourced settings (Bloch et al., 
2016).  While the CogState does not improve screening sensitivity for patients with 
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ANI, these individuals could be monitored longitudinally whilst controlling and 
treating alternate risk factors for cognitive decline (Kamminga et al., 2017). Some 
HIV health services and general practices with high HIV caseloads have started to 
adopt this model, with the overall HAND screening prevalence at one community 
medical practice in Sydney reported as high as 31% (Bloch et al., 2016).    
 
Further longitudinal studies are needed to assess the validity of instruments for 
screening all categories of HAND. Thus far, longitudinal decline, as measured with 
repeat assessments of the HIV dementia scale (HDS), was reliable in the retest 
setting; however, similar to CogState, this technique was only able to robustly detect 
moderate to severe cognitive decline (Lu et al., 2014). There is also a need for 
screening tests that are simple for all health practitioners across a range of settings, 
and that can quickly and effectively monitor risk and the effects of treatment over 
time, whilst adhering to HAND Frascati Classification Criteria for relevant and 
universally standardized reporting of results. The outcome of regular screening is also 
important to validate the experience of PLHIV and/or their informal caregivers by 
offering evidence of cognitive change and prompting acceptance of diagnosis and the 
development of appropriate management plans. 
 
1.8.4  Co-morbid medical conditions and HAND 
Co-morbid conditions increase complexity in the diagnosis of HAND and may 
independently contribute to poor neuropsychological performance without actually 
being the cause of HAND (Kamminga et al., 2013; Nightingale et al., 2015). Risk 
factors for general cognitive impairment may also mimic and /or confound the signs 
and symptoms of HAND, therefore the accurate diagnosis of HAND relies on other 
co-morbid conditions and pre-existing causes of dementia or brain injury being 
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excluded (Antorini et al., 2007). As noted above, these may include diabetes, hepatitis 
C infection, hypertension (Rodriguez-Penny et al., 2013; Tedaldi et al., 2015),  
substance use (Elbirt et al., 2015) and cerebrovascular disease (Heaton et al., 2010; 
Tedaldi et al., 2015; Wright et al., 2010).  
 
Further, decreased brain reserves in an ageing HIV seropositive population may be 
the result of several factors, including the synergistic effect of neuropathology related 
to ageing and other age-associated degenerative diseases. Age-associated comorbidity 
may affect physical function in HIV-infected patients and may modify the effect of 
ageing, for example, co-morbid conditions may appear 10 to 20 years earlier in 
PLHIV when compared to the general community (Oursler et al., 2011). The Veterans 
Aging Cohort Study compared HIV-positive veterans to HIV-negative controls and 
noted that PLHIV had a higher rate of co-morbidities at all ages. For those older than 
60 years, the rate of co-morbidities was 63% compared to 12% for HIV–negative 
controls (Oursler et al., 2011). Data from an Australian study conducted by Positive 
Life NSW (2015) also found that for 126 PLHIV responding to a survey, 41% had 
HIV as a single condition, 21% self-reported one additional co-morbid condition; 
14% self-reported two conditions; 10% three; 7% four and; 2% self-reported having 
five or six existing co-morbid conditions. In another recent study, Petoumenos et al. 
(2017) noted no difference in self-reported smoking rates between older PLHIV 
compared to HIV-negative controls, but found that recreational drug used was 
increased in PLHIV who also had increased risk of diabetes, neuropathy and 
thrombosis. The risk of heart disease was not significantly different in this study. 
Deeks and Philips (2009) note that for many PLHIV, HIV is no longer their primary 
health concern as conditions such as cardiovascular disease, diabetes, cancers, 
osteoporosis, cognitive impairment, liver and kidney disease and mental health issues 
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impact their health as they age (Oursler et al., 2011). Any screening tool must 
therefore be able to distinguish specific factors related to HAND among many 
possible competing presentations.   
 
The Frascati Classification Criteria have significantly improved the reliable detection 
of neuropsychological impairment and confounding conditions (Heaton et al., 2010). 
The Frascati Guidelines give instruction for classifying the most common co-morbid 
conditions with respect to whether they should be considered Incidental (conditions 
that have little impact on HIV-related neuropsychological impairment); Contributing 
(conditions that probably affect HIV-related neuropsychological impairment to some 
degree); or Confounding (conditions that make it impossible to say whether HIV 
alone is causing neuropsychological impairment) (Heaton et al., 2010). As an 
example, neurocognitive impairment was seen in 52% (814 of 1555) of all 
CHARTER study participants (Heaton et al., 2010). More than half of the total 
participants (54.2%, n=843) were classified as having incidental co-morbidities and 
30.4% (n=473) had contributing conditions. A further 15.4% (n=239) had 
confounding co-morbidities that precluded a HAND diagnosis. Among those 52% 
(n=814) participants with neurocognitive impairment, co-morbidities were incidental 
in 40%; contributing in 59% and; confounded in 83%.  Impairment was associated 
with AIDS diagnosis, lower nadir CD4+ T cell, but only in the incidental group and 
was consistent with having more advanced HIV disease. When considering the entire 
CHARTER sample without severe co-morbidities (n= 1316) the overall number of 
participants diagnosed with HAND was 32.7% with ANI; 11.7% with MND; and 
2.4% with HAD (Heaton et al., 2010). Predictors of HAND (exclusive of severe co-
morbidities) in the CHARTER study included nadir CD4+ T cell <200, cumulative 
duration of cART treatment, CNS CPE score for current antiretroviral regimen, 
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detectable HIV in plasma (viral load), and hepatitis C sero-status (Heaton et al., 
2010).  
 
In summary, the recognition and treatment of co-factors for cognitive impairment 
could improve cognition in PLHIV and reduce complexity and confounding in the 
diagnosis of HAND. The increased longevity of PLHIV, secondary to treatment with 
antiretroviral drugs, and the relationship between longer HIV infection and several 
chronic conditions, has seen the proportion of deaths attributed to chronic non-
infectious co-morbid conditions increase among this group (Peters et al., 2013). Many 
of the co-morbid conditions, such as diabetes and cardiovascular disease, are 
associated with modifiable risk factors (Klein et al., 2011) and management 
guidelines for HIV recommend regular risk evaluation for these conditions (Peters et 
al., 2013). 
 
1.9  CONCLUSION 
HIV-related neurological presentations in Australia have changed significantly since 
the early days of the HIV epidemic, largely due to access to antiretroviral drugs. But 
similar to PLHIV globally, more than 20% remain at risk of developing a subcortical 
neurodegenerative disease caused by HIV-1, known as HIV neurocognitive disorder 
(HAND) (Clifford & Ances, 2013). HAND can cause various levels of disability, 
impact quality of life, and is associated with increased morbidity and mortality in 
younger PLHIV (Skinner et al., 2009). Cognitive changes attributable to HAND can 
be mild and may become normalized by PLHIV, especially as they age (Gisslen et al., 
2011; Cummins, 2014); these include changes in language, memory, problem solving 
and slowing of psychomotor skills (Barber et al., 2014; Ghate, 2012). Diagnosis is 
multifactorial and can be compromised by the presence of co-morbid conditions. 
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Early identification is important as treatment of HAND offers opportunity for 
improved clinical outcomes and quality of life for PLHIV (Robertson et al., 2007).  
HAND can be diagnosed through neuroimaging, neuropsychological testing and 
cerebrospinal ﬂuid examination but is more often diagnosed by exclusion of other 
causes of changes in cognition. However not all PLHIV will agree to, or have access 
to neuropsychological testing, therefore regular screening is important to identify 
which PLHIV are at risk of HAND to investigate and confirm diagnosis. For those 
PLHIV diagnosed with mild forms of HAND, early identification and treatment could 
prevent progression of neurocognitive disease. Additionally, screening can provide 
baseline information for monitoring the potential for future risk of cognitive decline. 
Screening also offers information leading to the diagnosis of other co-morbid medical 
conditions, which can mimic signs and symptoms of HAND.  Treatment for co-
morbid conditions can be commenced, whilst reassuring the PLHIV they do not have 
a diagnosis of HAND. Screening may also have supplementary benefit in supporting 
medication adherence, which can decline in PLHIV with HAND. This potentially 
enables PLHIV and their caregivers to develop individualised approaches for 
medication management, thus having a positive effect on treatment adherence and 
health outcomes.  
People living with HIV may attribute changes in cognition to morbidity associated 
with ageing, other co morbid conditions, or be unaware of their cognitive decline. 
Personal assessment of everyday function relies on self-insight (Chiao et al., 2013) 
but when impairment is moderate, insight into the self-assessment of everyday 
functioning can be diminished (Blackstone et al., 2012). Informal caregivers are 
generally in a position where they can provide evidence of cognitive changes through 
their observation or daily support of PLHIV. For those PLHIV who live alone and/or 
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do not have the support of an informal caregiver, a professional caregiver may be the 
only other regular contact able to observe changes in cognition whilst providing 
clinical care and support over time. This is especially relevant for professional 
caregivers who provide community based care and who are observing unique 
evidence of changes in the home environment, or behavioural changes while the 
PLHIV undertakes activities of daily living.  
This chapter has provided an overview of cognitive impairment in HIV; historical and 
current models of care provided to PLHIV in Sydney Australia; and has made a case 
for improving screening for HAND. Knowledge of change in cognition, decline in 
daily functions, medical information including co-morbid conditions and social 
circumstances could provide further information to aid the diagnosis of HAND in 
PLHIV. Informal and professional caregivers are well placed to provide some of this 
information, especially as they usually offer clinical care and support to PLHIV in 
their home. The next chapter will discuss aspects of caregiving provided by informal 
and professional caregivers and explore reasons why some PLHIV may not have 
informal support.  
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CHAPTER TWO 
The role of informal and professional caregivers 
 
Background 
Chapter One provided an overview of the historical aspects of cognitive impairment 
and HIV, classification changes resulting from the introduction of the Frascati 
Classification Criteria in 2007 and introduced factors that contribute to the 
complexity of diagnosing HAND in people living with HIV. The aim of Chapter Two is 
to illustrate the significance of support provided by informal and professional 
caregivers to people/persons living with HIV (PLHIV) through a scoping review of 
literature. As literature relating specifically to caregiving in the context of cognitive 
impairment was very limited, the review was expanded to explore who caregivers are, 
what types of support they provide to PLHIV, and why some PLHIV may not have the 
support of an informal caregiver. An argument is made that caregivers, both informal 
and professional, are well placed to recognise early cognitive changes in PLHIV. 
These changes may be mild but indicative and support the early diagnosis of HAND.  
 
2.1 INTRODUCTION 
The psychosocial and health-related consequences of HIV infection continue to 
impact the lives of PLHIV and the support of caregivers remains central to PLHIV 
continuing to maintain their quality of life. Caregivers, both informal and formal 
(usually health professionals), have been shown to have a positive impact on health 
and well-being across a range of conditions (Uchino, 2004), and for PLHIV, 
caregivers may also be the first to notice mild health changes and to encourage and 
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support attendance for early medical review (Decarlo & Folkman, 1997). PLHIV have 
also found the support of caregivers potentially beneficial to enhance communications 
and relationships with health care providers and other services, and to encourage 
adherence to medications (Mosack & Petroll, 2009).  
 
2.1.1  Defining informal and professional caregiving 
The terms most commonly used to describe a person who supports family members or 
friends are caregiver, carer or informal carer. For the purpose of this thesis, informal 
caregivers include: family members, friends, partners and peers (HIV positive 
volunteers), that is, anyone who offers unpaid support and care to a PLHIV.  
 
Carer’s Australia is a not for profit organisation and national peak body representing 
Australia’s unpaid caregivers.  It is estimated that Australia has over 2.7 million 
informal caregivers, almost 12% of the total population (Carer’s Australia, 2016). 
Carer’s Australia (2016 p.1) identifies informal caregivers as “people who provide 
unpaid care and support to family members and friends who have a disability, mental 
illness, chronic condition, terminal illness, an alcohol or other drug issue or who are 
frail aged”. Informal caregivers offer social, emotional and financial support and 
symptom management for the recipient of care, whilst supporting activities of daily 
living; and as such models of care should include caregiver participation where 
appropriate (Zarit & Reamy, 2013). In addition to physical and personal care such as 
showering and dressing, lifting, help with cooking and feeding, informal caregivers 
may also provide transport, medication management, organisation of social and other 
support services and often accompany the person to appointments (Chio et al., 2006). 
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The definition of family may be broad for some PLHIV.  Care and support are largely 
perceived as the role of women – mothers, wives and daughters (Flaskerud & Tabora, 
1998, Wight et al., 1998). The Australian Survey of Disability, Ageing and Carers 
(2015) showed that females represented 68% of primary caregivers and 56% of all 
caregivers. The number of female primary caregivers (134,500) aged between 55-64 
years was almost double the number of male primary caregivers (70,800) (Australian 
Bureau of Statistics, 2015). More daughters live with and care for a frail elderly 
parent than do sons (Ekwall, Sivberg, & Hallberg, 2007) and women are more often 
the primary caregiver to unwell family members (Asuquo, Etowa, & Akpan, 2017; 
Bunting, 2001). Yet for some PLHIV primary caregivers may not come from the 
traditional female caregiving relationship. One of the aims of this literature review is 
to explore who caregivers for PLHIV actually are.  
 
In contrast, professional caregivers are those who receive payment for caregiving 
work, often being employed by a formal service or system such as a government 
health service or non-government organisation (Family Caregiving Alliance, 2014). 
Professional caregivers often include allied health, medical, nursing and community 
support workers. In this thesis, the term community based health care professionals 
refers to any health professional or support worker providing support to PLHIV in a 
community setting. 
 
2.1.2  Supportive communities 
Between the 1940s and 1950s, the term “gay” was used to describe both men and 
women who were attracted to the same sex. In the 1970s, women chose to use the 
term “lesbian” to differentiate themselves from gay men and the acronym LGB 
(lesbian, gay and bisexual) was introduced during the 1980s to include those who 
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identified as bisexual. As Australian society has become more accepting and inclusive 
of diversity, this acronym has expanded to include many orientations. For example, 
the acronym LGBTI (lesbian, gay, bisexual, transgender and/or intersex) has been 
used since the 1990s to describe diverse communities living around the world and has 
more recently been expanded to be inclusive of those identifying as lesbian, gay, 
bisexual, transgender, queer and questioning, intersex and intergender, anonymous 
and allies (LGBTQIA) (Gregg, 2017). In Australia, LGBTI people and populations 
are recognised in a range of Commonwealth Government policies and programs. 
Since 2013, there has been federal protection from both direct and indirect 
discrimination on the basis of sexual orientation, relationships status, gender identity, 
and intersex status, and individuals from these Australian communities are identified 
as a special needs group under the Aged Care Act 1997 (National LGBTI Health 
Alliance).  
 
The National LGBTI Health Alliance acknowledges the limitations of using the 
LGBTI acronym; that identities are far broader than the acronym can comprise such 
as the wide diversity seen with gender, relationships and sexuality. The Alliance also 
acknowledges that the intersection of body, gender, sexuality and relationship 
identities and cultural identity, including indigenous identity, results in self-
determined terminology not encompassed by the LGBTI acronym (National LGBTI 
Health Alliance). With respect to this view, the collective term LGBTI will be used in 
this thesis to encompass all diverse groups referred to above. The LGBTI community 
continue to support PLHIV in many ways and are an important part of the informal 
caregiver community.   
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2.2  INITIAL LITERATURE REVIEW 
The aim of the initial literature review was to determine whether information was 
available about who and what types of support are offered by informal and 
professional caregivers to people/persons living with HIV (PLHIV) who experience 
changes in cognition. The significance of caregivers within this context is their 
potential to be able to recognise early cognitive changes in PLHIV. However, despite 
broad searching across several databases, initially from 1980 to 2012 and updated in 
2018, literature on this topic was extremely limited. Early publications focussed on 
the informal and professional care of PLHIV, and not specifically on the care of those 
experiencing cognitive decline.  
 
The absence of an evidence-base led firstly to a decision to explore the broader 
concept of caregiving within the literature, that is, who are the caregivers providing 
care and support to PLHIV and what are the main supports they provide? The result 
of the preliminary pilot study also established some basic insights and a beginning 
evidence-base about the care and carers of PLHIV experiencing cognitive decline 
(reported in Chapter 4).  
 
2.2.1  Initial search method and keywords 
As little was known about the types of support offered by informal and professional 
caregivers to PLHIV who experience changes in cognition, a scoping review method 
was chosen. Scoping reviews are used for the identification and definition of 
parameters for a study, and for the development of research/search questions 
(Armstrong, Hall, Doyle, & Waters 2011). Initially, three main keywords (HIV, 
dementia, caregivers) were used to search within seven databases (Medline, Embase, 
Pubmed, psycINFO, Cochrane Library Database, PROQUEST and CINAHL) from 
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the period coinciding with the beginning of the HIV epidemic internationally in 1980, 
through to August 2012. Studies were excluded from the review if they were written 
in a language other than English, were not a peer-reviewed original article, and/or the 
mean age of participants was below 18 years.  
 
Despite many publications for single keyword searches, combinations of keywords 
yielded no results (Table 1). The term ‘aids dementia complex’ was added as this term 
was frequently used at the beginning of the HIV epidemic, yielding a total of eight 
papers, however, six of these did not fulfil the initial search criteria (two written by an 
anonymous author, one not in English and the remaining three focussing on patient 
management and caregiver needs more generally).  
 
Table 2.1: Initial keyword search 
 
The three original keywords were then “exploded” and each database was searched 
using the terms:  HIV associated cognitive impairment (including the terms HIV 
encephalitis, subacute encephalitis, HIV associated dementia, HIV dementia, AIDS 
dementia, AIDS dementia complex, HAND, ANI, MND and HAD) separately or in 
combination with keywords related to caregiving (caring, carer, informal carer, formal 
carer and professional care); caregiver; informal caregiver; formal caregiver; and 
professional caregiver. Additionally, the words: family, parent, mother, father, aunt, 
Key search terms Yield Search combinations and result 
1. HIV 92901 1+ 2+ 3 = 0 
2. Dementia 148849 1+ 2 + 4 = 0 
3. Caregivers 31019 1 + 3 + 4 = 0 
4. AIDS dementia complex 3606 3 + 4 = 8  
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uncle, brother, sister, sibling, wife, husband, partner and children (including son and 
daughter) were included as examples of informal caregivers and the words: nurse, 
doctor and allied health professional, including social worker, physiotherapist, 
occupational therapist and dietician as examples of professional caregivers.  
 
Given the continuing lack of relevant literature emerging, types of support for PLHIV 
were then included with all caregiver search terms using the keywords: emotional 
support; practical support; financial support; and medication management. Each of 
those terms were also searched in combination with terms relating to HIV associated 
cognitive impairment as listed above. Using varied combinations of terms elicited no 
articles at all, including searching each individual informal caregiver (mother, father, 
brother, sister, etc.) and professional caregivers (nurse, social worker, doctor etc.) in 
combination with the various terms for AIDS dementia which had changed over time 
with new information from research and use of HIV medications (HIV encephalitis, 
HIV dementia, ANI, MND etc.).  
 
Eventually after using all combinations together, only eight relevant articles could be 
found from a final total of 270 papers (including two from the initial search) that met 
the search criteria (Table 2.1). As previously, articles that were excluded were those 
not written in English, were not peer-reviewed, related to HIV neurology; were about 
the burden of care for caregivers; the stress of providing care; caregiver burnout; 
caring for PLHIV who were dying; caring for children with HIV, or were from a 
developing nations context. An updated search using the same exploded keywords 
and method was performed to capture any additional publications between August 
2012 and May 2018.  Following application of exclusion criteria as previously, this 
updated search resulted in four additional publications (Cummins, 2014; Hopcroft et 
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al., 2013; Murray et al., 2016; Terpstra et al., 2018). These four, in addition to Kelly 
(2010), appear to be the only studies relevant to PLHIV and/or caregiver experience 
of HAND in PLHIV published since the revision of the Frascati Classification 
Criteria in 2007. 
 
2.2.2  Outcome of the initial review  
Despite repeat testing of the significant number of keywords and search term 
combinations within the above databases, the initial (1980 – 2012) and updated search 
(2012 – 2018) revealed a total of only 12 papers published over the past 38 years that 
related directly to caregivers and neurocognitive function in PLHIV. The content of 
these final 12 papers was so varied that attempts to synthesize findings were not 
successful however the combined results are discussed below in 2.2.3. 
  
As identified in Chapter 1, the introduction of the Frascati Classification Criteria in 
2007 was a significant time-point for noting changes in practice in the literature (that 
is, pre and post introduction of HAND classification criteria). It is of note that those 
studies relating to professional caregiving in the period before introduction of the 
Frascati Classification Criteria in 2007 rarely discussed cognitive impairment but 
reflected the historical context of care and treatment of HIV-associated dementia at 
the time, focussing on stress and burnout among professional caregivers (Barbour, 
1994; Lusby, 1985; Macks & Abrams, 1992; Nesbitt, Ross, Sunderland, & Shelp, 
1996; Rinella & Durbin, 1988), particularly in relation to caring for PLHIV in acute 
and palliative care settings (Barbour, 1994; Gueritault-Chalvin, Kalichman, & Denni, 
2000). For caregivers who were HIV-negative, concern about HIV exposure and fear 
of transmission to others was also part of the caregiving literature at this time (Brown 
and Powell-Cope 1991; Prachakul & Grant, 2003). 
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The caregiver literature also revealed discussion of HIV in many other contexts such 
as caregiver burden (Asuquo, Etowa, & Adejumo, 2013; Chandran et al., 2016; Lee, 
Li, Jiraphongsa, & Rotheram-Borus, 2010), grief and loss (Brown & Powell-Cope, 
1993; Folkman, Chesney & Christopher-Richards, 1994), caregiver exhaustion 
(Raveis & Seigel, 1990), caregiver mental health and emotional support (Casale, 
Wild, Cluver,  & Kuo, 2014; Flaskerud, Cater & Lee, 2000; Prachakul, & Grant,  
2003), personal reward (Haviland et al., 1997), caregiving in resource poor settings 
(Kohli et al., 2012; Majumdar, & Mazaleni, 2010), burden and fear of HIV disclosure 
(Baker, Sudit & Liwak, 1998), caring for children with HIV (Casale et al., 2014; 
 Osafo, Knizek, Mugisha,  & Kinyanda, 2017) and barriers to care (Liboro et al., 
2018). While of great importance to the care of PLHIV, contexts of caregiving to 
children; personal experiences of caregiving; or caregiving in resource poor settings 
are not relevant to this thesis and will not be discussed further. However, what is 
relevant to this thesis is the notion of complexity and the repeated finding that 
caregiver burden and grief was multifactorial and complex (Baker et al., 1998). 
 
2.2.3  Results: Caregivers and HIV-related cognitive impairment    
The combined findings of the 12 papers included in the initial and updated review 
revealed that prior to antiretroviral drugs becoming available for the treatment of HIV 
in the early to mid-1990s, and the introduction of the Frascati Classification Criteria 
in 2007, discussion of cognitive symptoms in literature relating to HIV and caregiving 
was rare. Stajduhar (1997) describes the experience of informal caregivers caring for 
PLHIV dying with AIDS dementia, with the burden of caring for people with AIDS 
dementia complex and the development of depression in caregivers discussed by 
Meadows, Le Maréchal & Catalan (1999) and Flaskerud & Lee (2001), respectively. 
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It was often the case in this early literature that the caregiver had become aware that 
their loved one was HIV positive, homosexual, and dying all at the same time.  
 
Other studies published around this time examined the impact of diminishing 
communication between caregivers and those with AIDS dementia complex, noting 
that maintaining quality could enrich quality of life in PLHIV (Morrow, Allen, & 
Campbell, 1997). Others detail the clinical implications of the experience of cognitive 
decline (Morgan, Clark & Hartmann, 1988), and how PLHIV deal with the unknown 
future of AIDS Dementia (Kelly, 2010). A case study from Cripps, Spencer & Clark 
(1994) discusses the complex care needs of a person with an intellectual disability and 
schizophrenia also diagnosed with AIDS dementia. Hilton (1989) discussed nursing 
interventions for supporting informal caregivers, and caring for PLHIV with an acute 
diagnosis of dementia, concluding that nurses could be instrumental in the recognition 
of disease progression. Similarly, in a study preceding candidature, Cummins (2014) 
had utilised a case study approach to describe the community support offered by 
professional caregivers, finding that potential existed for professional caregivers to 
play a greater role in the context of caring for PLHIV who may be at risk of HAND. 
Interestingly, however, Terpstra et al. (2018) reported that there was limited 
discussion about HAND between PLHIV experiencing signs and symptoms of 
cognitive changes and professional caregivers across  three sites included in their 
study (a community-based organization, a community-based HIV specialty hospital, 
and a neuropsychology clinic at a large urban hospital).,  
 
Hopcroft et al. (2013) reflected on the experiences of ageing men with HIV-related 
cognitive changes, noting that support from family and friends was significant as they 
accepted who they were regardless of cognitive change in the PLHIV. While Murray 
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and colleagues (2016) examined whether informal caregivers were observing signs 
and symptoms of decline in cognition in PLHIV, concluding that informal caregivers 
were instrumental in providing additional evidence of changes in cognition 
experienced by PLHIV.   
 
2.3 EXPANDING THE REVIEW 
The aim of the initial literature review was to determine who and what types of 
support are offered by informal and professional caregivers to people/persons living 
with HIV (PLHIV) who experience changes in cognition. As literature relating 
specifically to caregiving in the context of cognitive impairment was so limited, a 
further scoping review was undertaken to expand the topic to include caregiving for 
all PLHIV (regardless of their cognitive state). Using the same scoping review 
method, the search was re-run to include any publications about who caregivers of 
PLHIV are, what types of support they provide to PLHIV, and why some PLHIV may 
not have the support of an informal caregiver. The rationale for this second scoping 
review was specifically to identify which key populations provide care, and exactly 
what kind of supports they provide, under the assumption that caregivers may observe 
changes in the cognition of PLHIV whilst undertaking these roles. The expanded 
scoping review was intentionally broad and included all relevant publications relating 
to caregiving and HIV over the period 1980 – 2018. Results are qualitatively 
synthesized within the broader framing of the expanded search questions.  
 
2.4 CAREGIVERS: WHO ARE THEY? 
2.4.1 Informal caregivers 
Because of the key populations involved, individual’s traditionally providing care and 
support to PLHIV have come not only from traditional family and partner networks, 
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but also from peer social networks and professional caregivers (Bor, Miller, & 
Goldman, 1993).   
 
The impact of providing care can have significant effects on the physical and mental 
health of both the caregiver and the person they care for (Robles & Kiecolt-Glaser, 
2003). Professional caregivers can identify informal caregivers at risk of declining 
health such as depression (Arai, Kumamoto, Mizuno, & Washio, 2014; Arai & Zarit, 
2014; Fauth, Femia, & Zarit, 2016) and can help informal caregivers improve health 
and well-being by promoting self-efficacy and goal setting to focus on the caregivers 
own needs (Chenoweth et al., 2016; Nogales-Gonzalez, Romero-Moreno, Losada, 
Márquez-González, & Zarit, 2015). Prachakul and Grant (2003) reviewed the 
categories of caregivers of PLHIV and found these were variously described as family 
members (Brown & Powell–Cope, 1991), significant others, or friends and volunteers 
(Reynolds & Alonzo, 1998; Stajduhar & Davies, 1998). For PLHIV, the traditional 
definition of family can be broad, as some may not have support from traditional 
family members.  A broad definition of family is offered by Levine (1990 p36): 
 “…family members are individuals who by birth, adoption, marriage 
or declared commitment share deep, personal connections and are 
mutually entitled to receive and obligated to provide support of 
various kinds to the extent possible, especially in times of need.” 
 
 2.4.2  Peer supports 
Peer support within a health context is the provision of emotional and informational 
assistance by a member of the social network who has similar characteristics to the 
person being supported, and who has practical knowledge of specific behaviours or 
stressors (Dennis, 2003). Traditional support relationships for PLHIV may be 
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compromised for a range of reasons including being estranged from their family due 
to non-acceptance of lifestyle choices, or religious and cultural beliefs. In the absence 
of support from family members, caring networks generally expand to include lovers, 
life partners, friends, and volunteers from peer communities such as the LGBTI 
community (Ama, 2011). The LGBTI communities mobilised early in the HIV 
epidemic to care for PLHIV when they did not have support from traditional families 
(Turner & Catania, 1997). Due to ongoing discrimination related to sexual orientation 
or gender identity, LGBTI communities still provide much of the support for PLHIV, 
as these communities were disproportionately affected by HIV/AIDS (Barrett, 
Crameri, Lambourne, Latham & Whyte, 2015). Care provided by friends belonging to 
LGBTI communities is under-recognised, as is the fact that these friends may 
experience similar stress and depression to partners and spouses (Shiu, Muraco, & 
Fredriksen-Goldsen, 2016). 
 
Homosexual and bisexual men are over-represented as caregivers for their HIV-
positive peers (Turner, Catania & Gagnon, 1994). In one study of 125 caregivers of 
PLHIV, McCann and Wadsworth (1992) found that 77% (96) of caregivers were male 
and of these, 28% (21) had a health problem themselves. As such, male partners in 
particular may experience alienation and stigma, leading to increased depression and 
social isolation (Prachakul & Grant 2003; Pirraglia, 2005). While exact proportions 
are not given, this conclusion is supported by Munro and Edward (2008) who 
reported that of the twelve men in their study, some identified social isolation firstly 
from being homosexual, and secondly from caring for someone with HIV. As there 
are limited resources and services to support caregiving to PLHIV, Munro and 
Edward (2008) also suggest that services need to include resources for men who care 
for men. This is especially relevant currently, as challenges continue for ageing 
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LGBTI communities in need of basic health, housing and financial support (Brennan-
Ing, Seidel, Larson, & Karpiak, 2014). 
 
2.4.3  HIV-positive caregivers 
From the beginning of the HIV epidemic, much of the care provided to PLHIV was 
by those who were also HIV-positive. In a study of 642 caregivers of PLHIV in 1994, 
Wardlaw found that more than one-third were HIV positive themselves, with 96% 
(616) having experienced the loss of someone close to them with HIV/AIDS. One-
third (211) of the caregivers also reported attending to the safety of the PLHIV 
because of cognitive or behavioural problems, providing medication support, enteral 
tube feeding for nutrition support and undertaking their household chores (Wardlaw, 
1994).  
 
HIV-positive caregivers have also reported experiencing burden, role overload and 
depression resulting from feelings of stigma and isolation, and grieving and adjusting 
to their personal losses (Pirraglia, et al., 2005), including loss of their own health and 
the loss of close friends (Wight, 2000). Murray et al. (2016) noted that 33% (15/44) of 
HIV positive caregivers in their study continued to provide support to someone with 
HAND whilst they themselves may be at risk of developing HAND or other medical 
conditions.  
 
2.4.4  Professional caregivers 
In addition, or as an alternative to traditional caregiving supports, PLHIV may rely on 
professional caregivers. Professional caregivers are those in paid employment who 
provide health care and other services to PLHIV. Nurses, for example, are well placed 
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to provide emotional and psychological support to PLHIV and their significant others 
(Firn & Norman, 1995; Govoni, 1988).  
 
A model of care broadly relates to the provision of health services that incorporate the 
best evidence to provide patient-centred care (Cretin, Shortell & Keeler, 2004; Cripps 
et al., 1994). Current models of care for PLHIV are largely interdisciplinary and are 
mostly delivered in the community. An interdisciplinary approach involves 
professionals of different disciplines working collaboratively with a common purpose 
to plan care, whereas a multidisciplinary approach involves team members working 
independently to create discipline specific care plans with the person (Department of 
Human Services, 2008). Community health care services provided to PLHIV in the 
home setting often include case management and coordination of services (Cummins, 
2014; Terpstra et al., 2018).  
 
2.4.5  HIV Community Teams 
To reflect the evolving needs of PLHIV in Sydney, NSW, HIV specialist community 
based services were established by the Central Sydney Area Health Service in 1996 
and the South Eastern and Illawarra Area Health Service in 2007 (Chapter 1). 
Utilising a holistic model of person-centred care, these expert services continue to 
provide both discipline-specific clinical care and case management in partnership 
with PLHIV. For the purpose of this thesis, these services will be referred to 
throughout as HIV community teams.  
 
HIV community teams use both interdisciplinary and multidisciplinary approaches. 
The teams consist of members from several disciplines, including primary health 
nurses, mental health nurses, social workers, physiotherapists, dietitians and 
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occupational therapists who provide a range of expertise and experience to address 
the needs of the PLHIV and improve their health outcomes.  
 
The key features driving the philosophy of HIV community teams are an 
understanding of stigma and discrimination, cultural competence, and acceptance of 
diversity.  The team aims to maintain a culture that promotes an environment without 
stigma for PLHIV and advocates for services on behalf of patients (Ojikutu et al., 
2014). Members of HIV community teams are generally trained in cultural 
competence and aim to understand the needs of people from diverse backgrounds. 
HIV community teams also aim to provide services to vulnerable and hard to reach 
populations such as the homeless and those with mental health conditions.  
 
2. 5 CAREGIVERS: WHAT CARE DO THEY GIVE? 
The Australian National HIV Strategy, released in 2010, highlighted that those 
PLHIV who have cognitive impairment were at greater risk of loss to follow up, 
disease progression and the potential for onward HIV transmission. This population is 
more likely to have higher support needs (Commonwealth Department of Health and 
Ageing, 2010), ranging through clinical, social and psychosocial care (Health 
Resources and Human Administration, 2014), with evolving and increasingly 
complex co-morbidities (Chu & Selwyn, 2011; Rodriguez-Penny et al., 2013). 
Maintaining access and engagement with all health services, and retaining consistent 
care, are crucial to maintaining health goals for PLHIV (Flores, Leblac, & Barroso, 
2016).  
 
Professional caregivers must remain responsive to the changing clinical, 
psychological and social needs of the person – offering a flexible and partnering 
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approach to care, reflecting the diversity of the person and their needs (Bainbridge, 
McCahman, Clifford & Tsey, 2015). Informal caregivers also have an important role 
to play in what has been described by O’Brien and Feeney (2018) as highly complex 
care. O’Brien and Feeney (2018 p18) refer to the different types of complexity related 
to caring for PLHIV as incorporating: 
 
“…any set of co-occurring and interrelated medical conditions of 
varying severity and chronicity (medical complexity); compounded by 
ageing, frailty and socio-economic factors, as well as cultural, 
environmental and behavioural issues (situational complexity); 
together with systemic factors relating to access, delivery and 
coordination of health services (systemic complexity).”  
 
2.5.1  Informal caregiver support 
Many of the signs and symptoms of HAND are mild and it may be difficult for 
informal caregivers to know whether such changes are directly attributable to HAND, 
another health condition, or the subtle consequences of ageing. PLHIV who are 
experiencing signs and symptoms of HAND can have changes in memory and 
become forgetful. This may impact their ability to complete daily tasks, remember 
doctors’ appointments, maintain medication adherence and sustain employment. The 
psychosocial consequences of HIV infection are also far reaching and emotional 
support from informal caregivers can have a hugely positive impact on the person’s 
quality of life.   
 
The main types of support provided by informal caregivers are practical (Ama, 2011), 
emotional (Kelly, Hartman, Graham, Kallen, & Giodano, 2014) and financial (Ama, 
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2011). HIV-positive peers, for example, can describe the symptoms of an illness, side 
effects from treatments, how to manage social issues related to HIV infection (such as 
stigma and discrimination) and suggest personal strategies to manage situations from 
their own or shared experience (Dennis, 2003). Each of these contributions can act to 
increase social connectivity (London, Leblanc & Aneshensel, 1998), improve 
medication adherence and biologic outcomes (Mitchell, Robinson, Nguyen, & 
Knowlton, 2015; Uchino, 2004). Whilst providing this ongoing support, informal 
caregivers may observe changes in cognition and behaviour (Kindersley, 2013), and 
are therefore well placed to discuss these changes with the PLHIV and support their 
medical referral and treatment. 
 
Social and emotional support 
PLHIV generally receive emotional and psychological support from family, friends 
and volunteers through encouragement, keeping company, counselling and health 
education (Ama, 2011). Information exchange occurs during casual and social 
interactions, and living with another person further offers the opportunity to give and 
receive emotional support on a day-to-day basis (Peterson et al., 2012). Kelly et al. 
(2014) found that social support was a predictor of adherence to antiretroviral drugs 
and that higher social support scores were associated with earlier HIV diagnosis and 
timely access to care.  
 
Due to stigma, discrimination, and lack of education in the early days of the HIV 
epidemic, many affected individuals became estranged from family or community, 
with caregiving peer communities largely fulfilling these emotional and social support 
roles. In a study from 1992, McCann and Wadsworth found that 56% (70) of friends 
and partners providing emotional support to a PLHIV were doing so alone, and most 
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of these were close friends of the PLHIV (Friedland, Renwick & McCoil, 1996).  A 
number of peer support social networks were created around this time, including 
support groups, buddy systems and specialist HIV agencies (Dennis, 2003). These 
networks become places for socialising and bonding, enhancing wellbeing and esteem 
by providing an atmosphere of acceptance and self-worth (Peterson et al., 2012). de 
Souza (2014) found that volunteer peer support workers had a great desire to give 
back to the community by being role models for other PLHIV. Connecting in this 
way, peer supports draw on their own emotional pain and personal journey to build 
empathy for others (Peterson et al., 2012).   
 
Practical support 
Practical support includes shopping, cleaning, preparing food and cooking (Baker et 
al., 1998; McCann & Wadsworth 1992; Peterson et al., 2012), providing financial 
assistance and transportation (Folkman et al., 1994; London et al., 1998). Prior to 
highly active antiretroviral drugs becoming available in the early to mid-1990s, 
PLHIV were becoming increasingly unwell and needing intensive care and support. 
As symptoms worsened, informal caregivers took on more clinical roles such as 
keeping track of medications, giving injections, bathing, inserting catheters, enteral 
tube feeding and wound care (Folkman et al., 1994; McCann & Wadsworth 1992). In 
the late 1990s, a study by London et al. (1998) found that 90% of 642 caregivers to 
PLHIV in San Francisco and Los Angeles, USA were helping with activities of daily 
living. Interestingly, these caregivers were younger than others providing support to 
people with non-HIV related dementia. Further, informal caregivers were also taking 
care of the practical and personal needs of PLHIV who were dying at home (Folkman 
et al., 1994; McCann & Wadsworth, 1992). The Metlife report (2010) has more 
recently found that while members of the LBGTI community continue to provide 
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company and assistance with household chores, fixing meals, driving and financial 
support, the need for intimate caring support (such as daily hygiene) is required less 
frequently due to the overall better health of PLHIV since antiretroviral treatment has 
become available.  
 
Not only do informal caregivers need to observe PLHIV for opportunistic infections 
and other health issues, they also need to observe activities of daily living to assess 
their safety. For example, informal caregivers of PLHIV who had a confirmed 
diagnosis of AIDS dementia complex stated that they needed to be extra vigilant, as 
PLHIV often put themselves at risk by forgetting things, not being able to drive 
safely, getting lost and burning food (Meadows et al., 1999). This need for constant 
vigilance may contribute to the social isolation of informal caregivers who may also 
be dealing with their own health issues, and the stigma associated with caring for a 
person with HIV, all while struggling to manage various appointments, medical 
regimens and the possible denial of cognitive decline by the PLHIV themselves 
(Munro & Edward, 2008). 
 
Medication management 
PLHIV may experience poor health outcomes secondary to impaired medication 
adherence (Thames et al., 2011), with symptoms of HAND potentially confounding 
this problem (Katz et al., 2013). Poor medication adherence has also been associated 
with an increased risk of antiretroviral drug resistance (Robertson et al., 2007). 
Informal caregivers have an important role in assisting PLHIV to maintain their 
health through medication management (Kelly et al., 2014). This includes supporting 
attendance at medical appointments (Baker et al., 1998; McCann & Wadsworth, 
1992; Munro & Edward, 2008; Wacharasin & Homchampa, 2008), collecting 
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medications from a pharmacy or health service (Ama, 2011; Baker et al., 1998; 
Munro & Edward, 2008) and offering general medication adherence support (Baker et 
al., 1998; Miller, Bishop, Herman & Stein, 2007; Wacharasin & Homchampa, 2008).  
 
The support of informal caregivers in the ongoing monitoring of medication has also 
been shown to have a positive effect on HIV viral load (Denison, Mitchell, Maragh-
Bass & Knowlton, 2017). Maintaining adherence to medications maintains viral 
suppression and immune function, leading to a positive impact on current and future 
health (Kelly et al., 2014). Additionally, peer supports can facilitate the development 
of coping and decision making skills for medication management, as peers may have 
their own personal experiences and solutions to contribute (Peterson et al., 2012). 
‘Buddies’ or peers assigned to support those who are newly diagnosed with HIV, can 
provide important early support to empower personal growth and decision-making 
about health choices and future care (Peterson et al., 2012).  
 
Support for lifestyle changes 
As previously noted, HIV is now regarded as a chronic illness (Deeks et al., 2013), 
and PLHIV may develop other age-related health conditions as they age (Berg, 
Michelson & Safren, 2007). Informal caregivers can therefore support PLHIV by 
promoting health and health related education (Ama, 2011), including safe sex 
education and personal relationship advice (Baker et al., 1998). They can encourage 
healthy lifestyle modifications to diet and exercise, and reduction of harms such as 
substance misuse, alcohol intake and smoking (Wacharasin & Homchampa, 2008). 
London et al. (1998) found that informal caregivers may also act as unofficial case 
managers, engaging and coordinating community services for the PLHIV. Informal 
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caregivers may also contribute by promoting self-care and independence with PLHIV 
(Boehmer et al., 2014; Clark et al., 2017). 
 
2.5.2  Professional caregiver support 
The needs of ageing PLHIV differ from those of the general ageing population 
(Foebel et al., 2016) and HIV community teams are aware that PLHIV have 
additional biomedical complexities related to their HIV infection and treatments 
(Cahill & Valadez, 2013).  Combining the expert skills of a range of disciplines, HIV 
community teams provide clinical care, education and health promotion (Chu & 
Selwyn, 2011), and through a case management role, develop person-centred care 
plans for the management of chronic disease and ageing. Their knowledge of HIV 
also provides an opportunity to work with non-HIV providers and to advocate on 
behalf of PLHIV when required (Chu & Selwyn, 2011).  
 
HIV community teams promote and equip PLHIV with skills to augment their self-
care, and to sustain treatment regimens and health goals. To achieve these goals in 
partnership with the PLHIV, HIV community teams offer varied clinical services and 
care in the home, clinic or other setting chosen by the PLHIV (e.g. coffee shop or 
park for privacy reasons). Clinical care may include medication management 
(including organising prescriptions, medication packs, pharmacy collection, 
medication adherence and monitoring side effects); primary and sexual health 
assessment and monitoring; mental health assessment and monitoring; drug and 
alcohol assessment; access to dental health care; counselling and welfare support with 
housing and other agencies; dietetic support and nutritional advice; shopping advice 
and cooking classes. Physiotherapists offer individual exercise programs, group 
classes such as hydrotherapy and physiological support for injuries. Occupational 
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therapists assist with assessing the home for modifications to improve the person’s 
ability to live independently, set and achieve their goals for activities of daily living, 
energy conservation and vocational advice.  
 
The ineffective navigation of health systems contributes to inadequate or 
uncoordinated care and has the potential for disengagement with care (Allen, 2014). 
Health professionals working within HIV community teams understand their roles 
and responsibilities with clear objectives to provide holistic care in partnership with 
the PLHIV. Whilst respecting the individual’s experience and autonomy, team 
members share responsibilities and promote role interdependence while recognizing 
of their own knowledge and expertise. The extensive communications, networking 
and advocating functions of the HIV community teams may enhance linkage to care 
and have shown potential in decreasing emergency department and hospital 
admissions and increases in primary health visits (Allen, 2014).  
 
Case management  
The standard goals of case management are that PLHIV are involved in all aspects of 
their care. The designated case manager develops relationships and agreements 
among care partners and maintains optimal communication between all involved to 
achieve a coordinated approach to achieving these goals in an agreed timeframe 
(Wagner, Sandhu, Coleman, Phillips, & Sugarman, 2014). The Case Management 
Society of America (CMSA, 2016 p11) defines case management as:  
“…a collaborative process of assessment, planning, facilitation, care 
coordination, evaluation and advocacy for options and services to 
meet an individual’s and family’s comprehensive health needs 
 
 
60 
 
through communication and available resources to promote patient 
safety, quality of care and cost-effective outcomes.”  
 
Crock et al. (2017) note that PLHIV are concerned about maintaining future 
independent living. The need for case management is therefore more likely to arise as 
PLHIV age and become more dependent on support to remain living independently in 
the community (Brennan-Ing et al., 2016). Following a diagnosis of HAND, a case 
manager will develop and implement a comprehensive care plan, working with the 
multidisciplinary team, such as family doctor, outpatient clinic staff, inpatient 
services, allied health, nursing staff and other informal supports (Johansson & 
Harkey, 2014) to help PLHIV achieve their independent living goals. 
 
There is evidence to suggest that when a person is positively engaged with case 
management, their uptake of other services required to maintain health (such as social 
supports and medication management) are also positively influenced (New York City 
Department of Health, 2010). Positive experiences with case management have also 
been found to influence the therapeutic relationship between professional caregivers 
and people living with chronic conditions (Wagner et al., 2001).  Regular case 
conferences in a case management model could improve knowledge of signs and 
symptoms and declining health of the individual due to additional co-morbid 
conditions (Agar et al, 2017). The collaborative partnership between PLHIV and their 
HIV community team offers opportunity for professional caregivers to detect any 
changes in cognitive behavior, and initiate assessment of neurocognitive impairment 
if indicated. This is especially pertinent if the PLHIV does not have the support of an 
informal caregiver who may normally notice such changes. As part of the 
interdisciplinary team, HIV case managers assist PLHIV to access and maintain 
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engagement with health services (Cahill, Mayer & Boswell, 2015; Mugavero, Amico, 
Horn, & Thompson, 2013) whilst promoting support for self-care (Gardner et al., 
2005).  
 
As noted in Chapter One, a goal of the NSW HIV Strategy 2012-2015 was that 
specialist HIV community health care services would provide support for PLHIV with 
complex care needs requiring enhanced care through case management, with an 
increased focus on managing co-morbidities. HIV community teams achieved this by 
working closely with mainstream services to meet future health needs; by developing 
focused care plans and; through monitoring changes in health such as assessing for 
the development of HAND. 
 
2.6  FACTORS INFLUENCING INFORMAL CAREGIVER SUPPORT 
The psychosocial impacts of HIV infection are complex and multifactorial prompting 
many reasons why those with HIV infection may not have the assistance of an 
informal caregiver. Even with informal support, the informal caregiver may not 
actually reside with the PLHIV, potentially further limiting their opportunities for 
close observation and care (Schnall, Hirshfield, Liu, Siegal, & Gradilla, 2017).  
 
2.6.1 Stigma and discrimination 
Fear of stigma and discrimination are major reasons why PLHIV do not disclose their 
HIV status to family, friends or society. HIV/AIDS related stigma and discrimination 
refers to the prejudice, negative attitudes and possible maltreatment directed towards 
PLHIV. The World Health Organisation (2008) cites fear of stigma and 
discrimination as the main reason why people are reluctant to be tested, to disclose 
their HIV status, or to take antiretroviral drugs to treat HIV. The consequences of 
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stigma include being shunned by your family, friends and wider community, poor 
access to health care and treatments, erosion of human rights and psychological 
damage (WHO, 2008).   
 
Factors contributing to stigma include the notion that HIV infection is the result of 
diminished personal responsibility. Certain religious or moral beliefs may lead some 
to believe that the person deserves to be punished because being infected with HIV is 
the result of moral fault (Canavan, 2007). Further, stigma and discrimination may 
result from incorrect assumptions and judgements about homosexuality, substance 
use, commercial sex work, and promiscuity (Canavan, 2007; Ryan, Huebner, Diaz, & 
Sanchez, 2009).  
 
2.6.2  HIV positive status 
Although much has changed regarding the knowledge, understanding and acceptance 
of HIV across the globe, stigma and discrimination continue to concern people who 
are diagnosed with HIV.  Disclosure of HIV status is a paramount concern for PLHIV 
and the fear of personal rejection may be high. In an early study, Crystal & Jackson 
(1989) found that 31% of 77 gay men diagnosed with HIV had been rejected by at 
least one family member; 38% (29) were abandoned by friends and; 11% (8) had lost 
their housing. A global study of 2035 PLHIV by Nachega et al. (2012) further 
illustrated that 79% (1607) of this sample feared social discrimination following 
disclosure of their HIV status, with 35% (712) being worried about losing their family 
and friends if they disclosed their status. In this study, 17% (345) reported being in a 
long-term sexual relationship where they had not disclosed their status to their 
partner.   
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Although families play an important role in caring for someone with HIV, not all 
family responses are supportive. PLHIV can experience stigma and discrimination within 
their home, experiencing social avoidance, or being told to conceal their HIV status 
(Nachega et al., 2012).  Research by the International Centre for Research on Women 
(2006) reported that some of the consequences of HIV-related stigma among women 
were loss of income/livelihood, loss of marriage options, withdrawal of care giving in 
the home, loss of reputation and poor care within the health sector.  In Australia, 
medical professionals continue to make judgments about the lifestyle choices of HIV 
positive women when they disclose their HIV status (Parr, Burkitt & Jennings, 2012).  
Additionally, HIV positive women may be responsible for the care of children at 
home, adding further complexity to accessing caregiving support for themselves 
(Cummins & Millar, 2004; Decarlo & Folkman, 1997) and continuing with normal 
daily routine even when feeling unwell (Songwathana, 2001). 
 
In another study of 63 PLHIV, Schrimshaw & Siegel (2003) found that many 
participants in their study (exact numbers were not given) thought disclosure of their 
HIV status would be a barrier to accepting care from family and friends and also 
feared casual transmission of HIV to their informal caregivers. Wacharasin & 
Homchampa (2008) further reported that PLHIV and their family members did not 
want to disclose HIV status for fear of rejection, discrimination, disgust and impact on 
their career, including expulsion from work. In the climate of sexual negotiation, 
stigma about revealing HIV status clearly continues to be a major issue.  
 
A report prepared by Parr, Burkitt and Jennings (2009) for the Australian Federation 
of AIDS Organisations and the National Association of People with HIV Australia, 
concluded that PLHIV experienced high levels of stigma with negative attitudes remaining 
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unchanged over the last twenty years. This study reported the results of the attitudes 
approximately 90 gay men. While exact numbers were not given, the study reported 
findings from eight focus groups with 6 to 8 participants; 14 in-depth interviews with 
HIV-negative men older than 35 years; and a focus group with four HIV-negative 
men under the age of 35 years. The study found that younger participants had little 
personal experience of knowing anyone with HIV and were often explicitly negative 
and prejudiced when discussing PLHIV (Parr, et al., 2009). Younger respondents 
articulated an “us and them” attitude; often refusing to openly engage with HIV 
positive men via the internet; associating HIV positive men as belonging to a different 
“club”; identifying HIV positive men as “unclean”; and likening sexual interactions 
with them as equivalent to playing “Russian roulette” and “poison” (Parr, Burkitt & 
Jennings, 2012). The report further identified that as the internet is now a more 
common place to meet a sexual partner than at a “gay venue”, asking questions such 
as “are you clean?” are commonplace on these sites. Therefore, HIV positive persons 
are likely to continue to experience feelings of shame and poor self- esteem into the 
future (Parr et al., 2009).  
 
2.6.3  Culturally and linguistically diverse communities 
In Australia in 2016, 21% (209/1013) of new HIV diagnoses were attributed to 
heterosexual contact. According to the United Nations, 17% (35) were in people born 
in a HIV high-prevalence country and a further 17% (35) were in people who reported 
heterosexual contact with a person from a HIV high-prevalence country (Kirby 
Institute, 2017).  Between 2012 and 2016, the proportion of people with a late HIV 
diagnosis was higher in people born in Central America (45%), sub-Saharan Africa 
(43%) and Southeast Asia (43%); with the HIV risk exposure higher for heterosexual 
sex (47%) than for male-to-male sex (37%) (Kirby Institute, 2017). 
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Australia is a multicultural society that experiences a range of cultural and religious 
views towards HIV and/or homosexuality. The Culturally and Linguistically Diverse 
(CaLD) Periodic Review (2009) noted that among CaLD communities HIV related 
stigma is a key factor connected to late HIV diagnoses (Asante & Körner, 2011). Of 
286 HIV positive people from CaLD communities included in this review, late HIV 
diagnoses had impacted on the ability of the person to disclose their homosexuality to 
family or friends, and further impacted access to treatment and health services 
(Asante, Körner, McMahon, Sabri, & Kippax, 2009). For nearly 61% (174) of the 286 
respondents in this study, the shame of a positive result was a major concern and 43% 
(122) also thought that PLHIV bring shame to themselves and their families (Asante 
et al., 2009).  
 
People from CaLD backgrounds may also be less likely to identify and nominate 
informal caregivers. In a study of 126 HIV positive participants from three clinical 
sites, Murray et al. (2016), noted that only 36% (45) identified an informal caregiver 
that could be contacted as part of the study. For the 64% (81) who did not identify an 
informal caregiver, reasons included not wanting to bring up their HIV status, or 
sexual or drug related behaviours attributed to transmission of HIV, and this was 
particularly the case for those from CaLD backgrounds (Murray et al., 2016).  
 
2.6.4  Sexual orientation 
For many people, disclosing their HIV status also means disclosing their 
homosexuality (Altman et al., 2012). Homosexuality remains misunderstood, feared 
and discriminated against, even though globally, heterosexual transmission of HIV is 
higher than homosexual transmission (Altman et al., 2012). Ryan et al. (2009) found 
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that a higher rate of rejection by family members was significantly related to poorer 
health outcomes in young homosexual, lesbian and bisexual adults. In this study of 
224 participants, those who felt rejected because of their sexual orientation were 8.4 
times more likely to report attempted suicide, 5.9 times more likely to report higher 
levels of depression, 3.4 times more likely to use illegal substances and, 3.4 times 
more likely to report having engaged in risky sexual activity such as unprotected sex 
(Ryan et al., 2009).  
 
Human rights abuses related to sexual orientation are major social determinants of 
vulnerability to exposure to HIV (Beyrer et al., 2012). Individuals from the LGBTI 
community are subject to criminalisation for their sexual orientation in over 80 
countries and homosexuality is punishable by death in others (Altman et al., 2012). 
The LGBTI community continue to face stigma, discrimination in housing, 
employment, education, health care and family life, despite legal protections (Altman 
et al., 2012).  Thirty-eight countries in Africa criminalise same sex relationships with 
punishment ranging from imprisonment to death, with some also being the victims of 
blackmail and extortion (Pew Research Centre, 2013). Homosexuality is still framed 
by codes of silence and secrecy in many countries, preventing disclosure and 
discourse, because to speak about such things is socially unacceptable (Altman et al., 
2012).  
 
The Pew Research Centre is a not for profit organization which informs society about 
global issues, attitudes and trends. In the Pew Global Attitudes Report (2013), 37,653 
representatives from 39 countries were asked whether homosexuality should be 
accepted.  Many countries voted against acceptance (e.g. Nigeria 98%, Egypt 95%, 
Indonesia 93%, and Malaysia 80%). There is also known to be a strong relationship 
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between the acceptance of homosexuality and religion, but this is likely a 
generalisation, for example, while Brazil is a country largely regarded as accepting of 
homosexuals and transgender individuals, there are still frequent reports of murder 
among these groups due to their sexuality (Pew Research Centre, 2013).  
 
2.6.5  Ageing 
Large observational studies and results from a recent study of national registry data 
suggest that life expectancy for PLHIV who are receiving effective treatment in high 
income countries such as Australia has almost normalised to that of the population 
average (Marcus et al., 2016; Siddiqi, Hall, Hu, Song, 2016). More than 50% of the 
25,000 PLHIV in Australia are estimated to be over 50 years of age (Murray, 
McDonald & Law, 2009), with the proportion of those over 55 years predicted to 
increase from 25.3% of all PLHIV in 2010 to 44.2% in 2020 (ACON, 2017). 
Moreover, the number of HIV positive gay men over 60 years of age has been 
increasing by 12% per year since 1995 (Jansson & Wilson 2012; Murray et al., 2009).  
 
The National LGBTI Ageing and Aged Care Strategy (2012), recognises that “Older 
LGBTI Australians have lived through a time in the nation’s history when they 
suffered stigma, discrimination, criminalisation, family rejection and social isolation” 
(Department of Health and Ageing 2012, p. 4). Older persons who identify as part of 
the LGBTI community still rely on close peers to provide informal care and 
Fredriksen-Goldsen et al. (2011) have noted that of 2560 in their study, 54% (1382) 
were receiving care from a partner and 24% (614) from a friend. Having survived 
partners, friends and peers who may have succumbed in the early days of the HIV 
epidemic, facing increasing geographic mobility whereby support from friends or 
family is at a distance (Musheke, Bond & Merten, 2013), and the parallel ageing of 
 
 
68 
 
social networks and informal supports, PLHIV are experiencing increasingly 
diminishing support networks. Paddick et al. (2017) found that living alone was a 
predictor of HAND, therefore, ongoing engagement with HIV specialist community 
teams may be able to fulfil some of the roles of absent informal caregivers, including 
the monitoring of behavioural or cognitive change and awareness of the social 
circumstances of PLHIV who are increasingly becoming more isolated (Emlet, 2006).  
 
2.7 GAPS IN KNOWLEDGE  
 
This chapter has aimed to illustrate the significance of support provided by both 
informal and professional caregivers to PLHIV. There is a paucity of research 
pertaining specifically to caregiving in the context of HIV positive individuals 
diagnosed with cognitive impairment, both before and after introduction of the 
Frascati Classification Criteria in 2007 (Cripps et al., 1994; Cummins, 2014; 
Flaskerud & Lee, 2001; Hilton, 1989; Hopcroft et al., 2013; Kelly, 2010; Meadows et 
al., 1999; Morgan et al., 1988; Morrow et al., 1997; Murray et al., 2016; Stajduhar, 
1997; Terpstra et al., 2018).  However, a range of other background literature was 
able to offer further information about ‘who’ formal and informal caregivers might be 
and ‘what’ they contribute to the care of PLHIV more generally.  
 
Early in the HIV epidemic (pre-Frascati), the signs and symptoms of neurological 
involvement were acute, and early studies of PLHIV related to the social context of 
the HIV epidemic: families dealing with HIV, disclosure of homosexuality, end of life 
care, informal caregivers quality of life, burden and fear of disclosure (Baker et al., 
1998), caregivers health (Flaskerud & Lee, 2001; Raveis & Seigel, 1990) and, grief 
and loss (Brown & Powell-Cope, 1993; Folkman et al., 1994). Literature regarding 
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the experience of professional caregivers at the time related to stress, burnout 
(Barbour, 1994; Macks & Abrams, 1992; Nesbitt et al., 1996) and working with 
young PLHIV that were dying (Barbour, 1994).  
 
By the time the Frascati Classification Criteria had been revised (Antinori et al., 
2007), many PLHIV were experiencing milder signs and symptoms due to 
antiretroviral treatments but there continued to be limited published research on the 
experience of PLHIV and their informal caregivers regarding HAND, how they 
recognise signs and symptoms of HAND, and how or where they discuss their 
concerns with others. There is also very limited information published about 
professional caregiving for PLHIV with a diagnosis of HAND in the community, or 
how health professionals can identify PLHIV at risk of developing HAND.  In the 
post-Frascati era, much of the published literature has pertained to the prevalence of 
HAND (Heaton et al., 2010; Heaton et al., 2011; Skinner et al., 2009); predictors of 
HAND (Antinori et al., 2007; Bhaskaran et al., 2008; Ellis et al., 2011; Fiala et al., 
2005; Heaton et al., 2011; Letendre et al., 2011; Schouten et al., 2012); screening tests 
(Antinori et al., 2007; Valcour et al., 2011); and the treatment of HAND (Cysique et 
al., 2009; Heaton et al., 2010; Letendre et al., 2008; Tozzi et al., 1999; Tozzi et al., 
2007). However, the significance of caregivers in this thesis, is their potential to be 
able to recognise early cognitive changes in PLHIV.  
 
2.8  CONCLUSION 
The experience of cognitive impairment has changed for PLHIV over time, with mild 
cognitive signs and symptoms possibly attributed to a range of other medical 
conditions, or morbidity associated with ageing, rather than consideration of HAND. 
In the past, PLHIV had regular and intensive health monitoring. With improved HIV 
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treatments, and if medically stable, PLHIV possibly only access their prescribing 
doctor every four to six months. Their health could significantly change between 
visits and further, PLHIV may be fearful of discussing their concerns about what they 
are experiencing with their doctor or others.  For those who live alone without 
informal caregivers, failure to recognise cognitive decline may also significantly 
delay seeking medical review. HAND is a potentially treatable condition (Skinner et 
al., 2009), as such, early investigation and diagnosis can impact the overall health and 
wellbeing of PLHIV.  
 
For those PLHIV who do not have the support of an informal caregiver, a professional 
caregiver based in the community may fulfil the role of an alternative caregiver, being 
well placed to observe cognitive and behavioural changes whilst providing care in the 
home environment. Furthermore, their knowledge of the past and current health 
history of the PLHIV can facilitate the early identification of HAND. Early screening 
could lead to investigation and treatment, not only improving clinical outcomes but 
having a positive effect on the type and timeliness of health and service interventions, 
and potentially preventing or reducing the need for hospital admission.  Additionally, 
professional caregivers can assist ageing PLHIV with strategies to reduce the 
development of co-morbid conditions that may impact cognition, such as 
cardiovascular disease and diabetes.  
 
The initial and broader scoping review has determined why PLHIV may not have 
caregivers, who their caregivers may be, and has identified the main supports 
caregivers provide. As the population of PLHIV age, the uncertainty of maintaining 
good health and the possibility of future ill health due to co-morbid conditions is 
concerning. Those PLHIV in same sex relationships may become increasingly 
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socially isolated without traditional supports, and a diagnosis of HAND within the 
relationship may impact the ability of partners to provide care for each other.  Despite 
minimal quality evidence on the role of caregivers in recognising HAND in PLHIV, 
this review of published literature over the past 38 years (1980 – 2018) has shown that 
both informal and professional caregivers do provide practical and emotional support 
to PLHIV and are therefore well placed to notice mild signs and symptoms and 
support the early diagnosis of HAND.   
 
However, it remains largely unknown whether PLHIV themselves, or their informal 
and professional caregivers, are aware of the signs and symptoms of HAND, or 
whether they have discussed early identification and diagnosis of HAND with others, 
including health professionals. In support of the early diagnosis of HAND, it is also 
unknown whether professional caregivers are collecting appropriate and timely 
medical and social information to identify which PLHIV may be at risk of developing 
HAND. Therefore, an additional outcome of this review was a decision to conduct a 
preliminary pilot study to address these gaps in the literature by firstly examining the 
personal experiences of PLHIV and their informal and professional caregivers to 
determine whether they encounter and recognise signs and symptoms of HAND. It is 
anticipated that findings from this and other studies undertaken for this thesis will 
enhance awareness of HAND for PLHIV and their informal and professional 
caregivers and will inform interventions for community based health professionals to 
identify who is at risk of HAND so that referrals can be arranged for early medical 
review. This is especially significant for those PLHIV who live alone and do not have 
the support of an informal caregiver who would normally observe changes in 
cognition, behaviour or the person’s environment. Additionally, for those PLHIV who 
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live together as a couple and both are HIV positive, both may be at risk of developing 
HAND and may need additional support from professional caregivers.  
 
This chapter has outlined the results of an initial review of literature relating to the 
carers of PLHIV who are experiencing cognitive change. The initial review revealed 
an extremely limited evidence-base and therefore, an expanded review was 
undertaken to capture a broader scope of literature pertaining to who caregivers are 
for PLHIV; what types of supports they provide and reasons why PLHIV may not 
have the support of an informal caregiver. Both informal and professional caregivers 
are able to observe for signs and symptoms of cognitive change that may be indicative 
of HAND and their support and confidence to contribute information may lead to the 
early identification of HAND. Chapter Three discusses the mixed method approach to 
studies reported in this thesis to illicit knowledge about the identification of HAND in 
the context of PLHIV, their caregivers and community health care professionals.  
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CHAPTER THREE 
Methodology and methods 
Background 
This chapter offers an overview of the thesis aim and objectives, and explains the 
methodological approach chosen to explore the research questions. The relationship 
between the aim, methodology, development of research questions and subsequent 
design of studies is described, with the study results contained as published works 
within this thesis (Chapters 4 – 7). A preliminary exploratory study was conducted to 
inform and refine research questions for three subsequent study phases utilising a 
mixed method sequential design. The preliminary study, Phase 1 and Phase 2 used a 
quantitative method, and Phase 3 a modified Delphi design.  
 
3.1 INTRODUCTION 
 
The candidate has worked with PLHIV in Sydney, Australia for the past 25 years. 
Anecdotal conversations with HIV positive patients and their informal caregivers over 
this time had indicated concern about cognitive changes and confusion as to whether 
symptoms were related to HIV or to other issues such as morbidity associated with 
ageing. Some individuals had expressed apprehension about the effects of HIV 
infection on the brain. Others reported that discussion with their medical doctor had 
elicited an unsatisfactory response, resulting in PLHIV feeling their concerns were 
not being heard or were not valid. Poor documentation of the signs and symptoms of 
cognitive change were also evident. This, and limited available literature specifically 
addressing these experiences collectively led to developing the overarching aim of 
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this thesis which was: to explore the complexity of this phenomenon by investigating 
whether the early detection and diagnosis of HAND could be facilitated by PLHIV, 
and/or their informal and professional caregivers from their knowledge and 
experience of signs and symptoms of cognitive changes. 
  
Chapter Two has shown that since revision of the American Academy of Neurology 
nomenclature for HIV related cognitive impairment in 2007 (the Frascati 
Classification Criteria), there has been little published about the experiences of 
cognitive decline among informal and professional caregivers of PLHIV, or among 
PLHIV at risk of or living with HAND. The approach to this thesis therefore needed 
to be both exploratory and descriptive. To gain more insight into this largely unknown 
and possibly complex phenomenon, a pragmatic approach was taken to the design of 
an explanatory sequential study with three phases. Sequential designs transpire when 
one phase of data collection occurs before the next (Fetters, Curry, & Creswell, 2013; 
Ivankova, Creswell, & Stick, 2006) and the intent of explanatory studies is to use the 
results of one or more studies to help explain the results of others (Creswell & Plano 
Clark, 2011). Research questions relating to the aims and objectives of the study were 
further refined following an initial pilot study, and after each study phase and are 
presented in Table 3.1 and Figure 3.1 below.   
 
The preliminary pilot study was designed to discover whether PLHIV receiving health 
care at three different clinics were experiencing signs and symptoms that could be 
related to HAND, and whether their informal caregivers had noticed and were able to 
offer further evidence of this by asking a broad initial research question “Can people 
living with HIV and their informal caregivers identify HAND?”. Following the results 
of the preliminary study, four further research questions were designed to specifically 
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ascertain the experience of PLHIV related to HAND. An online survey was conducted 
as the Phase 1 study, to explore two research questions “Are PLHIV aware of and/or 
concerned about HIV associated neurocognitive disorder?” and “Are PLHIV 
experiencing signs and symptoms of cognitive change and/or observing them in 
others?”.  
 
The results from Phase 1 lead the candidate to further consider the situation of PLHIV 
who may not have the support of an informal caregiver.  This raised a further question 
of whether HIV community teams were (or could) act as alternate caregivers to 
identify those PLHIV at risk of HAND in their care. Therefore, a patient file audit 
was conducted as the Phase 2 study to determine whether HIV community teams were 
collecting health information that was both sufficiently detailed, accurate and relevant 
to identifying PLHIV at risk of developing HAND by asking the research question 
“What information collected by HIV community based teams identifies patients at 
risk of HAND?”. The results of this Phase 2 study identified a clear need for an 
appropriate risk assessment process to screen for HAND in PLHIV. The Phase 3 
study used a modified Delphi method with a panel of HIV health experts to reach 
consensus on the content of a risk assessment screening tool to be used in community 
settings to screen those PLHIV at risk of developing HAND. Phase 3 explored the 
final research question “What assessment criteria are essential to identify those at risk 
of HAND in the community?”. This Delphi group also recommended that content be 
extended to develop an accompanying annual monitoring tool.  
 
3.2 RESEARH PARADIGM 
The philosophical framework chosen for this explanatory sequential study is based on 
pragmatism. Pragmatism focuses on what succeeds as the truth relating to questions 
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posed for the research topic (Tashakkori & Teddlie, 2003, p.713).  In an attempt to 
solve practical problems in the real world, pragmatism accepts that there are singular 
and multiple realities that are open to empirical inquiry (Dewey, 1925; Creswell & 
Plano Clark, 2007).  Pragmatism is ‘real world’ and ‘practice orientated’ and explores 
practical consequences to inform decisions for action and problem solving 
(Mackenzie & Knipe, 2006), placing high regard on the reality of human experience 
in action (Johnson & Onwuegbuzie, 2004). Creswell (2003, p.11) notes that the 
pragmatic paradigm places “the research problem as central” and applies all 
approaches in an attempt to understand the phenomenon; that is, to focus on the “here 
and now” of the research problem. The pragmatic paradigm offers a frame for the 
researcher to move back and forth between induction and deduction during the 
inquiry process (Morgan, 2007) to examine and explore evidence that consistently fits 
with theory and peer agreement to inform practice (Tashakkori & Teddlie, 2009).  
 
Pragmatism is concerned with the interplay between action and knowledge, and with 
action and change (Goldkuhl, 2012) and aims to solve a problem by unravelling the 
complexity within a research question (Brannen & Halcomb, 2009).  As pragmatic 
knowledge is constructed from people’s perspectives (Tashakkori, & Teddlie, 2009), 
mixed methods were chosen, with pragmatism as the underlying philosophical 
framework building a bridge between the quantitative and qualitative results of each 
study phase (Leech & Onwuegbuzie, 2009). Data were able to be considered from a 
multidimensional point of view with each data set informing and enhancing the others 
(Feilzer, 2009) allowing for a more comprehensive exploration of the experiences of 
PLHIV, their informal and professional caregivers.  
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3.3 MIXING METHODS 
The concept of mixing qualitative and quantitative research methods was introduced 
as a means of validating study results around the 1950s (Campbell & Fiske, 1959), 
and further developed by Webb, Campbell, Schwartz and Sechrest (1966) who are 
credited with being the first to construct the term ‘triangulation’. A third paradigm 
emerged with Denzin (1978 p.291) defining mixed methods as “the combination of 
methodologies in the study of the same phenomenon”. Mixed method approaches are 
popular in many disciplines including nursing, health sciences and education. 
Integrated mixed method designs increasingly allow researchers to pursue emerging 
questions with fieldwork, for example, where qualitative data is used to help clarify 
the implication of responses to survey questions to better understand the social 
processes that might produce broad outcome patterns (Driscoll, Appiah-Yeboah, 
Salib, & Rupert, 2007). 
 
The mixed method approach has the advantage of studying the phenomenon in 
different parts, examining them in relation to each other, whilst obtaining a holistic 
view that draws on the strengths of both approaches to explore complexity in the 
research (Creswell & Plano Clark, 2011).  This is an approach to knowledge that 
endeavours to regard multiple viewpoints and perspectives (Johnson, Onwuegbuzie & 
Turner 2007; Creswell & Plano Clark, 2011) and allows objectives to be addressed 
within multiple phases to increase the breadth and depth of understanding of the 
subject (Johnson et al., 2007).  With a more complete picture of the phenomena, 
findings produce a more superior insight than would be possible using each approach 
alone (Johnson & Onwuegbuzie, 2004). Polit and Hungler (1999) note that a mixed 
method approach strives to discover knowledge, insight and understanding by 
developing generalisations from specific lived experiences. Selected samples should 
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therefore produce enough data pertaining to the phenomenon to allow a rich 
description, enabling the researcher to make analytical generalisations to other 
populations and settings (Onwuegbuzie & Collins, 2007).  
 
An explanatory sequential design using mixed method studies involves multiple 
phases of data collection whereby the research questions and purpose are determined 
by the particular sequence (Andrew & Halcomb, 2009). Sequential designs may be 
either exploratory (wherein qualitative data are collected first and followed by the 
quantitative element) or explanatory, where quantitative data are collected first and 
followed by the qualitative element (Creswell & Plano-Clark, 2007). Andrew and 
Halcomb (2009) suggest that in explanatory designs the weight is usually, but not 
always, afforded to the quantitative element of the study.  Either way, different 
research strategies produce data from each phase which are analysed and scrutinised 
in relation to each other to inform and supplement findings (Tashakkori, & Teddlie, 
2009). Therefore, the findings from each phase aim to achieve a more comprehensive 
understanding of the data and allow new questions to be developed (Subedi, 2016).  
The findings from varied data collection methods (mixed methods) are expected to 
converge, thereby confirming and increasing the validity of findings (Denzin, 1989).  
 
3.3.1  Rationale for mixed method approach 
To date, few studies have explored the personal experiences of PLHIV and their 
caregivers in relation to recognising the signs and symptoms of HAND. Information 
and insights from informal caregivers are essential to obtaining a holistic picture of 
the circumstances of PLHIV and as such, informal caregivers should be included in 
health consultations (with permission of the PLHIV) when available.  Additionally, 
professional caregivers, acting as alternates to informal caregivers, should be 
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equipped with accurate information and knowledge to identify those PLHIV who live 
alone, or are without informal supports, who may be at risk of developing HAND. 
This information can shape the development of models of care, informed by the views 
and personal experience of PLHIV and their caregivers, to improve health and social 
strategies for PLHIV in the community into the future. 
 
Mixed method approaches are useful for examining unexpected results in more detail 
(Creswell, 2009) and have been adopted for this thesis because so little previously 
published research is available. Data were collected sequentially, with analysis 
occurring separately, whilst allowing emerging data to generate questions and 
methods for the following phases. 
 
3.4  AIM AND OBJECTIVES 
The aim of this thesis was to explore the complexities of identifying HAND by people 
living with HIV, and their informal or formal (professional) caregivers. The three 
objectives were to:  
 Explore whether people living with HIV and their informal caregivers can 
identify HAND. 
 Explore the experience of HAND in people living with HIV. 
 Explore whether community based health care professionals can identify 
HAND. 
 
3.5  RESEARCH QUESTIONS and STUDY PHASES  
3.5.1  Preliminary pilot study 
Fundamental to the development of this thesis was an understanding of whether 
PLHIV and their caregivers were aware of HIV-associated cognitive decline. In the 
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absence of literature on this topic, it could not be assumed that in asking research 
questions about HAND, people living with HIV and/or their caregivers knew what 
they were being asked about. The preliminary study therefore acted as pilot to inform 
the development of four further research questions for the thesis by posing the 
exploratory question:  
 Can people living with HIV and their informal caregivers identify HAND?  
 
3.5.2  Phase One 
The Phase 1 study used an online survey with PLHIV, focusing on their experience 
HAND to explore the research questions:  
1. Are PLHIV aware of and/or concerned about HIV associated 
neurocognitive disorder?   
2. Are PLHIV experiencing signs and symptoms of cognitive change and/or 
observing them in others?  
 
3.5.3  Phase Two  
The Phase 2 study used a cross-sectional design to conduct a file audit of patient data 
collected by interdisciplinary specialist HIV community teams. A descriptive analysis 
was undertaken to explore the research question:  
3. What information collected by HIV community based teams identifies 
patients at risk of HAND?  
 
3.5.4  Phase Three 
The Phase 3 study used a Modified Delphi method to answer the final research 
question: 
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4. What assessment criteria are essential to identify those at risk of HAND in 
the community?  
 
The relationship between the thesis objectives, study phases, research questions and 
methods are outlined in Table 3.1 below. This table also lists the publications relating 
to the results of the pilot and three study phases, as outlined in Chapters 4 – 7. The 
detailed methods of each of the studies are in the related publications and are 
described further below. 
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Table 3.1: Relationship between objectives, research questions, study methods and results 
 
 
Objectives 
 
 
Research Questions 
 
 
Method 
 
 
Published study results (Chapters 4 – 7) 
Preliminary pilot study 
Objective 1 
Explore whether PLHIV and 
their informal caregivers can 
identify HAND.  
 
 
Can PLHIV and their informal caregivers identify HAND? 
 
 
Prospective observational 
study (including self-
assessment questionnaire) 
 
 
Cummins, D., Murray, K., Trotter, G., Batterham, M., Healey, 
L., O’Connor, C.C. 2017. Can patients and their caregivers 
boost identification of HIV associated neurocognitive disorder 
(HAND)? Australian Journal of Advanced Nursing, 34 (3), 24-
33 
Phase 1 
Objective 2 
Explore the experience of 
HAND in PLHIV. 
 
 
1. Are PLHIV aware of and/or concerned about HAND? 
2. Are PLHIV experiencing signs and symptoms of cognitive 
change and/or observing them in others? 
 
Online survey 
Cummins, D., Waters, D., Aggar, C., Crawford, D., Fethney, J., 
O’Connor, C.C.  2018. Voices from Australia– concerns about 
HIV associated neurocognitive disorder. AIDS Care, 30 (5), 
609‐617. doi: 10.1080/09540121.2018.1426826 
 
Phase 2 
Objective 3 
Explore whether community 
health care professionals can 
identify HAND. 
 
 
3. What information collected by HIV community based 
teams identifies patients at risk of HAND? 
 
Cross sectional file audit 
Cummins, D., Waters, D., Aggar, C., O’Connor, C.C.  2018. 
Potential impacts of poor communication on early diagnosis of 
HIV associated neurocognitive disorder. Journal of Advanced 
Nursing, 74 (6), 1342-1348. https://doi.org/10.1111/jan.13533 
 
Phase 3  
Objective 3 
Explore whether community 
health care professionals can 
identify HAND. 
 
4. What assessment criteria are essential to identify those at 
risk of HAND in the community? Modified Delphi method 
Cummins, D., Waters, D., Aggar, C., O’Connor, C.C.  2018. 
Assessing risk of HIV associated neurocognitive disorder: a 
modified Delphi study. Nursing Research, Aug 2. 
doi:10.1097/NNR.0000000000000312. [Epub ahead of print] 
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3.6  METHODS 
The detailed methods of each of the study phases are outlined in the published papers 
(Chapters 4 – 7) but are summarised below and in Figure 3.1.  
 
3.6.1  Preliminary pilot study: prospective observational study 
Anecdotal reports from PLHIV have indicated that discussion on issues relating to 
HAND are highly dependent on clinician knowledge and experience. The preliminary 
study was conducted with PLHIV attending outpatient clinics in three different 
geographic areas of Sydney, Australia. Those consenting to participate in the study 
were also asked to identify an informal caregiver that could be contacted to 
participate. Both groups were asked to complete a self-assessment questionnaire (a 
booklet) that had been previously developed by the candidate and colleague (Trotter 
and Cummins, 2008) to explore whether clients and caregivers had experienced or 
had observed any signs and symptoms of cognitive change in themselves or others 
over the previous 12 months. The questionnaire had 36 items grouped into four 
categories of behaviours: concentration, memory, motor skills and social issues, as 
well as information about signs and symptoms which could indicate HAND. The 
study was conducted from June 2012 to October 2014 to explore the exploratory 
research question: Can PLHIV and their informal caregivers identify HAND? 
 
The self-assessment questionnaire was completed by 121 PLHIV and 44 informal 
caregivers. Participants who had self-identified cognitive behaviour changes were 
contacted within two weeks of receipt of the assessment. At the same time, clinical 
and risk data from the electronic medical record (eMR) and notes from the 
participant's medical file were recorded. Initially, participants were asked to discuss 
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any items identified from their self-assessment with their doctor during the next 
consultation. It soon became apparent that this discussion was not taking place as 
participants stated they were either “not remembering” to mention issues to the 
doctor, “did not think it was important” or there “was not enough time”. The 
researchers intervened by transcribing the list of items selected by participants and/or 
their nominated caregiver and placing this list in a prominent place in the clinical 
notes to prompt discussion at their next appointment.  
 
Participants were able to provide free text in addition to completing the quantitatively 
designed survey. Informal caregivers provided additional insights and experiences 
relating to cognitive changes they had observed. As there were no other similar self-
reflective clinical assessment tools available at the time, the researchers decided that 
selection of four or more items of concern would determine the need (clinical 
indication) for further discussion with a medical practitioner. Therefore, when 
clinically indicated, patients were referred for neuropsychological testing with results 
made available to the researchers (as per patient consent). This clinical review process 
did identify participants at risk, some of whom were subsequently diagnosed with 
HAND.  
 
The preliminary study revealed that PLHIV and their informal caregivers are able to 
identify some of the signs and symptoms of HAND and indicated that discussion 
regarding the signs and symptoms of HAND could lead to an earlier diagnosis in 
some PLHIV. The quantitative data from this study offered beginning evidence to 
pose further questions for Phase 1.   
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3.6.2  Phase One: Online survey 
The preliminary study had been conducted with a purposive sample of PLHIV and 
their informal caregivers but was not designed to answer whether changes in 
cognition were affecting a wider population of PLHIV. A number of other questions 
were also raised by the preliminary study such as: Were other PLHIV experiencing or 
observing signs and symptoms of cognitive change? Had PLHIV heard of the term 
HAND? Were PLHIV concerned about HAND and were they talking to someone 
about these concerns? Would resources be useful to enhance communication between 
PLHIV, their caregivers and doctors so that they can speak confidently and feel safe 
about raising their concerns? 
 
In order to reach a larger and more diverse group of PLHIV and their informal 
caregivers, an online survey was collaboratively developed and distributed by a not-
for-profit community-based organisation supporting people with HIV called Positive 
Life New South Wales (PLNSW). Distributed over a three-week period in 2015, the 
survey contained open and closed-ended questions designed to elicit information on 
the demographic background of respondents and their awareness and experience of 
HAND. The survey focused on four signs and symptoms of cognitive change: Being 
slower in your thinking than you used to be; Being more forgetful than you used to 
be; Finding it harder to organise things than in the past and; Being able to find 
pleasure in the things you used to enjoy.    
 
Hosted on the Survey Monkey platform and accessed via the PLNSW website, the 
survey was also available via the PLNSW Facebook™ and Twitter™ accounts and 
therefore accessible to individuals living outside of NSW. Respondents could be HIV 
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positive or HIV negative, as some questions pertained to observing signs and 
symptoms of neurocognitive decline in others. One hundred and twenty-six 
respondents with an Australian postcode were included in the final sample (Figure 
3.1). As per ethical guidelines, completion of the online survey was considered 
consent and all responses were anonymous. Participants were advised prior to 
completion of survey the names of two researchers they could contact if they had any 
questions or concerns. No participant contacted the researchers.  
 
3.6.3  Phase Two: File audit 
The findings from Phase 1 confirmed that a broader sample of PLHIV and their 
caregivers were likely aware of HAND and were concerned about it. Further, the 
survey results suggested that cognitive changes related to HAND were being 
experienced by PLHIV and were possibly being observed by others. The next 
question was therefore, who fulfils the role of observing changes in daily functioning 
or cognition when a PLHIV does not have the support of an informal caregiver, 
especially if the PLHIV has little personal insight into the neurological changes they 
may be experiencing? In the absence of an informal caregiver, professional caregivers 
(those who are paid to provide health care and social support) are sometimes the only 
other group who has regular contact with PLHIV and who may be able to observe for 
changes in cognitive function over time. The next research question therefore sought 
to understand what kind of information routinely collected by HIV community-based 
teams could alert or assist health professionals to identify HAND. 
 
Phase 2 used a file audit method to collect clinical and social information from the 
medial records of PLHIV who were being cared for by two interdisciplinary HIV 
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community teams.  The file audit was completed over a four-week period using an 
electronic spreadsheet that had been designed with relevant data labels for community 
team members to populate. All members returned their spreadsheet to a nominated 
team leader to collate, ensuring that no personal identifying characteristics remained. 
Data fields included demographic, social and health information, co-morbid medical 
conditions and specific pathology results related to clinical indicators pertaining to 
HAND. Newly referred patients (within the four-week period) who had not been 
assessed were excluded from the audit. The files of all 262 PLHIV who were 
currently receiving health services at home from the two HIV community teams were 
included in the audit (Figure 3.1).  Quantitative data from the file audit were then used 
to build upon the explanatory sequential design, with selection of a modified Delphi 
method to expose essential items of assessment to identify those at risk of HAND in 
the community. 
 
3.6.4  Phase Three: Modified Delphi Method 
The main purpose of the Delphi method is to achieve consensus from a group of 
experts. Linstone and Turoff (1975 p.3) defined the Delphi method as “a method for 
structuring a group communication process so that the process is effective in allowing 
a group of individuals, as a whole, to deal with a complex problem”. Consensus is 
obtained from experts, termed ‘panel members’ through a series of structured 
‘rounds’ that examine the evidence to then reach agreement about a target issue 
(Keeney, Haason, & McKenna, 2006).  There are no universally agreed guidelines for 
the Delphi method (Evans, 1997), as such, flexibility can exist in the qualitative 
design which can be dependent on the objectives of the study.  In the traditional 
Delphi method, content for the first round is usually obtained from a literature review 
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and further rounds enable a number of individuals to provide their opinion 
anonymously as questionnaires are sent to each individual panellist, thus avoiding 
dominance of one person’s opinion (Boulkedid, Abdoul, Loustau, Sibony, & Albeti, 
2011; Linestone & Turoff, 1975).  More recently, a modified Delphi process has been 
used to introduce a hybrid of techniques to Delphi rounds including face-to-face 
meetings, use of secondary data, or qualitative interviews with participants (Keeney et 
al., 2006; Diamond et al., 2014; van Vliet et al., 2016; Eubank et al., 2016).  
 
Similarly, there is no universal approach to the selection of experts for Delphi panels, 
with choice of members more often related to practical logistics and the subject under 
investigation. The selection of the panel is important as the quality of expertise has 
been shown to be directly related to the quality of the results (Judd, 1972). Individuals 
who are primary stakeholders with first-hand knowledge of the subject area are 
targeted to elicit their enhanced experience and perspective (Anderson & Schneider, 
1993; Jones, 1974). Although many Delphi studies comprise between 15-20 panel 
members (Ludwig, 1997), it is usually more important that the panel size is able to 
represent a collective judgement of the target issue (Delbecq, Vande Ven & 
Gustafson, 1975). Commitment to participate in a multi-round Delphi can be inferred 
by the round-by-round response rate (Keil, Tiwana & Bush, 2002) which is related to 
a willingness by panel members to continue and good communication skills (Adler & 
Ziglio, 1996). 
 
The scoping review had raised a number of items for the Delphi panel to consider for 
the assessment tool. These included the monitoring of behavioural or cognitive 
change, and awareness of the social circumstances of PLHIV – who are increasingly 
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becoming more isolated (Emlet, 2006; McDonald et al., 2013). Other items included 
risk factors for HAND, including CD4+ T cell nadir count  (Ellis et al., 2011; Heaton 
et al., 2011); low CD4+ cell count (Schouten et al., 2012; Heaton et al., 2011); current 
or past drug and alcohol use (Letendre, 2011; Elbert et al., 2015) and; hepatitis C co-
infection (Schouten et al., 2012).  Additional items raised through the literature 
review included, knowledge of other co-morbid conditions which can  confound the 
diagnosis of HAND (Nightingale et al., 2015; Kamminga, Cysique, Lu, Batchelor, & 
Brew, 2013) such as  diabetes (Pinhero et al., 2016), cerebrovascular disease (Heaton 
et al., 2011; Tedaldi, Minniti, & Fischer, 2015) and hypertension (Rodriguez-Penny et 
al., 2013; Tedaldi et al., 2015). Furthermore, anecdotal evidence and professional 
experience of the clinical experts was considered such as medication, mental health 
and legal issues.  
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Figure 3.1: Phased explanatory design and development of research questions (Adapted from Jones & Hunter, 1995) 
PRELIMINARY STUDY                                        METHOD                                                  RESULTS            OUTCOME 
 
 
 
PHASE 1 
     
 
Can PLHIV and their informal 
caregivers identify HAND? 
YES. PLHIV and informal 
caregivers can identify HAND.  
Documentation of medical 
consultations limited. 
The preliminary study was conducted with a small and 
selected cohort.  
This led to further exploration of whether cognitive 
changes were a concern for a wider HIV positive 
population? 
Are PLHIV talking to others about their concerns?   
Do PLHIV feel they are being listened to? 
1. Are PLHIV aware of and/or 
concerned about HIV associated 
neurocognitive disorder?   
2. Are PLHIV experiencing signs 
and symptoms of cognitive change 
and/or observing them in others?  
 
YES PLHIV are concerned about 
HAND and outcome of 
discussion with others varied. 
YES PLHIV are observing S&S 
of cognitive change. 
Develop resources to facilitate discussion with 
others. 
This led to thinking, if the PLHIV does not have 
support of informal caregiver can a professional 
caregiver act as alternative to identify those at risk 
of developing HAND? 
Survey and file audit: 
121 PLHIV, 44 informal 
caregivers recruited. 
Online survey:  126 
responses. 
3. What information collected 
by HIV community based 
teams identifies patients at 
risk of HAND?   
NO, file audit noted incomplete 
documentation in every patient file.  
This led to thinking would HIV community teams 
find a risk assessment tool to identify PLHIV at 
risk of developing HAND useful? 
File audit of 2 teams:  
262 files reviewed. 
          PHASE 2 
YES, > than 80% consensus 
reached for information initial 
risk assessment tool and annual 
monitoring tool. 
 
Modified Delphi Method. 
Expert panel (n=25) from 
4 community health 
services. 
Flow chart to guide clinicians and an initial risk 
assessment tool and annual monitoring tool to 
assess PLHIV for HAND developed. 
4. What assessment criteria 
are essential to identify those 
at risk of HAND in the 
community? 
          PHASE 3 
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Requirements for expertise for this Delphi panel included knowledge and experience with 
PLHIV, HAND and working in a community setting.  The candidate purposefully selected 
experts from community-based services to maximize understanding of the underlying 
phenomenon. Twenty-five Delphi panel members were selected from four HIV community 
teams that had direct experience of providing clinical care, support and case management. 
Three teams were from three different locations within two local area health services in 
Sydney, Australia. Expert panel members from the fourth service deal with the additional 
complexity of offering a state-wide service with extended care to people with HAND living 
in regional and rural areas of NSW. All 25 participants were retained for each of three Delphi 
rounds (Figure 3.2). 
 
Typically, in the Delphi method, panel members are asked to rate indicators relating to the 
topic (such as functional and social indicators of decline in cognition in this study) and then 
the ratings are compiled, summarized and distributed for review before the next round 
(Davies, Romano, Schmidt, Schultz, Geppert, & McDonald, 2011). Each panel member then 
makes a judgement to agree or disagree (using a Likert or categorical scale) for the topic 
under consideration and so, consensus is determined (Jones & Hunter, 1995). Responses from 
each round are then fed back in summarised form to panel members who are then given an 
opportunity to respond again to the emerging data (Boulkedid et al., 2011).  The modified 
Delphi method selected for this study enabled panel members to contribute their expertise 
from a range of perspectives and to reach consensus on what observational and clinical 
information is important for risk assessment. The first small group meetings with each team 
received and rated data from the Phase 2 study (Round 1, Figure 3.2) and asked panel 
members how they would like the next round to take place. Due to time constraints and also 
to allow robust discussion, each panel member suggested that a large group meeting would be 
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beneficial in Round 2. At the conclusion of Round 2, the group decided that analysis of this 
round be distributed via email to each panel member to provide an opportunity for each panel 
member to independently and anonymously review the final documents (Round 3, Figure 
3.2). It was decided by consensus that if there were minimal comments and over 80% 
consensus had been achieved, a further “round” would be unnecessary.  
 
This ability to participate in decisions about modifications to the Delphi process, and a 
commitment by panel members to their patients was integral to full retention of all panel 
members within each round. A qualitative process was followed to iteratively develop 
quantitative content from the Phase 2 study which, on the recommendation of the panel of 
experts, would form the basis of an initial risk assessment and subsequent annual monitoring 
tool to be utilised by community based health professionals to assist in their identification of 
HAND for referral for early medical review. 
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Figure 3.2:  Modified Delphi Method Design 
 
 
 
Selection of experts 
 
 
 
 
 
 
 
 
 
ROUND 1 
 
 
 
 
 
 
 
 
 
 
ROUND 2 
 
        
 
 
 
 
ROUND 3 
 
 
 
 
 
 
 
 
 
 
Data analysis for consensus 
 
Report results to panel 
  
 
 
Inclusion criteria: 
 Employed in community setting 
 Experience providing care to PLHIV 
 Experience providing care to PLHIV with 
HAND 
 Four small group meetings (25 participants in 
total) 
 Identify content for initial risk assessment 
tool 
 Identify content for annual monitoring tool 
 Participant score agree/disagree on 5 point 
Likert Scale 
 Large group meeting (25 participants) 
 Feedback from Round 1 
 Agreement of questions for each tool 
 Analysis of Round 2 data 
 Redistribution of 2 tools by email to each 
“expert” 
 Panel asked to consider Round 2 
information  
 Analysis of Round 3 data 
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3.7  SUMMARY 
Techniques or methods of data collection and analysis are key to mixed method research and 
Creswell and Plano Clark (2007) argue that as research has an underlying worldview or 
assumption which guides the inquiry, the mixed method approach offers multiple world 
views. Structured data collection techniques (questionnaires, surveys and a file audit) used in 
this study led to potential strengths in quantification and reliability. Alternatively, qualitative 
data from the free text of surveys and from group work within the modified Delphi study 
brought a richer, more holistic understanding of the experience of HAND from the 
viewpoints of PLHIV, and their informal and professional caregivers. This is consistent with 
the use of an explanatory sequential design using mixed method studies in which the 
quantitative data and subsequent analyses provide a general understanding of the research 
problem, while the qualitative data and their analyses refine and explain quantitative results 
in greater depth  (Tashakkori & Teddlie, 1998; Creswell & Plano Clarke, 2007; Creswell, 
2008). The combination of quantitative and qualitative approaches provides a better 
understanding of the problem than either approach can achieve alone (Tashakkori & Teddlie, 
2003; Creswell & Plano Clark, 2007).  
 
A rigorous yet exploratory approach was needed to deliver the thesis argument. On a 
background of little or no published data, the aim was to gain a beginning understanding of 
the complexities of identifying HAND in PLHIV in order to facilitate their early diagnosis. 
The mixed method approach added strength to the design and a range of methods and tools 
were used for data collection in order to methodically study the phenomenon and answer 
research questions which likely could not be answered by designing a single approach. 
 
 
   
95   
3.8  CONCLUSION 
 
This chapter has described the underpinning paradigm and design of studies for this thesis. 
Pragmatism is guided by knowledge to unravel the complexities of the research questions by 
providing insights and experiences from the multiple realties and viewpoints of PLHIV, and 
their informal and professional caregivers, to bring about changes in practice.  The mixed 
method approach enabled movement back and forth between data to follow emerging ideas 
and allowing further exploration of the phenomenon that influenced research question 
development for each of three study phases.  Additionally, in a pragmatic decision to exploit 
unexpected qualitative data from Phase 1 and free text responses from Phase 2, several 
themes were revealed that offered new insights to the quantitative data.  
 
The explanatory sequential design chosen for this thesis allowed representation of varied 
viewpoints on the research topic using data from a preliminary study and three phases to 
explore the objectives of the study and enrich understanding to provide a more complete 
picture of the phenomenon from the specific experiences and perspectives of the participants.  
 
The following Chapters (Four to Seven) present the published results of the four studies 
conducted for this thesis (described as thesis with publication). As shown in Figure 3.1, 
Chapter Four outlines results from the preliminary study that included a self-assessment 
survey conducted within a larger prospective observational design. Chapter Five addresses 
the results from the Phase 1 online survey while Chapter Six presents results from the Phase 
2 file audit. Chapter Seven presents results from the modified Delphi Study conducted as 
Phase 3. Finally, Chapter Eight examines the results of each phase of the study and 
summarises the significance of the overall findings. Each phase has contributed to the 
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understanding of PLHIV and their caregiver’s experience of HAND and has identified agreed 
and specific content for the development of risk assessment screening tools for use by HIV 
community teams. The implications and suggestions for practice and future research are the 
focus of the final discussion. The chapter concludes with recommendations arising from the 
study and a proposal for future research. 
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CHAPTER FOUR 
Identifying HAND 
 
4.1 Overview and research question 
PLHIV may be experiencing signs and symptoms of cognitive decline which could be 
HAND. However, the identification of early signs and symptoms of HAND by PLHIV or 
their informal caregivers relies on both having an understanding of what HAND is, and the 
appropriate information to identify it. This chapter presents findings from a prospective 
observational study incorporating a self-assessment questionnaire. This study was designed to 
explore initial concepts and ideas through an exploratory research question: 
 
Can PLHIV and their informal caregivers identify HAND? 
 
The preliminary pilot study was designed to give context and direction for this thesis, as 
minimal published literature could be located relating to the possibilities and complexities of 
identifying HAND in PLHIV.  
 
4.2 Major findings 
A selected sample of PLHIV and their informal caregivers were observing signs and 
symptoms of cognitive change and can therefore potentially contribute to the diagnosis of 
HAND. Twenty three of 121 (19%) HIV positive participants from this study were offered 
further clinical neuropsychological examination following observation of signs and 
symptoms of HAND, by either themselves or their caregivers. Seventy percent (16) of these 
23 participants underwent standard neuropsychological testing as described in Chapter One 
and four were subsequently diagnosed with HAND as a result of these examinations. 
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4.3 Conclusion 
PLHIV and their caregivers are potentially able to identify early signs and symptoms of 
cognitive change and are therefore important partners in clinical assessment and future care 
planning, including contribution to the early diagnosis of HAND.  
4.4 Statement from co-authors confirming authorship contribution of the PhD 
candidate 
 
Chapter Four is published as:  
Cummins, D., Murray, K., Trotter, G., Batterham, M., Healey, L., O’Connor, C. C. (2017). 
Can patients and their caregivers boost identification of HIV associated neurocognitive 
disorder (HAND)? Australian Journal of Advanced Nursing, 34 (3), 24-33. 
Reprinted with the permission of AJAN. 
All authors made substantial contributions to editing and revising the manuscript.   
As co-authors of the paper titled: Can patients and their caregivers boost identification of 
HIV associated neurocognitive disorder (HAND)? we confirm that Denise Cummins made 
the following contributions: 
i. Concept and design of the study; 
ii. Collected, managed and analysed the data;  
iii. Primarily responsible for the interpretation of results;  
  iv.  Drafting, revising and writing up of the manuscript for submission to peer-reviewed 
journals. 
 
 
All authors read and approved the final manuscript. 
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In addition to the statement above, as supervisor for the candidature upon which this thesis is 
based, I can confirm that the authorship attribution statements above are correct. 
 
Name     Signature   Date 
Professor Donna Waters               06.08.2018 
 
 
 
 
 
 
 
 
 
   
100   
Title: Can patients and their caregivers boost identification of HIV Associated 
Neurocognitive Disorder (HAND)? 
Abstract 
HIV Associated Neurocognitive Disorder (HAND) may be difficult to identify as signs and 
symptoms (S&S) are nonspecific.  
Objective: to ascertain whether people living with HIV and their caregivers using a self 
reflective tool could identify S&S of HAND. 
Design: This study was a nurse led prospective observational multi-site study using a 
quantitative design. 
Setting: Participants were recruited from 3 sites in Sydney Australia: an inner metropolitan 
HIV clinic, an inner metropolitan sexual health clinic and a suburban hospital HIV clinic. 
Subjects: 121 patients and 43 caregivers who attended ambulatory clinics providing HIV 
care. 
Main Outcome Measures: Observing usual standard of care to follow patients who had 
formal neuropsychological testing and diagnosis of HAND.  
Results: Sixty one percent of participants and 57% of caregivers identified more than four 
symptoms.  Sixteen had neuropsychological exams; four were diagnosed with HAND. After 
changes to their medication regime all of those four showed an improvement in cognition. Of 
the remaining 11, four results were inconclusive, with some deficits noted.   
Conclusion: Patients and caregivers stated the booklet helped them to reflect on behavior 
changes which they could subsequently discuss with their doctor. The booklet was considered 
useful to identify S&S of HAND. 
KEY WORDS: People living with HIV, HIV associated Neurocognitive Disorder, mild 
neurocognitive disorder, Caregiver 
INTRODUCTION 
HIV is treated with medications known as antiretroviral drugs which has had a substantial 
positive impact on morbidity and mortality for People Living with HIV (PLHIV) and has 
   
101   
resulted in life expectancy approaching population norms for those individuals who have 
optimal adherence to HIV medications. (Clifford and Ances 2013). Yet, despite HIV 
virological suppression and immune recovery, studies suggest 30% of PLHIV are affected by 
HIV associated Neurocognitive Disorder (HAND), (Heaton et al 2010; del Palacio et al 2012; 
Clifford and Ances 2013)  significantly impacting quality of life (Tozzi et al 2004).  
In the 1980s, the clinical features of AIDS dementia complex (ADC) were those of a sub-
cortical dementia characterised by cognitive impairment, behavioural abnormalities and 
disturbed motor function. With the introduction of antiretroviral medications, ADC largely 
disappeared from clinical practice, but now milder forms of cognitive impairment are being 
observed.  In 2007, the classification for ADC was revised, and is now known as HAND. 
HAND is divided into three categories, each with varying degrees of disability impacting 
quality of life: Asymptomatic Neurocognitive Impairment (ANI), Mild Neurocognitive 
Disorder (MND), which causes symptomatic disease, and HIV Associated Dementia (HAD) 
(Antorini et al 2007).  This study focuses on the S&S associated with MND. 
MND affects the person’s ability to perform activities of daily living such as preparing meals, 
managing finances, attending doctors’ appointments and driving. It may also affect their 
social relationships and the ability to retain employment or be promoted. Caregivers can have 
a positive effect on the health and well being of PLHIV (Gisslen et al 2011) and may be well 
placed to notice any changes in the PLHIV. Signs and symptoms of MND may be subtle and 
are potentially normalised by PLHIV and may be difficult to detect by clinicians. Individuals 
may start to notice mild memory problems and slowness, difficulties in concentration, 
planning and multitasking (Grant 2008; Heaton et al 2010; Schouten et al 2011). 
A booklet was developed (Trotter and Cummins 2008) The booklet focuses on four key areas 
that affect cognition (memory, concentration, motor skills and social skills) for patients and 
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their caregivers to reflect on any changes in cognition. Using the booklet enabled the 
caregiver to recognise potential signs and symptoms of MND. It should be noted that some 
PLHIV may be socially isolated (McDonald et al 2013) and not have the support of a 
caregiver and may have no one they can rely upon who may notice changes in their cognition 
including memory, motor function and social behaviour. 
There are currently no biological markers for a definitive diagnosis of HAND (Atluri et al 
2014). Studies suggest predictors of HAND are: past history of AIDS defining central 
nervous system disease (Fabiani et al 2013), other central nervous system disease (Valcour et 
al 2004), low CD4 cell count (Schouten et al 2011), drug and alcohol use (Fiala et al 2005), 
low education level (Tedaldi et al 2015), and Hepatitis C infection (Schouten et al 2012).  
 PLHIV with cognitive impairment have been shown to be less adherent to HIV medication 
regimes. (Skinner et al 2009; Robertson et al 2010).  This may lead to drug resistant HIV, 
resulting in their current medication regime becoming ineffective (Skinner et al 2009; 
Robertson et al 2010).  Morbidity and mortality can then be affected as the person 
experiences poor health outcomes secondary to impaired adherence (Thames et al 2011).   
If identified and treated early, using aggressive HIV drug treatment or changing the 
medication regimen may lead to improvement in previous cognitive changes related to MND 
thus improving outcomes for patients (Cysique et al 2009). 
In addition as PLHIV age they may be at risk of other neurologic conditions associated with 
ageing such as vascular dementia and Alzheimer’s disease (del Palacio et al 2012). Thus the 
complexity of neurological health for PLHIV may be on the increase. The prevalence of 
MND among Sydney Australia  PLHIV is unknown. There is a paucity of literature regarding 
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PLHIV’s experiences of and reflections on signs and symptoms, which may be predictors of 
HAND.  
METHOD: study design, participants and study period 
Aim 
To consider the value of patient and caregiver use of a self-assessment booklet in leading to 
early medical assessment of MND.  
Design 
A quantitative study from a prospective observational multi-site study to evaluate the 
usefulness of a patient self-assessment booklet "HIV associated MND:  How to recognise 
signs and symptoms.”  (Trotter and Cummins 2008)  by PLHIV and their caregivers in 
recognising any signs and symptoms of cognitive impairment.  The study period ran over 28 
months from June 2012 to October 2014. 
Setting  
The study was conducted at three outpatient sites within two Health Districts covering a 
greater part of Sydney, Australia. 
Each site provides HIV specialist care: an inner city hospital based clinic, an inner city sexual 
health clinic and a suburban hospital based clinic.  The inner city clinics are in the inner west 
of Sydney, which has the second highest number of HIV diagnoses in NSW, Australia. A 
high proportion of patients seen at these clinics are men having sex with men (NSW HIV 
Strategy 2012-2015). The suburban hospital HIV clinic is in the outer suburbs of Sydney and 
cares for a high proportion of participants from culturally and linguistically diverse (CaLD) 
backgrounds.  
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Participants 
Participants were recruited whilst attending their regular multi-disciplinary consultation 
reviews at outpatient clinics at one of the three sites. Participants were eligible for inclusion if 
they were HIV positive over 18 years of age and they provided written consent at time of 
recruitment.  Participants could nominate a caregiver to be invited to participate in the study. 
For the purpose of this study caregivers were considered unpaid individuals who provide 
practical, emotional or financial support to the person, such as partners, family members and 
friends. Initial recruitment was over a 4 month period in 2012.  
Individuals were excluded if they were diagnosed with HIV in the last twelve months; had a 
preexisting identified cognitive impairment; were experiencing current social chaos or had 
inadequate English language skills. As depression may confound cognitive symptoms 
(Woods et al, 2009), patients who had current untreated depression were excluded but 
became eligible once their depression was treated. Current alcohol and substance use was 
assessed and patients with dysfunctional use were excluded from the study until substance 
and alcohol use was addressed. 
Participants completed a demographic questionnaire and were given the booklet "HIV 
associated MND:  How to recognise signs and symptoms” ( Trotter and Cummins 2008). The 
self assessment booklet was developed by a HIV Psychiatrist and HIV Clinical Nurse 
Consultants, informed by literature review and professional experience.  It was focus group 
tested for readability, clarity, design, flow and acceptability. The booklet has 36 items 
grouped into four categories of behaviours: concentration, memory, motor skills and social 
issues.  
Participants and caregivers were provided with the booklet and were asked to reflect on any 
changes experienced or observed over the last twelve months. If they noted any change in 
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behaviour over the previous twelve months we asked them to respond “Yes” to each relevant 
item. They were contacted two weeks later via telephone to provide responses to items 
selected from the booklet. 
A file audit was attended to ascertain specific risk factors for cognitive impairment including 
the participants’ HIV viral load, CD4 T cell nadir and current CD4 T cell count.  Current 
medication regimen was noted. The researchers observed the usual standard of care at 
medical consultations. Initially the researchers asked participants to discuss items identified 
in the booklet with their doctor during the next consultation. It became apparent that the 
discussion was not taking place as participants stated that they were either not remembering 
to mention issues to the doctor, did not think it was important or that there was not enough 
time. The researchers intervened by transcribing the list of items selected by participant 
and/or their nominated carer, placing the list in a prominent place in the clinical notes to 
promote discussion at the next appointment. This resulted in increased discussions of the 
items selected. 
As there was no other PLHIV self-reflective booklet available at the time to use as a guide, 
the researchers decided selection of 4 or more items would be flagged with medical 
practitioner for patient discussion. Previously we relied on clinical judgement and incidental 
anecdotal evidence from PLHIVs to discuss issues relating to HAND. 
All neuropsychological testing was conducted by a trained clinical neuropsychologist. This 
procedure followed the usual required battery of tests required as a neuropsychological exam. 
The results were made available for the researchers to ascertain which participants completed 
the exam and final results. The clinical review process of participants diagnosed with MND 
was observed for changes in treatment prescribed by their doctor and the outcome of the 
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treatment. Data entry was completed by one member of the team who was not involved in the 
recruitment process.  
STATISTICAL ANALYSES  
Data was analysed using SPSS (V21 IBM Corporation Armonk, NYl, USA). Analysis 
included presentation of descriptive statistics, Chi Square tests, Mann Whitney and Kruskall 
Wallis tests as indicated. 
ETHICS 
Ethics submission had been approved by Royal Prince Alfred Hospital Research Ethics 
Committee (X10-0354+ HREC/10/RPAH/618) and Liverpool Hospital Research Ethics 
Committee (SSA/11/LPOOL/203) Sydney Australia.  
RESULTS 
Of 331 people screened for enrolment in the study 165 (50%) were ineligible and 45 (14%) 
declined participation.  At the suburban hospital site 30 people were not screened for 
enrolment due to limited staffing issues during study period which impacted on the overall 
number of participants able to be recruited at that site. Table 1.summarises the exclusion 
criteria of the 165 ineligible PLHIV. 
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Table 1: Exclusion criteria of patients excluded  
Criteria Total 
New Diagnosis of HIV 12 
Pre-existing Ccognitive Impairment  34 
Social chaos 16 
Poor English 44 
Drug and Alcohol Use  16 
Current untreated depression 13 
Declined  30 
Total excluded 165 
 
In total 121 participants and 43 caregivers across the 3 sites were recruited (Table 2). 
Table 2: Participants and Caregivers recruited 
 Total 
Number of participants 121 (100%) 
Number of participants who identified 4 or more S&S 74 (61%) 
Number of caregivers 44 (35%) 
Number of caregivers who identified 4 or more S&S 25(57%) 
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More than one third of participants (39%) noticed some behaviour change in themselves and 
28 (23 %) were concerned about these changes in behaviour. 
The mean age of participants was 49 years old, range 25 to 75years.  Ninety six per cent were 
men (116). Forty nine participants (40.5%) lived alone, 46 (38%) lived with a partner and 24 
(20 %) lived in shared households. Two participants lived (2 %) with children. 
Depression  
Forty eight (39.7%) participants had a history of depression, which is consistent with the 
prevalence of depression in HIV positive populations (Grierson, et al, 2009).  32 (26.4%) 
were currently being treated for depression.  Those with depression tended to have more 
symptoms selected from the booklet than those without current depression. P=0.056 Mann 
Whitney Test.  
HIV Information 
The median duration of HIV infection of participants was 10 years, range (0 – 29) which 
indicated that the participants had been infected for some time and therefore be at increased 
risk of developing co-morbid conditions. The CD4 T lymphocyte cell count is a marker of 
antiretroviral treatment responses and HIV disease progression. The participants’ median 
CD4 count was 590x107 (10 – 1720) which is within normal limits, indicating that 
participants have adequate immunity; CD4 nadir count is the lowest that it has ever reached 
and low CD4 nadir count is also a predictor of HAND, the median CD4 nadir was well below 
normal CD4 count at 180 x107 (0 – 750); median prescribed antiretroviral medications 
therapy was 6 years (0 – 28). 
Risk factors for non-HIV related cognitive impairment 
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Many PLHIV have co-morbid conditions. A review of participants’ clinical notes revealed 
risk factors for non-HIV related cognitive impairment( Table 3).  Of these factors, none were 
statistically significant.   
Table 3: Identified from clinical notes patient Risk factors for cognitive impairment 
Current Conditions Yes P Mann 
Whitney 
P t test 
Hepatitis C virus 10 (8.3%) 0.046 0.159 
Hypertension 31 (25.6) 0.443 0.155 
Prescribed Antihypertensive drug 29 (24%) 0.734 0.280 
Hypercholesterolemia 79 (65.3%) 0.803 0.452 
Hyperlipidaemia 61 (50.4%) 0.203 0.406 
Sleep Apnoea 5 (4.1%) 0.498 0.361 
Diabetes 7 (5.8%) 0.078 0.033 
Current smoker 38 (31.4) 0.010 
(Kruskal 
Wallis) 
0.23 ova 
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Antiretroviral medications 
Ninety four per cent (114) were currently taking antiretroviral medications.  Of these, 30% 
(n=36) were on a once daily co-formulated single pill regimen, and 33 (n=40) took 3 or more 
pills per day. 
Eleven per cent (n=13) had missed more than two doses of medications in the last month. 
There was a trend for a higher number of symptoms in the group who were not adhering to 
their medications P=0.070 Mann Whitney Test.  
Caregivers 
Seventy seven participants (64%) did not nominate a caregiver to be contacted.  Six 
caregivers declined to be involved.  The suburban hospital recruits (n=14) did not identify 
any caregivers. Of the caregivers identified (n=44), 82% (n=36) were male and 18% (n=8) 
were female.  The relationship of the caregiver to the PLHIV varied:  twenty-eight were male 
same sex partners, six were female partners of men, three were husbands of women, one was 
a mother, one a son, four were male friends and one was a female friend. 42% (n=15) of the 
caregivers identified as PLHIV.  Of these, 73% (n=11) were in same sex relationships. 
The most reported symptoms by both caregivers (47%) and participants (67%) was “being 
mentally tired at end of day” and caregivers 64% and participants 67%,  “have you noticed 
you don’t go out socially as much as you used to?”  
Neuropsychological examination 
Twenty three (19%) participants were offered clinical neuropsychological examination from 
their doctor following use of the booklet, 70% (n=16) underwent the usual standard battery of 
tests performed in the clinical neuropsychological examination and 30% (n=7) declined 
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testing  (Table 4).  Four participants were diagnosed with MND as a result of these 
examinations. 
Table 4: Neuropsychological Exam Results 
Number of Neuropsychological exam (n=16) Results of Neuropsychological exam  
5 (31%) Inconclusive, ongoing monitoring 
recommended 
7(44%) Within normal limits (1 depression, 1 sleep 
apnoea) 
4 (25%) MND diagnoses (medication regimen 
optimised, subsequent improved cognition 
noted) 
 
DISCUSSION  
MND can have a detrimental impact on the health and well-being of PLHIV. As part of the 
HAND spectrum, MND may be difficult to identify because key signs and symptoms are 
nonspecific. Signs and symptoms of MND may be subtle and often the PLHIV and their 
caregivers may believe signs and symptoms are attributable other issues such as ageing, stress 
and/or lifestyle factors.  
There were no previous studies regarding PLHIV and/or Caregivers’ self-reflection of signs 
and symptoms of cognition to guide us. The researches chose the identification of 4 or more 
symptoms by either participants or caregivers as a cue to monitor subsequent investigations 
and current standard of care. The 61% of participants and 57% of caregivers who identified 4 
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or more symptoms supported adoption of   using the booklet to reflect on changes in the 
participants behaviour . 
Caregivers are well placed to notice changes in cognitive behaviour (Glissen et al 2011). 
Many stated that they welcomed being involved in the study and that using the booklet to 
help reflect on the PLHIVs behaviour enabled them to start a discussion regarding behaviours 
they had noticed but did not know how to raise with the person.  In addition some of the 
caregivers also identified as PLHIV and this may impact on future support if they as the 
caregiver also become ill or cognitively impaired.  
Many of the participants live alone and did not identify caregivers who may be well placed to 
notice any changes in cognitive behaviour. At one site, none of the participants identified a 
caregiver. A majority of these participants were MSM who were married to women. Their 
lifestyle did not include HIV culture of gay men in Australia, perhaps best illustrated by one 
participant “We don’t talk about the HIV much, and I sure don’t want to mention this”. The 
clinician needs to be more vigilant in asking PLHIV without identified carers about 
cognition. The combination of PLHIV reflecting regularly on their behaviour and staff with a 
therapeutic relationship with the PLHIV, including knowing their social situation may 
combine to improve identification of impairment (as PLHIV may underrate signs and 
symptoms). As this population age they may become isolated socially (McDonald et al 2013) 
and the relationship with their clinician may become very important for asking questions 
about cognition.  Discussion of cognition and memory should be incorporated and normalised 
into an annual review of HIV care, and may result in early detection (Wright and Watson 
2012). This may reduce fear and apprehension of results from neuropsychological testing and 
enhanced discussion of signs and symptoms (Several participants declined testing due to fear 
of the outcome and being labelled cognitively impaired).  
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Regular reflection by the PLHIV and their caregiver may assist in early interventions for 
HAND screening and diagnosis. Many of the participants had long standing HIV which may 
place them at risk of developing HAND even though their HIV was well managed (Antorini 
et al 2007). The average age of participants was 49 years and as they age they may be at risk 
of developing co-morbidities such as heart disease which may affect cognitive impairment 
and may need to be closely monitored for signs and symptoms of cognitive impairment. The 
greatest co morbidity risk factors for cognitive impairment identified in the participants were 
vascular risk factors, such as:  current nicotine smoking (31%), those with 
hypercholesterolaemia (65%), hyperlipidaemia (50%), or hypertension (25%). (Table 3) 
These figures point to the need to monitor patients and develop strategies to improve 
management of co morbidities such as smoking cessation. In addition successful management 
of co morbidities may help improve HAND outcomes (Wright and Watson 2012).  
The signs and symptoms of depression may confound MND diagnosis so it is important to 
screen the PLHIV for this (Grierson et al 2009).  Forty per cent of participants in this study 
had a previous history of depression, 26% were currently being treated for depression and 9% 
identified signs and symptoms of depression, and so were excluded from the study until 
reviewed by their doctor. The group who were currently being treated for depression were 
non-significantly more likely to have S & S of cognitive impairment (p=0.056).  Many 
PLHIV were excluded from this study due to current untreated depression, substance use 
issues and language difficulties. Early detection and treatment of depression, providing 
assistance with depression and substance issues and developing resources in different 
languages would support improvement of rates of PLHIV being identified with and treated 
for MND. 
Ninety four per cent of the participants were prescribed antiretroviral medications.  Of these 
33% were taking more than 3 antiretroviral drugs.  The researchers did not enquire about 
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other medications.  Pill burden may be a factor in adherence (Skinner et al 2009; Robertson et 
al 2010).  Eleven per cent had missed > 2 doses of medications in the last month.  This group 
had a non-significantly higher number of items from the booklet (P=0.070).There is a 
potential for a closed feedback loop whereby the patient with adherence problems may, as a 
result of the poor adherence, suffer further cognitive decline, leading to further impairment of 
adherence. 
This study enabled some people who would otherwise been missed to be identified and 
referred for neuropsychological assessment. Using this booklet the PLHIV was able to reflect 
and use the booklet to report to clinicians, leading to neuropsychological testing. Several had 
their treatments changed and had improvements in cognition when subsequently reviewed 
(Table 4).  Thirty per cent of PLHIV offered neuropsychological testing declined. Nurses are 
well placed to explore the reasons for declining and facilitating understanding of the 
improved outcomes formal testing could facilitate. The therapeutic relationship between 
patient and nurse may promote an open conversation, allowing the nurse to provide 
information to the PLHIV enabling further assessment and investigations. 
Initially participants did not divulge items they had noticed from the booklet with their doctor 
as they did not think it was important, forgot or ran out of time. Nurses are well placed to 
discuss this with patients prior to their appointment with their doctor, to ask if the person has 
noticed any recent changes in cognitive symptoms or behaviours. Information from this 
discussion can be documented and brought to the attention of the doctor prior to the 
consultation. Nurses can use the booklet to initiate discussion and with regular questioning 
normalize the issue with the patient. Scheduled annual review of the patient would also be of 
benefit, utilising the initial documentation as a baseline for noticing changes in behavior and 
cognition. 
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LIMITATIONS/CHALLENGES 
There were several challenges during this study. 
There was no HIV negative matched comparison group for this study. This study was 
designed to follow the patient through their usual standard of care at the clinic they attended. 
Future studies could include a comparison group. 
As there was no validated self reflective tool available we relied on professional judgement 
and incidental anecdotal evidence from PLHIVs to discuss issues relating to HAND. We 
decided to flag if four or more items from the booklet were selected. 
Exclusion of people who did not speak English well excluded many possible study 
participants. Translation of the resource into community languages would assist in 
recruitment of this group in future. 
IMPLICATIONS FOR PRACTICE 
Nurses providing care and support to PLHIV should be aware of HAND and what questions 
to ask, and should explore further patients’ experience. A booklet exists which can be used by 
clinicians, patients and their carers to start a conversation about any signs and symptoms the 
PLHIV may be experiencing - assisting the PLHIV to reflect on recent changes in behaviour 
such as memory and concentration problems which could affect their quality of life. 
Reflection of change may prompt further exploration by their doctor of cognitive decline.  
Early recognition and treatment may have a positive impact on the health and well being of 
the patient by reducing signs and symptoms and restoring independence. 
As PLHIVs age and are at risk of developing other diseases of the brain, a HAND diagnosis 
should be considered in a neurological setting.   
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CONCLUSION 
PLHIV are experiencing signs and symptoms of cognitive impairment which can affect their 
quality of life. HAND is a diagnosis of exclusion and PLHIV and their caregivers can have a 
major part in recognising signs and symptoms.  Self-reflection is very important, as is 
reflection from caregivers. 
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CHAPTER FIVE 
Experience of HAND 
 
5.1 Overview and research questions 
The preliminary pilot study indicated that some PLHIV are experiencing changes in 
cognition, are recognising these, and are concerned about HAND. An anonymous online 
survey was designed as Phase 1 of this thesis to give context to the experience of a broader 
population of PLHIV regarding HAND. The survey included questions about how PLHIV 
communicate with others about HAND. The results are presented here in the context of 
examining the research questions:  
1. Are PLHIV aware of and/or concerned about HIV associated neurocognitive 
disorder?   
2. Are PLHIV experiencing signs and symptoms of cognitive change and/or 
observing them in others?  
 
5.2 Major findings 
A total of 163 survey responses were completed. Thirty-seven were excluded (28 
international responses and 9 duplicate responses), leaving 126 surveys for the final analysis. 
Of 126 eligible responses to the survey from PLHIV across Australia, 94 (75%) had heard of 
HAND and 74 (59%) had noticed symptoms of HAND in themselves and in others.  Results 
showed that of the 94 respondents who had heard of HAND, 52 (55%) were concerned about 
it, and of these, 48 (92%) were anxious to talk about the subject. Yet of the 30 respondents 
who had spoken to someone about their concerns, 23 (77%) had received a positive response 
and stated that they felt they had been listened to. 
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Forty-nine (39%) of respondents indicated that they would like further guidance to initiate 
discussion about HAND with their doctor, caregiver or other PLHIV. The only statistically 
significant finding from this study was that those who had noticed a decrease in their ability 
to organise things in their daily lives had been diagnosed with HIV approximately five years 
longer, on average (17.4 years, SD 9.99 years), than those who responded ‘No’ to this 
symptom (11.9 years, SD 10.13 years, p = 0.033). 
 
5.3 Conclusion 
Further to the literature related to stigma and discrimination discussed in Chapter 2, the 
results of this study clearly show that responses to questions or discussion about HAND can 
impact on the willingness of PLHIV to seek further help for medical review and/or 
acceptance of other supports. Raising the awareness of HAND may reduce concerns and 
encourage engagement in open conversation with others for the benefit of PLHIV and their 
informal and professional caregivers. PLHIV also identified that the development of 
additional resources to facilitate communication with caregivers would be helpful.  
5.4 Statement from co-authors confirming authorship contribution of the PhD 
candidate 
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30 (5), 609-617.   doi: 10.1080/09540121.2018.1426826 
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TITLE: Voices from Australia– concerns about HIV associated neurocognitive disorder 
 
Abstract 
This study aimed to determine whether people living with HIV (PLHIV) are concerned about 
HIV associated deurocognitive disorder (HAND) and would find information and resources 
for HAND beneficial.  An online survey focusing on the experience of HAND was 
distributed via the website of Positive Life New South Wales: a peak peer-support non-
government organization in Australia.  
Of 126 respondents, 94 (74%) had heard of HAND, 52/94 (55%) had experienced concerns 
and of these, 48/52 (92%) felt anxiety about discussing the subject. Of those who had 
experienced concerns, 30/52 (58%) had spoken to someone about these concerns and 23/30 
(77%) had received a positive response. Across the entire sample, 74 (59%) had noticed 
symptoms of cognitive decline in themselves and/or others. Respondents who noted a 
decrease in their ability to organize were on average five years older than those who had not 
noticed a decline (p=0.012, effect size -.54). Forty-nine (39%) indicated that they would like 
guidance to initiate discussion about HAND with their doctor, caregiver or other PLHIV.  
The survey findings suggest that increasing awareness of HAND among PLHIV and their 
caregivers, and providing resources to facilitate discussion about HAND may assist to reduce 
concerns among PLHIV and enhance the effectiveness of clinical review. 
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People living with HIV, HIV Associated neurocognitive disorder, caregivers, stigma 
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Background  
Due to the success of HIV treatments, people living with HIV (PLHIV) are now an ageing 
population (Deeks, Lewin, & Havlir, 2013). In addition to being at similar risk of developing 
dementias as the general ageing population, ageing PLHIV have an increased risk of 
neurocognitive co-morbidities such as HIV associated neurocognitive disorder (HAND) 
(Rodriguez-Penney et al., 2013;  Hopcroft et al., 2013). HAND is an umbrella term used to 
describe a subcortical neurodegenerative disease caused by HIV-1 infection that may affect 
more than 30% of PLHIV (Antinori et al., 2007; Clifford & Ances, 2013). Older PLHIV, 
routinely defined as older than 50 years of age (Kirk & Goetz, 2009), have a three-fold risk of 
HAND when compared to younger peers (Valcour et al., 2004), resulting in experience of 
cognitive and neurological decline during mid-life  (Cohen, Seider , & Navia, 2015).  
Awareness, knowledge and experience of HAND is varied, and little is known about the 
perspectives of PLHIV towards HAND (Hopcroft et al., 2013; Moore et al., 2015).   
Cognitive impairment is associated with poor quality of life and may impact upon skills 
needed to perform activities of daily living (Cody & Vance, 2016; Tozzi et al., 2003).  
HAND can impact a range of cognitive domains, including motor skills, psychosocial, 
memory, concentration and executive function (Clifford & Ances, 2013).  Moore et al. (2015) 
found that for PLHIV with HAND, cognitive performance was inversely related to the 
amount of time spent engaged in passive leisure activities, with neurocognitive impairment 
being linked to passivity and decreased participation in cognitively stimulating activities 
(Fazeli et al., 2014). Conversely, engagement in physical, mental and social activities have 
been associated with improved cognitive outcomes and a lower prevalence of HAND (Tan et 
al., 2013).  
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While dementia primarily affects individuals over 65 years, HAND impacts a much younger 
population of PLHIV (Pascal et al., 2016).  A diagnosis of HAND can create fear about loss 
of independence and mental capacity, and is associated with delay in help seeking (Gagnon, 
2015; Chambers et al., 2015).  Those with HAND may experience increased social isolation, 
with some PLHIV already living alone due to an age related decrease in social participation 
and shrinking social networks (Rueda, Law, & Rourke, 2014).  Further, the symptoms of 
HAND may also affect medication adherence, with a resulting impact on general health (Katz 
et al., 2013; Vance, 2013). The recognition and diagnosis of HAND in PLHIV is therefore 
important, particularly as HAND is associated with an increased risk of morbidity and 
mortality (Skinner, Adewale, DeBlock, Gill, & Power, 2009) and there is potential to 
minimise the impact of HAND if treated early (Cysique et al., 2009).  
The purpose of this exploratory study was to gain an understanding of the knowledge of 
HAND among PLHIV. The aims were to investigate if PLHIV in Australia 1) had knowledge 
of and were concerned about HAND; 2) had noticed any signs and symptoms of cognitive 
decline in themselves or others; 3) had discussed HAND with either a professional or 
informal caregiver; 4) whether knowledge of and concern about HAND were associated with 
age and the duration of HIV diagnosis; and 5) whether PLHIV thought resources for HAND 
would be helpful.  It was anticipated that the results could be used to inform clinical care and 
the development of relevant resources for PLHIV and their caregivers.   
 
Method 
An online survey was designed with and distributed by Positive Life New South 
Wales (PLNSW); a non-profit community-based organization supporting people with HIV 
living in New South Wales (NSW), Australia. The PLNSW organization aims to eliminate 
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the stigma, discrimination and isolation of PLHIV, and advocates with government and non-
government organizations on behalf of this group (Positive Life, NSW). Although a state-
based organization, PLNSW has national and international reach through internet and social 
media networks.  
 
Survey development and distribution 
The online survey was developed by two of the study authors, both of whom have extensive 
clinical experience with PLHIV. The survey contained both open-ended and closed questions 
designed to elicit information on the demographic background of the respondent and their 
awareness and experience of HAND. Closed question response options were ‘Yes’, ‘No’ or 
‘Don’t know’ with embedded logical branching, while open-ended questions provided 
respondents with unlimited free text space to discuss their experience of HAND. The content 
of the survey focused on four signs and symptoms of cognitive change: slowed thinking, 
increased forgetfulness, decreased organisational skills and decreased pleasure in activities. 
The survey was piloted for readability, face validity and appropriate language with HIV 
positive volunteers. 
The researchers anticipated that awareness of HAND was likely to be varied and that concern 
and anxiety may be higher in older age groups for whom the signs and symptoms of HAND 
may be of longer duration or more obvious. As PLNSW applies standard age groupings 
across all investigations and reports, older age was defined in this survey as those over 45 
years. The analysis explored associations between age, duration of HIV infection, and signs 
and symptoms that could be indicators of HAND. The words ‘concern’ and ‘anxiety’ were 
purposefully not defined in the survey so that participants could answer questions about these 
emotions from their own perspective. The study was approved by the Human Research Ethics 
Committee (HREC) of the Sydney Local Health District, NSW, Australia and endorsed by 
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the HREC of the University of Sydney.  Consent was implied by online submission of the 
survey. 
 
The survey was distributed via the PLNSW website over a three-week period from August to 
September 2015. Access to the survey, hosted on the Survey Monkey platform, was also 
available via the PLNSW Facebook and Twitter accounts. Respondents were informed that 
participation was voluntary and results would remain anonymous. Only respondents with an 
Australian postcode were included in the final sample due to possible cultural and health 
service differences between countries. 
 
Data Analysis 
Responses entered into the Survey Monkey platform were downloaded for analysis into IBM 
SPSS Statistics (SPSS Version 21, IBM Corporation Armonk, NYI, USA). Demographic and 
other variables related to HIV and HAND are reported as number and percentage, or mean 
and standard deviation, as appropriate. Duration of HIV was analysed using Analysis of 
Variance (ANOVA) or independent groups t test following confirmation of normality 
through a histogram and Q-Q plot. Differences in categorical variables were analysed using 
Chi Square tests of independence. Adjusted Standardised Residuals (ASRs) were used to 
further interpret significant Chi Square test results (Field, 2013).  
 
For all analyses, a p value of <0.05 was considered statistically significant. As an indicator of 
the practical or clinical significance of differences in HIV duration and cognitive decline, 
effect sizes (Cohen’s D) are reported.  A 0.50 (medium) criterion was chosen as a benchmark 
against which to assess the effect sizes in this study, as this is conventionally the effect size at 
which a trained observer can detect a difference (Norman, Sloan, & Wyrwich, 2003). There 
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has been no adjustment for multiple testing in this exploratory study as measures to control 
for the Type I error rate (such as Bonferonni adjustment) are conservative and may fail to 
reveal potentially important early findings. 
Results 
A total of 163 survey responses were received over the three-week period the survey was 
open online. Thirty-seven responses were excluded (n=28 international responses and n=9 
duplicate responses), leaving 126 surveys for the final analysis. Table 1 outlines the socio-
demographic profile of respondents and notes a broad sample with the majority being English 
speaking males born in Australia and identifying as homosexual. 
<Table 1 here> 
Awareness of HAND 
Seventy-five percent of respondents (n=94) had heard of HAND and results in Table 2 are 
based on the responses of these 94. The remaining 32 (25%) respondents who did not know 
about HAND did not respond to questions about concerns or anxiety, nor identified having 
spoken to others about it. 
<Table 2 here> 
Of the 94 respondents who had heard of HAND, 52 (55%) reported concerns. Of these 52, 
the highest percentage (n=38, 73%) were in the 45-64 age range, 48 (92%) reported feeling 
anxious about discussing the subject and 30 (58%)  had already spoken to someone about 
their concerns. Of these 30, the majority (n=23, 77%) felt they had been listened to, usually 
identifying their HIV medical specialist. Seven (23%) respondents had a negative response, 
with 5 of these 7 (71%) stating they would not discuss their concerns again. 
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Those respondents who had heard of HAND (n=94) had been living with HIV for a longer 
period of time (mean 16.5 years, SD 10.00) than those 32 who indicated no knowledge of 
HAND (12.3 years, SD 10.62, p = 0.047, Cohen’s d 0.40). There was no statistically 
significant difference in the duration of HIV infection among those 52 people who expressed 
concern about HAND (mean duration 16.0 years, SD 9.12) and those 42 who did not (mean 
duration 17.1 years, SD 11.08, p>.05, Cohen’s d -.10).  
Experience of cognitive impairment 
When asked about which signs and symptoms of cognitive impairment 126 respondents had 
noticed in themselves or in their HIV positive friends, 74 (59%) reported that they were 
finding it harder to organise things; 68 (54%) had experienced or observed slowed thinking; 
65 (52%) noted increased forgetfulness; and 47 (37%) reported having less pleasure with 
activities. Fifty-three respondents (42%) reported that other people had noticed changes in 
their cognition and 30 (24%) had noticed some cognitive changes in their friends who were 
living with HIV. 
Respondents expressed varying levels of comfort in discussing cognitive changes with others. 
Just over one-third of respondents (n=49, 39%) indicated that they would be able to discuss 
cognitive changes with their friends. A further 49 (39%) responded that they would like more 
information on how to broach the subject of changes in cognition observed in themselves or 
in others. 
Cognitive change and duration of HIV infection 
The study focused on four signs and symptoms of cognitive change (slowed thinking, 
increased forgetfulness, decreased organisational skills, decreased pleasure in activities). The 
duration (in years) of HIV for those who responded ‘Yes’, ‘No’ or ‘Don’t know’ to each of 
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the signs and symptoms was compared using one-way ANOVA (Table 3). The only 
statistically significant finding was in the reported ability of respondents to organise things (p 
= 0.033). Post hoc testing indicated that those who responded ‘Yes’ to this symptom had been 
diagnosed with HIV approximately five years longer (17.4 years, SD 9.99) than those who 
responded ‘No’ (11.9 years, SD 10.13, p = 0.012, effect size 0.54).  Although not statistically 
significant, medium effect sizes were also evident for differences in HIV duration between 
those who responded ‘No’ and ‘Don’t know’ to experiencing slower thinking (0.51) and for 
those who reported being more forgetful (0.50). 
<Table 3 here> 
Cohen et al. (2015) has noted that some PLHIV may begin to experience signs and symptoms 
of HAND in their mid 40’s. The experience of the four cognitive signs and symptoms 
explored in this study were compared between three age ranges (18 – 44, 45 – 64, >64 years). 
There were no statistically significant associations between age and respondents’ experience 
of these four signs and symptoms of changes in cognition. There were also no statistically 
significant differences between the occupational status of the respondent (full time, part time 
work, or student) and three of the signs and symptoms of cognitive change. However, a 
statistically significant result was found for the association between occupational status and 
respondents’ experience of being more forgetful (p=0.016). The adjusted standardised 
residuals (ASR) indicated that 33 of 47 (70.2%) people on a government benefit had noticed 
becoming more forgetful (ASR 3.2), whereas this was the case for only 20 of 55 (36.4%) of 
people who were working full time (ASR -3.0).  
Themes from open ended questions 
In addition to the 52 (55%) closed question responses indicating concern about HAND, 62 
(49%) specific responses were also made to the open-ended survey question ’What are your 
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concerns about HAND?’ and a further 30 (24%) of all survey respondents also chose to 
provide additional final comments. Several consistent themes were identified from the two 
opportunities to provide comment to the open-ended questions.  Collectively, comments 
outlined fear of a HAND diagnosis (n=27, 29%); fear of losing mental capacity (n=26, 28%); 
general fear for the future (n=12, 13%); and fear of loss of independence (employment and 
becoming a burden on others) n=9 (10%).  
Examples of respondents’ comments include: 
Some family and friends have "heard" me when I bring up my sense that I am in early 
cognitive decline, but most doctors just look at you; say little, or dismiss it as not being all 
that bad.  This makes me feel dismissed; like I'm over-exaggerating it all. 
I am worried about …memory issues, concentration, multiple tasking issues, short attention 
span.  All of these affect my day to day living issues as well as ability to work well in 
employment. 
I don’t want to end up in a human waste facility, "rest home", ignored, and by some staff 
treated badly and by other staff. 
Of the total 126 respondents, 8 (9%) disclosed they had a current diagnosis of HAND and 
some (n=5, 5%,) expressed concern that they would not notice further cognitive decline. As 
the examples below illustrate, there was a genuine expression of fear of future consequences.  
 I don’t want to die lying in my own body waste, I don't want to be some brain dead vegetable 
that people are scared of or laugh at.   
I would rather go before any long term, visibly embarrassing traits develop.... I just don't 
want my family seeing me like that.     
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Discussion 
People living with HIV are ageing and are at risk of developing HIV associated 
neurocognitive disorder (Rodriguez-Penny et al., 2013; Hopcroft et al., 2013).  If diagnosed 
and treated early, the adverse impacts of HAND can be minimised (Alzheimer’s Australia, 
2014; Cysique et al., 2009). This explorative study utilised an online survey to gain an 
understanding of the knowledge of HAND among PLHIV.  Overall, respondents did know 
about HAND, had concerns about it, and some had experienced signs and symptoms which 
may be related to HAND. Respondents in the 45 – 64 year age group expressed the greatest 
levels of concern, and reported varied levels of comfort discussing HAND with others. 
Hopcroft et al. (2013) suggest that as PLHIV age, with an increasing duration of HIV 
infection, they become increasingly concerned about cognitive impairment. However this 
study found no statistically significant differences in respondents’ duration of HIV infection 
and concern about HAND.  
It was encouraging that many respondents who had discussed their concerns about HAND 
reported a positive response to those discussions. Many had already noticed changes in 
cognition among people in their social networks, but generally did not feel comfortable to 
talk to their friends directly about this. As almost one-third of respondents indicated that 
additional resources about HAND would be helpful to facilitate discussions with formal and 
informal supports, this could be one relatively simple and cost-effective solution to reducing 
fear and apprehension and promote early recognition of HAND. Resources could be used to 
provide ideas on how to communicate experiences to others, and could increase confidence to 
access medical review if signs and symptoms of HAND become apparent (Moore et al., 
2015; Morgan et al., 2012).   
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Although many respondents stated they had experienced some signs and symptoms of 
cognitive decline (which could be indicative of HAND), the only statistically significant 
symptom related to HIV duration was the inability to organise things as they used to. This 
symptom has potential impacts on general health and quality of life through a decreased 
ability to organise medical reviews, self-care, medication supply and adherence, and activities 
of daily living (Cody and Vance 2016).   
Moore et al. (2015) noted that cognitive performance was inversely related to time spent 
engaged in passive leisure activities. In this study, many PLHIV were not in paid 
employment, with over one-third receiving a government benefit. As respondents were not 
specifically asked about their social engagement, it cannot be assumed that they were not 
engaged in social activities, yet it was found that those not employed or studying did appear 
to experience forgetfulness more often than those who were currently employed.  
Limitations 
This was a small exploratory study aiming to understand current perspectives about HAND 
among PLHIV. Although the sample size was small, responses were received from across 
Australia. In the statistical analysis, small numbers within some sub-samples may have 
affected results, however, this was the rationale for also reporting effect sizes. It is entirely 
possible that survey respondents had a specific interest or concern about HAND and were 
therefore more willing to complete the survey. Survey questions did not request respondents 
to quantify the period of time related to their experience of signs and symptoms of HAND.  
For those who were not currently working, further questions about how they use their time, 
especially for those who live alone would be useful to explore. The respondent’s age was not 
significantly associated with self-reported symptoms, which may be due to the small number 
of responses of respondents over 65 years. Similarly, medium effect sizes for differences 
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between HIV duration and being slower in thinking or more forgetful are possibly due to 
those who have been HIV positive for longer having had more time to monitor their cognition 
and lack of statistical significance is likely attributable to small sample sizes in the ‘Don’t 
know’ categories for these variables.  
Further research would be useful focusing on comparable HIV-negative age groups; 
assessment of functional symptoms in PLHIV, and assessment of health provider awareness 
and assessment skills. Additionally, exploring the opinion of PLHIV regarding the role of 
stigma and discrimination associated with HAND, and the potential impact these may have 
on accessing care and support and the early diagnosis of HAND are important future areas of 
study. 
Conclusion 
PLHIV are an ageing cohort and many have experienced stigma and discrimination in their 
past (Karamouzian et al., 2015; Skinner & Mfecane, 2004).  If PLHIV are fearful or have 
concerns about HAND, they may be less likely to access medical care.  Health care providers 
can make greater use of resources to encourage PLHIV to discuss their concerns, thereby 
facilitating earlier diagnosis and treatment of HAND (Chambers et al., 2015). Further, 
opportunities to increase social engagement and passive leisure activities among PLHIV 
should be encouraged, as these may positively affect cognition at the same time as potentially 
improving support to ageing PLHIV (Rueda et al., 2014). 
This study has yielded some important and unexpected results indicating that PLHIV are 
concerned about HAND and are living with uncertainty and  vulnerability, particularly as 
they age. The collaborative development of resources may assist health professional and 
   
136   
other caregivers with improving and facilitating discussion about HAND, which may lead to 
reducing anxiety and to enhanced opportunities for clinical review. 
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Table 1: Social-demographic information of survey participants (n=126) 
 
  n (%) 
Geographic region of birth Australia  
Asia  
United Kingdom 
New Zealand 
North America  
Africa  
Europe  
Middle East, South America, 
PNG (one each) 
78 (62) 
10 (8) 
10 (8) 
9 (7) 
8 (6) 
6 (5) 
2 (1) 
3 (3) 
Language  English 
Non-English 
120 (95) 
6 (5) 
Gender Male 
Female 
Transgender 
116 (92) 
8 (6) 
2 (2) 
Sexuality Homosexual  
Heterosexual  
Queer  
Bisexual  
Other  
106 (84) 
10 (8) 
6 (6) 
2 (1) 
2 (1) 
Age range (years) 
 
18-44 
45-64  
>65  
36 (29) 
82 (65) 
8 (6) 
Employment Full time  
Part time 
Pension (aged/disability) 
Other e.g. student 
55 (44) 
19 (15) 
47 (37) 
5 (4) 
HIV status 
 
HIV positive 
HIV negative 
120 (96) 
6 (5) 
HIV duration  
Range (years) 
Mean (SD) 
 
<1-35 
15.4 (10.28) 
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Table 2: Experience of respondents who had heard of HAND (n = 94)  
 Experience 
Self-reported Yes No 
 n (%) n (%) 
Concern about HAND 52/94a (55) 42/94 (45) 
Anxiety at thought of discussing HAND 48/52b (92) 4/52 (8) 
Has spoken about concerns 30/52b (58) 22/52 (42) 
Had positive response when spoke to someone 23/30c (77) 7/30 (23) 
a 94= the total number who have heard of HAND; b 52 = total number concerned about HAND; c 30 = total 
number who had spoken to someone about HAND 
 
 
 
 
 
Table 3: Cognitive symptoms and HIV duration (in years) 
 HIV Duration (years) 
Sign or symptom 
present 
Yes  No  Don’t know   
 Mean (SD) n Mean (SD) n Mean (SD) n P value 
Slower in thinking 15.3 (9.68) 68 16.6 (10.58) 48 10.7 (12.40) 10 0.252 
Harder to organise 17.3 (9.99) 74 11.9 (10.13) 32 13.9 (10.33) 20 0.033* 
More forgetful 14.7(9.86) 65 17.4 (9.91) 47 11.8 (12.62) 14 0.149 
Less pleasure 13.7 (9.60) 47 16.6 (10.17) 61 15.8 (12.22) 18 0.345 
*Post Hoc test indicated statistically significant difference in mean HIV duration between No/Yes responses:  
p = 0.012, Cohen’s d = 0.054 
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CHAPTER SIX 
Professional caregiver assessment 
 
6.1 Overview and research question 
Some PLHIV do not have the support of an informal caregiver, may live alone and/or may 
lack insight into their own health state. This leads to question, who fulfils the role of 
observing changes in daily functioning or cognition when a PLHIV does not have personal 
insight or the support of an informal caregiver? The Phase 2 study was designed to examine 
the role of community based HIV professional caregivers in the early identification of 
HAND.  A cross-sectional study aimed to determine what type of patient information 
professional caregivers were collecting related to identifying risk of HAND as part of their 
initial and follow-up health assessments. The file audit method was used to examine the 
research question: 
3. What information collected by HIV community based teams 
identifies patients at risk of HAND? 
 
6.2 Major findings 
Documentation was incomplete in every one of the 262 audited patient records. The specific 
clinical information related to identifying risk factors for HAND that was missing from 
patient records included: nadir CD4+ T cell count (missing in 91%), HIV viral load (missing 
36%); support of current informal caregiver (missing in 19%) and; living circumstances 
(missing in 14%). Information recorded in files was largely from secondary sources, for 
example, self-reported by the PLHIV. Further, documented information was confirmed in 
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only 52 (30%) of the 262 records. Information classified as ‘confirmed’ was that provided 
directly by the person’s doctor, GP, HIV specialist or directly reported during attendance at 
medical appointments. The audit results revealed that clinical assessment records made by 
community based health professionals contained very minimal information that was relevant 
for identifying risk of HAND in PLHIV.   
 
6.3 Conclusion 
Access to integrated information is important for communication between service providers, 
the coordination of efficient and effective patient care, and for referral to further medical 
review or testing. Incomplete documentation in paper or electronic medical records does not 
only impact the integration of care for PLHIV and lead to poor health outcomes, but as 
shown in this study, may also be missing risk factors for the early identification of HAND. 
Professional caregivers are in a position to access, record and share knowledge of the 
psychosocial circumstances and health risk factors of PLHIV. Documentation of risk factors 
by community health professionals is important for the early identification of those who may 
be at risk of HAND, especially where informal care is absent.  
  
6.4 Statement from co-authors confirming authorship contribution of the PhD 
candidate 
 
Chapter Six is published as:  
 
Cummins, D., Waters, D., Aggar, C., O’Connor, C.C.  2018. Potential impacts of poor 
communication on early diagnosis of HIV associated neurocognitive disorder. Journal of 
Advanced Nursing, 74 (6), 1342-1348. doi: 10.1111/jan.13533 
All authors made substantial contributions to editing and revising the manuscript.   
   
144   
As co-authors of the paper titled: “Potential impacts of poor communication on early 
diagnosis of HIV associated neurocognitive disorder”. We confirm that Denise Cummins 
made the following contributions: 
 
i. Concept and design of the study; 
ii. Collected, managed and analysed the data;  
iii. Primarily responsible for the interpretation of results;  
  iv.  Drafting, revising and writing up of the manuscript for submission to peer-reviewed 
journals. 
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Title: Potential impacts of poor communication on early diagnosis of HIV-associated 
neurocognitive disorder 
 
Abstract 
Aim  
 To ascertain whether community-based health care providers were collecting appropriate 
information to identify patients at risk of HIV associated neurocognitive disorder and whether 
related documentation was complete.  
Background  
HIV associated neurocognitive disorder is a treatable neurological condition that can affect 
more than 20% of those infected with the HIV. Signs and symptoms of cognitive impairment 
may be subtle, therefore documentation of medical and social information could be beneficial 
in identifying those at risk  
Design  
Cross sectional descriptive study.  
Methods  
An audit of patient records was completed by two community-based interdisciplinary teams 
with particular attention to the documentation of clinical and social indicators for those at risk 
of HIV associated neurocognitive disorder. Data were collected over a four-week period 
during 2015.  
Results  
Data were retrieved from both electronic medical record systems and hard copy patient 
records. Documentation was incomplete in every patient record (n=262), including the 
absence of important clinical data relating to nadir CD4+T cell count (91%), HIV viral load 
(36%), current caregiver (19%) and living circumstances (14%). Up to 40% of recorded 
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medications and results were unconfirmed by the person’s medical practitioner.  
Conclusion  
Poor documentation can lead to incomplete information, which can delay early intervention 
for those at risk of HIV associated neurocognitive disorder. Collection and recording of 
patient data needs to be consistent, as complete documentation is essential for integrating 
care, provision of clinical support and importantly, for identifying those at risk of developing 
HIV associated neurocognitive disorder. 
Key words 
Nurse, interdisciplinary teams, communication, information technology, electronic medical 
record, HIV/AIDS, community care, HIV associated neurocognitive disorder 
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SUMMARY STATEMENT 
Why is the research needed? 
 
 HIV associated neurocognitive disorder is a treatable neurological condition that can 
affect more than 20% of people living with HIV.  
 Diagnosis is by exclusion, therefore access to complete patient information is 
essential to detect patients at risk of developing this condition.  
 Poor documentation could impact the early identification of those at risk of 
developing HIV associated neurocognitive disorder, with missing information leading 
to delayed medical assessment, diagnosis and treatment. 
 
What are key findings? 
 There are issues relating to missing and incomplete data when both electronic medical 
records and hard copy patient records (hybrid systems) are used. 
 Incomplete documentation was noted for every patient record in the audit, including 
clinical data necessary for the early identification of risk factors for HIV associated 
neurocognitive disorder.   
How should findings be used? 
 To develop strategies to improve the utility of hybrid systems to facilitate access and 
sharing of patient information across community-based teams. 
 To promote regular auditing of electronic medical records. 
 To develop case definitions for HIV associated neurocognitive disorder. 
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INTRODUCTION 
People living with the Human Immunodeficiency Virus (HIV) may experience increasingly 
multifaceted health and treatment challenges as they age. HIV is now considered a chronic 
disease (Clifford & Ances, 2013; Lai, Tarwater & Hardy, 2006) and subsequently, people 
living with HIV (PLWH) are at increased risk of co-morbid medical conditions. HIV 
associated neurocognitive disorder (HAND) is one such condition this is known to cause 
disability in up to 20% of PLWH (Antinori et al., 2007; Clifford & Ances, 2013; Heaton et 
al., 2010). Similar to other patients with chronic conditions, PLWH are cared for by a team of 
health care providers who may not work in the same location. Specialist community-based 
HIV teams often have an intimate knowledge of their patients’ health and well-being and the 
utilisation of electronic medical records (eMRs) enables a sharing of this information with 
other services (Ingram et al., 2017). Improved communication offers greater opportunity to 
identify and assess those who may be at risk of developing HAND to achieve early diagnosis 
and integrate care (Odlum et al., 2012). 
Australia is moving towards a national eMR, which will allow individuals to control 
healthcare provider access to their health information (NSW Health, 2013). Access to shared 
information through eMRs enables health care providers to develop strategies to manage 
complex chronic conditions, potentially reduce further risk and better integrate care, 
especially in vulnerable communities such as for PLWH (Kim et al, 2016).  
Early recognition of HAND is important as treatment offers opportunity for improved clinical 
outcomes for PLWH (Robertson et al., 2007). HAND is often diagnosed by exclusion and 
requires several testing methods as there are currently no biological markers for a definitive 
diagnosis (Atluri, Kurapati, Samikkannu, & Nair, 2014). Known clinical risk factors for 
HAND include low nadir CD4 T cell count (McCombe, Vivithanaporn, Gill, & Power, 2012), 
past history of AIDS defining central nervous system disease (Fabiani, Pinto, & Bruschi, 
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2013) and Hepatitis C co-infection (Schouten et al., 2012). Furthermore, other medical co-
morbidities with signs and symptoms that may mimic cognitive change, such as vascular or 
metabolic disorders, need to be ruled out (Kamminga, Cysique, Lu, Bachelor, & Brew, 2013; 
Nightingale et al., 2014).   
Recognition of HAND is also improved by enhanced knowledge of social circumstances, 
medical history and current health risk factors of PLWH. The clinical indicators of HAND 
should also be documented.  Awareness of social circumstances is significant as PLWH may 
be socially isolated due to age (Reuda, Law, & Rouke, 2014), gender or sexual orientation 
(Grierson, Pitts, & Koelmeyer, 2013).  PLWH who live alone and /or do not have the support 
of an informal caregiver may not notice subtle cognitive changes indicative of HAND 
(McDonald, Elliott, & Saugers, 2013). Community-based health professionals may be the 
only regular contact able to observe signs and symptoms of cognitive change when providing 
ongoing care and support.  
Because optimal communication of patient information is essential to identify those who may 
be at risk of developing HAND, and provides an opportunity for early assessment, health 
professionals have the potential to facilitate the early diagnosis of HAND and impact on the 
health outcomes of PLWH (Sittig & Singh, 2011) through complete and accurate 
documentation.  
THE STUDY 
Aims: 
 This descriptive study aimed to ascertain whether two interdisciplinary community based 
HIV specialist teams were collecting accurate and appropriate information to identify patients 
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at risk of HAND (HIV information, social and clinical indicators) and whether their 
documentation was complete.  
Design:  
Data were derived from a file audit of patient data collected by members of the community-
based teams over a four-week period. 
Participants:  
The two unique interdisciplinary community-based HIV specialist teams participating in this 
study are located in the State of New South Wales (NSW), Australia. Employed by two 
separate health districts, the teams cover 18 local government geographical areas with a 
combined total population of approximately 1,430,000 people of which, approximately 52% 
speak a language other than English at home. Delivering health services to an estimated 9,970 
people living with HIV in inner city Sydney and urban regions of NSW (NSW HIV Strategy, 
2015), these two teams provide care to the highest, and second highest number of PLWH in 
the State (n=5432, 31% and n=2857, 16.5%, respectively) (Sydney Local Health District 
website; South Eastern Sydney Local Health District Website; NSW HIV Strategy, 2015 ). 
Both interdisciplinary community-based HIV specialist teams utilise patient health records as 
a means of compiling and communicating patient data. The teams have access to the 
electronic medical record system maintained by the health district in which they are 
employed; the Community Health Information Management Enterprise (CHIME) and the 
Cerner Corporation Supplier of Health Information Technology (CERNER).  
 
Each team has a manager and ten members including social workers, occupational therapists, 
physiotherapists, dietitians, mental health nurses and primary health nurses. The teams 
provide clinical care and case management for patients with complex needs related to HIV 
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diagnosis. Each team works closely with local HIV inpatient and outpatient services, general 
hospitals and other health services, non-government organisations and family doctors within 
their respective locations to provide integrated care for PLWH across NSW. In one location, 
the HIV team (Team 1) uses a specifically built HIV electronic medical record (eMR) which 
allows local health district staff direct access to patient information, including the tracking of 
appointments and pathology results (CERNER). For those patients who access medical 
services external to the local health district, team members have to request information 
directly from the patient’s doctor. This system currently does not have capability to scan 
other documents into the eMR, therefore hard copies of clinical notes continue to be available 
within the paper-based medical record to file external reports. In the second location, the HIV 
team (Team 2) uses an eMR which currently does not link to any other clinical services 
within their local health district (CHIME); therefore, it is a standalone system relying on 
documents pertaining to the patient being scanned into the eMR. Antecedent paper based 
medical records are not readily available at this location as they are in secure storage at 
another site and there is a waiting time to access these records. 
 
Data collection 
The audit of the electronic and paper-based records of all patients seen by both teams was 
conducted over a four-week period in 2015 and was completed by individual team members 
(allowing each professional, as key worker, four-weeks to review their patient files and 
transcribe information). An electronic spreadsheet, pre-populated with labelled data fields 
relevant to HIV care was sent to a lead member of each team, who then distributed the 
spreadsheet to other team members. Individual team member had access to their local version 
of an eMR, and limited access to hard copy clinical notes from which they retrieved the 
requested information and transcribed this onto the electronic spreadsheet for each patient in 
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their care over the nominated period. The completed spreadsheet was returned to the lead 
member who collated all data onto one spreadsheet which was de-identified prior to returning 
to the researcher. Requested data fields included demographic, social and health information, 
including co-morbid medical conditions. Pathology results were requested, with particular 
interest in clinical indicators pertaining to HAND such as nadir CD4+ T cell count, current 
CD4+ T cell count, HIV viral load and information regarding prescribed HIV medications. 
Newly referred patients (within the four-week period) who had not been assessed were 
excluded from the audit. 
 
For the purposes of this study, information was considered confirmed if it was documented 
directly by the patient’s medical practitioner (either the HIV specialist or family doctor), or 
was witnessed by the team member (such as being present during a medical appointment) and 
transcribed into the patients record or eMR. Information was considered unconfirmed if it 
was provided by any other means such as directly from the patient, from hospital discharge 
summaries (which may have been based on incidental care such as an emergency department 
admission), from non- government organisations, or from specific reports documenting only 
limited or second hand information. Collated data from both HIV specialist teams were 
exported to SPPS (V21 IBM Corporation Armonk, NYl, USA) for statistical analysis.  
 
Ethical considerations 
The study was approved by the Human Research Ethics Committee of the Sydney Local 
Health District, NSW, Australia and Human Research Ethics Committee, South Eastern 
Sydney Local Health District, NSW Australia and endorsed by the Human Research Ethics 
Committee of the University of Sydney, NSW, Australia. 
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Data analysis  
Data from the spreadsheet was transferred for analysis using IBM SPSS for Statistics (SPSS 
Version 21, IBM Corporation Armonk, NYI, USA). Data were checked for data entry errors. 
Analysis included calculation of descriptive statistics. Demographic variables and variables 
related to HIV and HAND are reported as number (n) and percentage, or mean and standard 
deviation, as appropriate (Field, 2013). 
 
Validity and reliability/rigour 
The spreadsheet was pre-populated with column titles and descriptors for consistency of data 
collection and to minimise errors. As data were collected by clinical experts in HIV care, 
team members were invited to comment on the content validity of selected audit variables. 
The researcher met with each team and provided training to ensure consistency with data 
collection. Data were checked for missing values and outliers, with return to the team 
member by the lead member for confirmation if required. 
 
RESULTS 
During the four week study period, each community team provided direct care to 131 HIV 
infected patients (total 262). Initial examination of the data revealed no statistical differences 
between data collected at each location, therefore, results are reported for the combined 
dataset.  
 
Of the 262 files audited, the mean age of clients was 49.6 years (SD 11.2).  Ninety-one 
percent (n=238) were male, 8% (n=21) female and 1% (n=3) transgender.  Sixty nine percent 
(n=181) were born in Australia and 31% overseas (n=81). The most common language 
spoken was English 93% (n=243) and other languages 7% (n=19). 
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Community HIV team members receive information from several sources: HIV specialist 
doctor, family doctor, emergency and/or hospital discharge letters, test reports, non-
government organisations and the patient themselves. Thirty percent (n=78) of documented 
medical and social information was provided directly by the patient, 7% (n=18) from other 
services, 5% (n=13) from discharge plans.  It was not clear who had provided the information 
for 34% (n= 89) of recorded data. Thirty percent (n=52) of documented information was 
classified as confirmed in that it was provided directly by the person’s family doctor, HIV 
specialist or transcribed directly during attendance at medical appointments. 
 
Missing Information  
Recorded data were found to be either missing or incomplete for several of the key data fields 
including HIV related information and co existing medical co morbidities.  Table 1 shows 
that a large proportion of the audited patient records (up to 91%) had no documented 
evidence of predictors of HAND, for example, the nadir CD4+ T cell (91%, n=238) and 
current CD4+ T cell count (33%, n=87). Further, the duration of HIV diagnosis was missing 
in 22% (n=59) of the audited records.  
Key documentation about social support was also incomplete. Data about informal caregivers 
was missing in 19% (n=50) of the clinical records, and information about sexual orientation 
and whether PLWH were living alone was missing in 8% (n=21) and 14% (n= 37), 
respectively.  
<Table 1 here> 
Table 2 shows that 76% (n=199) of PLWH receiving care during the four-week study period 
had been prescribed antiretroviral (ART) medications with confirmation of prescription of 
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ART by medical practitioner evident in 16% (n=32) of clinical notes. The actual ART drug 
prescribed was documented in only 53% (n=139) of the clinical notes examined during the 
study period, and was not recorded at all within 47% (n=123) of files.  
<Table 2 here> 
Some ART drugs are known to have higher central nervous system penetration (CNS CPE) to 
cross the blood brain barrier and this is relevant to treatment success (Letendre, Ellis, Ances, 
McCutchan, 2010). Yet, no documentation of the calculated score for CNS CPE could be 
found in any of the eMR or paper-based medical records. Knowledge of which medications 
are prescribed is the basis of HIV care and could influence how clinicians review the patient 
in relation to monitoring for side effects, drug interactions, developing strategies to prevent or 
treat co-morbid conditions and for deciding when to change treatment. 
DISCUSSION 
This descriptive study aimed to ascertain whether community-based HIV health care 
providers were collecting necessary and sufficient information to identify patients at risk of 
HIV associated neurocognitive disorder and whether that documentation was complete.  
The results show that a considerable amount of clinical and social information was not 
documented in the patient’s clinical notes or eMR. This finding calls into question the 
accuracy of assessment and implies that the signs and symptoms of HAND may not be being 
optimally reviewed or formally investigated, thereby impacting on the early diagnosis of this 
condition.  
Whilst both interdiscplinary teams had access to an electronic record system, there was 
variance in how each team could document information into the eMR depending on which 
system that they had access to, and how external information was uploaded or transcribed 
   
156   
into this system. A large amount of clinical information that is central to HIV care was not 
documented, and often not confirmed by a medical practitioner. Specifically, key information 
relating to the care of PLWH and the early identification of symptoms of HAND was 
frequently not documented. Similarly, ART medications prescribed to treat HIV may be 
modified to have a higher penetration across the blood brain barrier (Letendre, at al., 2010). 
Although the audit revealed that many patients were currently prescribed ART medications, 
documentation of the drug name and dose was frequently missing. As a basic tenet of care, 
health professionals should be aware of which ART drugs the person is currently prescribed 
in order to ascertain whether the regimen can or should be switched to that which has 
improved CNS penetration. 
 
As PLWH have complex health modalities and treatments, confirmation of information from 
their medical practitioner is essential. Each team received information about patients from 
varied sources and some information was secondary, being provided by reports from other 
health professionals or agencies. Patients also provided much of the information themselves, 
which may or may not be accurate. Up to 40% of information documented in the patient 
records was unconfirmed by the patient’s practitioner. In addition, as HAND is a diagnosis of 
exclusion, knowledge of other existing medical conditions, or the signs and symptoms of 
these, is important (Nabha, Duong & Timpone, 2013) as some co morbid medical conditions 
may mimic the signs and symptoms of HAND (Kamminga et al., 2013; Nightingale et al., 
2014). Confirmation of co morbid medical conditions by a medical practitioner was found in 
only 16% of the audited records. Additionally, awareness of co morbid conditions in the 
patient could lead to strategies being developed to reduce risk factors such as cardiovascular 
disease. It is clearly important to ascertain permission during the initial assessment to contact 
the patient’s doctor for access to health records, including a list of current medications. 
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Development of a process to regularly update and routinely audit information in the eMR 
would also be beneficial. 
Awareness of the patients’ social circumstances is significant as PLWH may be socially 
isolated, may live alone and /or not have the support of an informal caregiver (Reuda et al., 
2014; McDonald, et al., 2013; Grierson, et al., 2013). Limited awareness of social 
information may impact patient care as many PLWH could be experiencing mild signs and 
symptoms of HAND which may be attributed to other conditions such as ageing. This study 
found that patient living circumstances were not documented in 14% of clinical records 
included in the audit, and it was unknown from 19% of patient records whether PLWH had 
the support of a caregiver. Community HIV specialist teams may be crucial as initial 
observers of signs and symptoms which could be indicative of HAND, especially if the 
patient does not have an informal caregiver. This information is important for planning care 
and support, and for identifying which patients are at increased risk of developing HAND.  
To broaden the utility of eMR data, case definitions must be specified and expanded to 
identify and characterize chronic conditions (Souri et al, 2017) such as HAND. Case 
definitions can also develop disease surveillance and health knowledge (Souri et al., 2017) 
and encourage a more efficient use of the eMR for PLWH. Collaborative data recorded by 
health professionals involved in a patient’s care can provide rapid feedback to the patient’s 
health team and specific information for the future development of case definitions relating to 
HAND. Furthermore, use of the eMR has already proven beneficial for case management of 
PLWH (Schnall, et al., 2011) and may allow the health care provider to develop 
individualized education for the PLWH (Schnall, et al., 2011) such as medication adherence, 
which is an important symptom of HAND.  
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Meaningful use of an eMR should result in improved coordination of patient centred care 
(Kokkonen, Davis, Lin, Debade, Felman, & Fleischer, 2003).  Access to clinical information 
was identified as a problem for both teams. Both had access to hardcopy paper documents 
and a variant of an eMR, but patient data was held in several locations, causing difficulties in 
accessing information (Bowman, 2013) and the potential to lead to errors, lost documents and 
delays in decisions. Good communication is essential for providing optimal clinical care. The 
quality of documentation in the patient record is contingent on the accuracy and completeness 
of the information entered into the system by all staff involved in the person’s care. Access to 
clinical records is also vital for integrated shared care and improved understanding of the 
patients’ circumstances (NSW Health, 2013).   Good documentation promotes efficiency, 
patient wellbeing, safety and continuity of care through shared clinical decision-making, 
leading to improved access to care through enhanced referral processes (NSW Health, 2013).  
The integrity, reliability and accuracy of documented health information is vital for the 
delivery of quality healthcare across the continuum (Bowman, 2013; Odlum et al., 2012). 
Limitations 
The audit of records was over a short period of time. The limitations of this study included 
that the teams used varied eMR systems, which prevented comparison of how information is 
uploaded to each system and how it is accessed by team members.   
CONCLUSION 
Complete documentation of the patient’s medical history, social circumstances, medications 
and current health would lead to increased awareness of potential risk factors and clinical 
indicators for HAND in PLWH and importantly, help to identify which patients require 
enhanced monitoring for HAND. Health care providers need to provide complete and verified 
documentation following their assessment and delivery of clinical care to PLWH to enhance 
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the sharing of accurate information between all health care providers involved in the patients 
care. The development of standardized and integrated data collection templates within eMRs 
would support regular assessment and monitoring.  
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Table 1: Documentation of HIV and co-existing medical conditions 
HIV 
information 
Documented 
% (n) 
Not documented 
% (n) 
Documented 
information 
confirmed by 
medical doctor 
% (n) 
CD4+ T cell 
Nadir 
9% (24) 91% (238) 3% (8) 
HIV viral load 64% (167) 36% (95) 13% (35) 
Current CD4+ T 
cell count 
67% (175) 33% (87) 15% (38) 
HIV Duration  88% (203) 22% (59) 15% (38) 
Co existing 
medical 
condition 
   
Hepatitis C 
virus infection 
78% (204) 22% (58) 16% (43) 
High cholesterol 59% (155) 40% (107) 16% (43) 
Hypertension 58% (152) 42% (110) 16% (43) 
Hyperlipidaemia 56% (146) 44% (116) 16% (43) 
Diabetes 48% (127) 52% (135) 16%(42) 
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Table 2: Prescribed HIV medications 
Medication 
Information 
Yes  
% (n) 
No  
% (n) 
Not documented 
% (n) 
Documented 
information 
confirmed by 
medical doctor   
% (n) 
Prescribed ART 
medications 
76% (199) 15% (39) 9% (24) 16% (32) 
Documentation 
of which ART 
medication 
53% (139) 
 
0% (0) 47% (123) 40% (105) 
CNS CPE* 0% (0) 0% (0) 100% (262) 0% (n=0) 
* central nervous system penetration score 
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CHAPTER SEVEN 
 
Improving risk assessment for HAND 
 
7.1 Overview and research question 
Use of a risk assessment tool can enhance the clinical practice of HIV community-based 
teams to identify which PLHIV may be at risk of developing HAND and provide additional 
evidence at medical review. Phase 3 of this thesis was a modified Delphi study, in which a 
panel of experts guided the development of items for inclusion in an assessment tool to 
identify those at risk of HAND in a community setting.   
 
This chapter presents the findings from a modified Delphi study to examine the final research 
question:  
 
4. What assessment criteria are essential to identify those at risk of 
HAND in the community?  
 
7.2 Major findings 
More than 80% consensus was reached at each Delphi round for agreement on clinical and 
social information to include in a risk assessment tool to guide community based clinicians to 
assess PLHIV who may be at risk of developing HAND. The modified Delphi method 
permitted panel members to engage in decisions about Delphi rounds and concluded in the 
panel recommending the development of both an initial assessment and annual monitoring 
tool (with flow chart) for direct translation to community practice.  
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7.3 Conclusion 
Known risk factors identified from the literature and new content from the findings of the 
earlier study phases was considered by panel experts to determine content for an initial risk 
assessment and an annual monitoring tool to monitor PLHIV for future changes in cognition 
which could be HAND.  While not yet validated for clinical use, the initial tool is intended to 
be used as a precursor to formal medical assessment, with the purpose of annual monitoring 
to facilitate regular assessment for early formal medical review for this condition.  
 
The risk assessment tools are a major outcome of the thesis. With the absence of published 
literature relating to the complexity of identifying HAND in PLHIV, the role of informal and 
formal caregivers, or the contribution of assessment by community based HIV teams, the 
studies performed for this thesis have resulted in the development of a consensus-based 
monitoring tool that after validation, could be used for the future assessment and early 
diagnosis of the approximately 20% of PLHIV who may develop HAND. 
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Title:  Assessing risk of HIV associated neurocognitive disorder: a modified Delphi study 
Abstract 
Background:  
People with HIV (PLHIV)  are ageing and 20% are at risk of developing a neurological 
complication known as HIV associated neurocognitive disorder (HAND). Signs and 
symptoms of HAND may be subtle; however treatment can improve clinical outcomes.  
Objective:  
To identify and agree on a risk assessment and monitoring process for the regular review of 
patients at risk of HIV associated neurocognitive disorder. 
Methods:  
Between March and September 2017, twenty five experts from four community health care 
services participated in three rounds of a modified Delphi study to reach consensus on the 
items, monitoring period and format of assessment tools to identify risk of HAND in people 
living with HIV in the community. 
Results:  
More than eighty per cent consensus was reached at all three Delphi rounds. A flow chart, 
initial assessment and annual monitoring tool were developed for ongoing assessment of risk 
of developing HAND.  
Conclusion:  
Twenty per cent of PLHIV may develop HAND, a treatable condition. The use of a modified 
Delphi method led to the successful development of two risk assessment tools to identify 
those at risk of HAND. The initial assessment tool may be used as a precursor to formal 
assessment by medical and nursing staff, while the annual monitoring tool may assist 
community-based health professionals in their ongoing assessment of risk of HAND in 
PLHIV, facilitating early formal medical review for this condition. 
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Key words: Modified Delphi method, consensus, human Immunodeficiency virus, cognitive 
impairment, interdisciplinary teams 
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HIV is a chronic disease and as people living with HIV (PLHIV) age, they become 
susceptible to developing co-morbid conditions. Twenty per-cent of PLHIV globally are at 
risk of developing a subcortical neurodegenerative disease caused by HIV-1, known as HIV 
associated neurocognitive disorder (HAND) (Clifford & Ances, 2013). HAND is associated 
with morbidity and mortality in younger PLHIV and can cause various levels of disability 
(Skinner, Adewale, DeBlock, Gill, & Power, 2009).  Cognitive changes attributable to 
HAND can be subtle and may become normalized by PLHIV (Gisslen, Price, & Nilsson, 
2011; Cummins, 2014). These can include changes in language, memory, problem solving 
and slowing of psychomotor skills (Barber et al., 2014; Ghate, 2012). Early recognition is 
important as treatment of HAND offers opportunity for improved clinical outcomes for 
PLHIV (Robertson et al., 2007). 
Risk factors for HAND include  CD4+ T cell nadir count (lowest T cell count) (Ellis et al., 
2011; Heaton et al., 2011); low CD4+ cell count (Schouten, et al., 2012; Heaton et al., 2011); 
current or past drug and alcohol use (Letendre, 2011; Elbert, et al., 2015),  and hepatitis C co-
infection (Schouten, et al., 2012).  Additionally, knowledge of other co-morbid conditions 
impacting cognition (Nix &Tien, 2014) can add to poor neuropsychological performance, 
confounding the diagnosis of HAND (Nightingale et al., 2015; Kamminga, Cysique, Lu, 
Batchelor, & Brew,2013). These include diabetes (Pinhero et al., 2016), cerebrovascular 
disease (Heaton et al., 2011; Tedaldi, Minniti, Fischer, 2015) and hypertension (Rodriguez-
Penny et al., 2013; Tedaldi et al., 2015). 
Lack of knowledge of risk factors, poor documentation of discussion during patient 
consultations (Cummins, Trotter  & Murray, 2014) and difficulty locating patient information 
in electronic health records (Cummins, Waters, Aggar & O’Connor,  2015) all contribute to 
possible delays in the early recognition of risk of HAND in PLHIV. Although there are 
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several validated screening tools for HAND, none are universally applicable across all 
settings (Kamminga et al., 2013) and none are specific to community-based care, where the 
signs and symptoms of cognitive change may be observed by professional caregivers 
providing care to PLHIV in the home setting. Subsequently, a method for monitoring and 
collecting patient information over time could assist community-based health care 
professionals to identify PLHIV at risk of developing HAND or who are experiencing signs 
and symptoms of HAND which they may attribute to another cause.   
 
The identification of HAND is multifactorial and complex.  Therefore, a modified Delphi 
method was chosen to elicit the expert knowledge, varied viewpoints and rich experience of 
stakeholders to gain consensus on the development of risk assessment tools for use by 
community-based health professionals as a precursor to formal medical review (Hong et al., 
2010). The Delphi method follows an iterative multi-stage process to combine opinion from a 
group of experts (termed ‘panel members’) into group consensus. Requirements for the 
expertise of Delphi panel members include knowledge and experience of the issues under 
investigation, willingness and time to participate and good communication skills (Adler & 
Ziglio, 1996). Individuals who are primary stakeholders with first-hand experience are 
targeted to elicit and enhance knowledge about the subject (Anderson & Schneider, 1993; 
Jones, 1974).  
 
The selection of content or target issue presented to the Delphi panel is also important as it 
will translate directly to the quality of the results (Judd, 1972). There are no universally 
agreed guidelines for the Delphi method (Evans, 1997), and as such, flexibility exists in the 
design and applicability to the objectives of the study.  In the traditional Delphi method, 
content for the first round is usually obtained from a literature review and further rounds 
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enable a number of individuals to provide their opinion anonymously, thus avoiding 
dominance of one person’s opinion (Boulkedid, Abdoul, Loustau,  Sibony, & Alberti, 2011; 
Linestone & Turoff, 1978).  Modifications to the traditional Delphi process occur when a 
hybrid of techniques are used, such as face to face meetings, using secondary data, or 
incorporating the qualitative views of participants (Keeney, Haason, & McKenna, 2006; 
Diamond et al., 2014; van Vliet et al., 2016; Eubank et al., 2016). In this study, use of a 
modified Delphi method facilitated experts in the field of HIV and HAND to contribute their 
knowledge and experience to the development of assessment and monitoring tools through 
both face-to-face and email communication rounds.  
AIM 
To achieve group consensus on the appropriate content of assessment tools to assist 
community based health professional to detect and monitor PLHIV at risk of developing 
HAND. 
 
METHOD 
The traditional Delphi method follows a series of structured “rounds” in which panel 
members examine the evidence to reach a consensus about the target issue (Keeney et al., 
2006). Typically, panel members rate indicators of the target issue, and then ratings are 
compiled, summarized and distributed for review before the next round (Davies et al., 2011). 
Each panel member makes a judgement (often using a Likert or categorical scale) to agree or 
disagree with the issue under consideration and so determine consensus (Jones & Hunter, 
1995). As part of the method, the responses from each round are fed back in summarized 
form to the participants who are then given an opportunity to respond again to the emerging 
data (Boulkedid et al., 2011).  Commitment to participate in a multi-round Delphi method can 
be inferred by the round-by-round response rate (Keil, Tiwana, & Bush, 2002). 
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The modified Delphi method chosen for this study aimed to capture opinions from panel 
members utilising varied approaches to develop clinically relevant topic areas and questions 
for two risk assessment tools (initial and monitoring) for community-based teams caring for 
PLHIV.  A literature review generated topic areas for consideration and was confirmed by the 
expert panel through three small group meetings; one large face-to-face meeting with all 
panel members present; and through the use of email communication. Each round of results 
led to the development of content for the next round. 
 
Expert panel members 
Criteria for selection of expert panel members was 1) health professionals who worked in a 
community setting, 2) who provided clinical care and support to PLHIV and  3) provided care 
for someone who had a diagnosis of HAND. It was anticipated that expert panel members 
would have the opportunity to provide opinion both as individuals, and as a group, following 
open and robust discussion of the issues at the face-to-face meeting at which all members 
were present.  
 
Between March and September 2017, twenty five experts from four community health care 
teams based in the state of New South Wales, Australia, participated in three rounds of a 
modified Delphi study to reach consensus on the items, monitoring period and format of 
assessment tools to identify risk of HAND in PLHIV in the community. Staff from each 
service represent a diversity of clinical backgrounds and a range of experience in providing 
holistic patient centered care for PLHIV with complex care needs in the community. Panel 
members also work across a range of geographical areas (inner city, suburban and rural 
settings). One team offers a primary statewide service caring exclusively for PLHIV who 
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have a diagnosis of HAND and their informal caregivers. Two are interdisciplinary teams 
consisting of nurses, dietitians, physiotherapists, social workers and occupational therapists 
who provided care and support to PLHIV at home. The fourth service offers specialist HIV 
nursing support for PLHIV providing clinical care, assessment and referral of PLHIV with 
complex care needs related to HAND, mental health and substance abuse. 
  
Literature review and consensus statement development 
Medline, Cinahl and Embase databases were searched for full text English language 
publications offering high quality evidence for the selection of items for both the initial 
assessment and monitoring tools. Information was reviewed regarding risk factors for 
HAND, other co-morbid conditions which could mimic cognitive signs and symptoms not 
attributable to HAND but which may confound diagnosis of HAND, validated screening 
tools for HAND and relevant social factors that may increase complexity of diagnosis such as 
living alone. Topic selection was also discussed with medical and psychiatry experts, with 
selected topics presented to the panel for initial discussion around the development of 
consensus statements.  
 
The definition of consensus for the Delphi method is varied and depends on the relative 
importance of an issue (Keeney et al., 2006). Lynn (1986) suggests that there should be at 
least ten participants when a target of 80% consensus is required to achieve content validity. 
For the purpose of this study, participants were made aware that a minimum of 80% 
consensus and interquartile range less than 2.5 (Kittell-Limerick, 2005) would be required to 
assess and determine agreement in any round. The study was approved by the local Human 
Research Ethics Committee. XXXXXXXXXXXXXX 
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Round 1: Small group meetings 
The researcher met each of the four community-based health teams separately to discuss the 
background of the research study and the expectations of the Delphi method. Written 
information was provided with the participant consent form and there was an opportunity for 
participants to ask questions for further explanation or clarity.  All team members (available 
pending annual and maternity leave) at each location agreed to participate as panel members 
for this study. A demographic survey was distributed at the small group meetings to collect 
information about the participant’s background and experience. Participants were made 
aware of the possibility of several Delphi rounds pending 80% consensus to reach agreement 
by panel members in order to accept the item; that the results of one round would inform the 
next round in a sequential process; and that feedback would be provided from the previous 
rounds.  
 
Panel members were invited to consider several topics identified from the literature review to 
be included as subject areas for the development of questions for the assessment tools. Nine 
topic areas had been identified for consideration within the initial assessment tool, with five 
areas identified for the annual monitoring assessment tool. Experts could also provide 
comments and suggest additional topics to be considered for both tools. Presented in the form 
of a survey to the groups, members responded using a five-point Likert scale (1= strongly 
disagree, 2 = disagree, 3 = undecided, 4 = agree, 5 = strongly agree) to indicate their level of 
support for the topic areas. Panel members had up to two weeks to respond, with individually 
completed surveys returned anonymously to the researcher.  
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Round 2:  Large group meeting 
At Round 1, each service stated they would prefer a large group meeting for the next round to 
enable a more robust discussion from varied points of view and to minimise time constraints. 
Consensus data from Round 1 was summarized into two draft questionnaires: the initial and 
the annual risk assessments. Both drafts were reviewed by a medical expert for 
appropriateness, relevance and accuracy prior to the meeting. A draft flow chart was 
presented for panel members to consider the process needed to guide community-based 
professionals and /or variably experienced clinicians through the risk assessment process. The 
draft of the initial assessment tool had 41 questions/statements for consideration, and the 
annual monitoring tool had 12 questions/statements. Each panel member was given a paper 
copy of the assessment tools and questions were also presented on video screen. Following 
robust discussion, panel members were invited to consider each of the 53 individual 
statements/questions for both tools and indicate their agreement or disagreement of the item’s 
inclusion by a show of hands.  Where there was disagreement or lack of consensus for a 
statement/question, open discussion was facilitated until consensus was reached of at least 
80% of the group, or the statement/question was excluded.  
 
Round 3: Consensus statements 
Both tools were further revised and formatted to reflect Round 2 consensus agreement and 
sent via email to each panel member for individual review.  As Round 2 was clearly not 
anonymous, Round 3 gave panel members an opportunity to independently and anonymously 
review the final draft documents and provide any further comments.  It had been agreed in 
the large group meeting that if changes to the draft assessment tools were minimal, and if 
response exhaustion was reached at Round 3 with over 80% consensus, a further round 
(Round 4) would not be necessary. It was also agreed in Round 2 that five volunteers from 
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the group (each from a different clinical discipline) would pilot the initial assessment tool on 
one patient each ( total of five people) to assess content and face validity, and record the 
length of time required to complete as the next stage of the study.  
 
RESULTS 
Twenty-five panel members from four community-based health services participated in a 
modified Delphi process to identify topics and agree on the final content of two assessment 
tools for patients at risk of HAND. The panel also elected to retain the summary flow chart 
presented during Round 2 as an aide to completion of the assessment tools, and agreed that 
the monitoring risk assessment should be conducted on an annual basis for PLHIV in the 
community. All 25 members participated in all three rounds. The response rate to surveys and 
questionnaires presented to the panel was 100% for each round. Response exhaustion was 
reached within three rounds.  
 
Members of the expert panel had a mean age of 45 years and all had completed some type of 
higher education. Some participants had been working within their specific health disciplines 
for up to 33 years (mean 16 years) and had been employed in their current position providing 
care to PLHIV for up to 16 years (Table 1).  
 
 
 
Results of the first Delphi round revealed more than 80% agreement from panel members for 
eight of the nine topic areas identified from the literature to be included in the initial risk 
assessment tool (Table 2). As questions about legal issues attained only 60% agreement from 
the panel, this topic area was excluded from the initial assessment tool content for 
consideration in Round 2. The five subject areas considered by the expert panel for inclusion 
in the annual monitoring risk assessment tool reached 100% consensus as shown (Table 2).  
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The face-to-face meeting for Round 2 lasted two hours and included further discussion about 
omitting questions related to legal issues. Panel members collectively agreed that 
incorporating legal issues relating to last will and testament, living will and guardianship 
would be confronting for patients at the time of an initial risk assessment and unlikely to 
make a significant contribution to the overall risk identification of HAND. All agreed (100% 
consensus) that a flow chart would be a beneficial adjunct to guide risk assessment, 
especially for new or inexperienced staff. Panel members were concerned about the length of 
time to complete the initial risk assessment containing 41 items and requested mapping to 
avoid repetition of routinely collected patient information such as date of birth, gender and 
past health conditions. There was debate regarding the necessity of asking the PLHIV about 
their living circumstances, finances and quality of life. Group consensus was that knowledge 
of whether a person lived alone and/or had limited informal supports could impact on the 
observation of signs and symptoms indicative of cognitive change. While two panellists 
indicated they felt uncomfortable asking, these questions were retained.  
 
Round 2 also offered opportunity for the panel to agree on a preferred format for the risk 
assessment tools. While some panel members suggested the shorter annual monitoring tool 
could be used for both initial and annual reviews, the majority of panel members agreed that 
the collection of baseline clinical and other information from the initial assessment would be 
useful for ongoing comparison at patient follow-up. At the end of Round 2, more than 80% 
consensus had been reached on the content and format of a flow chart, an initial assessment 
and annual risk monitoring tool for the detection of risk of HAND in PLHIV. The email 
distribution of the three draft documents to each panel member following Round 2 prompted 
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only one response to change wording from ‘Do you have housing issues’ to ‘Do you have 
stable housing’?  
 
As 100% consensus had been achieved after three rounds of the Delphi process, the content 
and face-validity of the initial risk assessment tool is currently being trialed.  While some 
group members were concerned about how long it would take to complete the initial risk 
assessment with a patient, early results from the pilot study suggest this can be achieved in 18 
– 20 minutes.  
 
DISUSSION 
 
Early identification of HAND in PLHIV is important as clinical intervention may have a 
positive impact on changes to cognition. With minimal evidence pertaining to the role of 
community-based health professionals identifying PLHIV at risk of HAND, the researchers 
believe this to be the first application of a modified Delphi process to develop HAND risk 
assessment and monitoring tools for  providing community-based care to PLHIV.  
 
More than 80% consensus was reached for all but one topic area included in the final version 
of both the initial and annual assessment tools.  Panel members thought that asking patients 
about legal issues such as their last will and testament could be confronting for the patient, 
and this line of question was not considered appropriate for an initial assessment.   Some 
thought this question was appropriate at a later date, whilst others did not feel they had 
sufficient skills to discuss this with their patients. As this was the only item initially identified 
by the literature review that was excluded, it raises a question about when and how such 
conversations are currently occurring.  Further training in legal issues around end of life may 
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be beneficial for professional caregivers, especially those who are inexperienced or feel 
uncomfortable discussing end of life with a patient. The home environment is often a more 
comfortable, supportive environment for patients to ask questions and reflect on what is 
important to them. Additionally, this environment may provide greater opportunity to discuss 
cognitive rehabilitation with the patient and their caregiver. 
 
The professional caregiver is in a unique position to observe for signs and symptoms of 
HAND while providing care in the home or community. Early results from piloting the initial 
risk assessment tool with patients has staff noting the value of collecting relevant information 
pertaining to HAND in a single document that gives an overall picture of the person. 
Information documented in an initial risk assessment is thereafter available as a comparison 
for annual monitoring of cognitive changes as the PLHIV ages, and raises awareness of co-
existing medical conditions and risk factors such as smoking.  As PLHIV are an ageing 
population, knowledge of their personal social circumstances is also significant for their 
community-based care. Some PLHIV may have minimal informal support from caregivers 
who would usually be best placed to notice subtle changes in their cognition (Murray et al., 
2016). A regularly visiting professional caregiver, with detailed knowledge of the personal 
circumstances of the PLHIV, may therefore be the only alternative observer of changes in 
cognition whilst providing care in the home.  
 
It has been shown that panel involvement in developing guidelines is a predictor of successful 
implementation in a clinical setting (Hong et al, 2010). The modified Delphi method chosen 
for this study (Keeney et al., 2006; Diamond et al., 2014; van Vliet et al., 2016; Eubank et al., 
2016) permitted panel members to have ownership of the outcome of each round. The full 
retention of all panel members during each round may be an indicator of their commitment to 
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PLHIV, their interest in the subject area and/or the need for resources to support their work. 
Their working relationship with the researcher may also have influenced the retention of 
panel members.  The face-to-face meetings provided a forum to openly debate issues, while 
any actual or perceived bias from dominant group members was able to be addressed by 
providing individuals with further opportunities to forward individual comments via email. 
Consensus methods such as the Delphi method have high face validity.  As both the initial 
assessment and annual monitoring tool record medical and social information, each could be 
modified for implementation in local environments.  
 
Limitations 
 
The selection of experts from four HIV services in only one state of Australia could be 
considered a limitation of this study, however, it is equally important in a Delphi method to 
include participants with experience of the specific health condition and key population. 
XXXXXXXXXXXXXXXXXXXXXXXXX 
Lack of anonymity in face-to-face meetings may have limited contribution, obliged members 
to conform to discussion or allowed some participants to dominate the group. Validity may 
also have been compromised when panel members changed their view due to discussion and 
strong opinions expressed in the face-to-face meeting. This was managed by asking other 
panel members to explicitly consider the question from another point of view to illicit further 
discussion.  Additionally the researcher attempted to minimise any bias following the large 
group meeting by sending final drafts via individual email to give each panel member as an 
opportunity to provide further (anonymous) comment.  
Conclusion 
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A modified Delphi process was used to develop an evidence and consensus-based initial risk 
assessment and annual monitoring tool for PLHIV at risk of developing HAND. The risk 
assessment aims to facilitate early referral to formal medical review if risk factors are present, 
and to document relevant social and health information for PLHIV. The Delphi method was 
successful in identifying and achieving consensus from experts about what information is 
required to improve clinical care and risk assessment for PLHIV in the community. A flow 
chart or guideline to accompany the tools was also retained for ease of use.  
 
The initial risk assessment and annual monitoring tool developed in this study may also have 
utility for health professionals with limited knowledge of the risk factors or signs and 
symptoms of HAND.  The tools can be used in different clinical or geographical settings, as 
patient information collected at baseline (the initial risk assessment) remains useful alone or 
as a comparison at annual follow up.  Once face and content validity of the tools has been 
established through the current pilot study, the next step is to implement the use of both tools 
as a routine standard of care in personalised electronic health records. This will provide an 
opportunity for the affected PLHIV to undergo regular monitoring and early referral for 
medical review, with the potential for early diagnosis and treatment if cognitive changes 
indicative of HAND are found.  
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 FIGURE 1. Cognitive screening flow chart.  
This flow chart is a guide for multidisciplinary clinicians to use when initiating assessment of the 
PLHIV who may be at risk of developing HAND. 
 
 
 
 
Outcome of screening 
(nothing/monitor/refer to 
nurse/Occupational therapist (OT) 
for further assessment) 
Assessment by nurse/OT 
(additional assessments e.g. 
mental health screen/activities of 
daily living) 
Outcome of nurse/OT review 
(nothing/monitor/referral to 
medical doctor for review) 
 
Outcome of medical review 
(nothing/monitor/radiological 
test/neuropsychological 
test//change medications); 
documentation in patient file) 
Screening by 
multidisciplinary staff  
(initial or annual monitoring 
risk assessment tool) 
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Table 1: Demographic profile of Delphi participants 
Participants in Delphi study                    N=25   Number (%) 
Mean Age (range) 
 
45 years (34 ‐ 59 years) 
 
21(84) 
Missing 4(16) 
Educational qualification 
 
Masters Degree 
Bachelor of Arts 
Bachelor of Science 
Graduate Diploma 
17(68) 
5(20) 
2(8) 
1(4) 
Health Discipline 
 
 
Nurse 
Social worker 
Dietician 
Occupational therapist 
Psychologist 
Counselor 
9(36) 
6(24) 
4(16) 
3(12) 
2(8) 
1(4) 
Mean years working in discipline (range)  16 years (6 ‐ 33 years)   
Mean years in current position (range)   6 years (1 month‐ 16 years)   
 
 
 
Table 2: Initial and annual assessment topics from Round 1 
 
Topics selected for Initial  
assessment tool 
 
n=25  >80%  
agreement 
Average 
rating 
(Scale 1 – 5) 
Median 
 
(Scale 1 – 5)  
IQR 
Reason for referral  24/25  96%  4.56  5  1 
Social information  24/25  96%  4.48  5  1 
HIV information  24/25  96%  4.72  5  1 
General health information  24/25  96%  4.64  5  1 
Mental health  25/25  100%  4.60  5  1 
Medication issues  24/25  96%  4.72  5  1 
Legal issues  14/25  60%  3.30  4  1 
Questions for the patient  24/25  96%  4.64  5  1 
Documentation of the outcome of the 
assessment 
24/25  96%  4.64  5  1 
 
Topics selected for Annual monitoring tool 
 
         
Changes in health in last 12 months  25/25  100%  4.84  5  0 
Changes in social circumstances in last 12 months  25/25  100%  4.80  5  1 
Cognitive changes in last 12 months (noted by 
patient) 
25/25  100%  4.80  5  1 
Cognitive changes in last 12 months (noted by 
informal caregiver/partner if present) 
25/25  100%  4.72  5  1 
Documentation of changes and outcome 
assessment 
24/25  96%  4.64  5  0 
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Chapter 8 
 
Conclusions, recommendations and dissemination of 
knowledge 
 
 
Background 
This final chapter discusses the overall findings of this thesis. The discussion is sequenced in 
accordance with the phased methodology chosen to answer the research questions and 
discusses of the overall strengths and limitations of the study phases, the significance of 
findings to practice, and conclusions for future recommendations. The chapter concludes 
with a proposal for additional contributions to the evidence-base for the improved community 
care of PLHIV who may be at risk of HAND. 
 
8.1  INTRODUCTION 
The absence of an evidence base informing the experience of PLHIV, the role of their 
informal and formal caregivers, and the contribution of community health care teams to 
identifying those at risk of HAND was a significant impetus for this thesis. This lack of 
published literature also determined the pragmatic approach and explanatory sequential 
design that was selected.   
 
The significance of this thesis is evidenced by the publication of four peer-reviewed research 
papers already contributing evidence to address this gap in the literature. The acceptance of a 
range of oral and poster presentations describing the approach and outcomes of the thesis at 
national and international research conferences outlined at the end of this chapter is further 
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evidence of the contribution this research has already made in closing some of the existing 
gaps in knowledge for the broader HIV communities and caregivers.  
 
8.2  SUMMARY OF FINDINGS  
 
Despite searching back to literature published at the beginning of the AIDS epidemic in the 
1980s, few studies had explored the personal experiences of PLHIV and their caregivers with 
regard to HAND. Even fewer studies exist to inform whether or how PLHIV and their 
caregivers might actually identify the signs and symptoms of HAND, and if so, what they 
could or would do with this information to facilitate early diagnosis, intervention and 
treatment to reduce the prevalence and severity of this condition.  
 
Anecdotal conversations with PLHIV in clinical practice had prompted the candidate to 
collaborate in the development of a self-assessment booklet titled HIV associated MND: How 
to recognise signs and symptoms (Totter & Cummins, 2008) more than 10 years ago. The 
booklet outlined various statements and questions relating to cognitive change for PLHIV to 
reflect upon and to consider in their therapeutic encounters with health professional 
caregivers. This led the candidate to conduct the preliminary pilot study, in which PLHIV 
were asked to retrospectively reflect on their experience of signs and symptoms that may be 
indicative of HAND within the context of a prospective observational multi-site study.  
Informal caregivers were also invited to participate in this study, as it was identified that they 
may they have unique insights into the experiences of PLHIV and are well placed to provide 
a more complete picture as observers of the daily functioning and experiences of PLHIV who 
they live with or care for. 
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A pragmatic methodological approach using an explanatory sequential design with mixed 
method studies was chosen in an attempt to unravel the complex insights and experiences of 
PLHIV, and their informal and professional caregivers regarding their experiences of HIV 
associated Neurocognitive Disorder (HAND). The explanatory sequential design aimed for 
representation of the multiple realities and viewpoints of PLHIV and their caregivers by 
building on the emerging results of each study phase to generate research questions from the 
specific experiences of the participants to enrich understanding and provide a more complete 
picture of the complex phenomenon that is HAND.  
 
8.2.1  PLHIV and their informal caregivers can identify HAND  
PLHIV are an ageing population. The mean age of the 121 participants contributing to the 
preliminary pilot study was 49 years, and similar to anyone who is ageing, were at a same or 
greater risk of developing a range of other age-related health conditions, including HAND. 
Forty per cent of participants in the preliminary study lived alone and only 36% nominated a 
caregiver for the study. Of the small purposive sample, 61% percent of participants and 57% 
of caregivers identified more than four signs and symptoms of cognitive change. As a result 
of this study, 16 of the 121 participants were referred for neuropsychological examinations 
and four were subsequently diagnosed with HAND. Significantly, all four showed an 
improvement in cognition after changes to their medication regimes.  
 
This study not only showed that PLHIV were indeed able to identify signs and symptoms of 
cognitive impairment, but also enabled some PLHIV who otherwise may not have been 
identified to be referred for early neuropsychological assessment and treatment.  Results from 
the preliminary pilot study indicated that both caregivers and PLHIV could identify HAND 
and in fact, the self-reflection of PLHIV and the observations of their informal caregivers was 
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instrumental to some participants being referred for further investigation and the eventual 
diagnosis of HAND. Others were identified for ongoing monitoring, which similarly, may 
have not happened otherwise. As HAND remains largely a diagnosis of exclusion, it is clear 
that PLHIV and their informal caregivers can play an important part in the identification of 
signs and symptoms. In the absence of informal caregivers, this role may fall to community 
or other health professionals who are in regular contact, but only if these formal caregivers 
are aware of and apply the essential assessment criteria required to identify those at risk of 
HAND in the community.  
 
8.2.2  PLHIV and their caregivers have experience of HAND 
The preliminary pilot study was conducted with a small cohort of purposively selected 
participants from one city (Sydney) in Australia. However, determining that this group of 
PLHIV and their caregivers could identify the signs and symptoms of HAND led to 
consideration of whether awareness and experience of HAND was also present among a 
broader population of PLHIV? A workshop with PLHIV and caregivers attending an 
international HIV conference facilitated by the candidate in 2014 had also indicated that there 
was concern about HAND, but workshop participants were unclear who to approach about 
their concerns and what to do about them. Following the conference, a ‘think tank’ was held 
with local experts and community HIV organizations (Cummins, Waters, Aggar, Crawford, 
& O’Connor, 2017). This led to the development of an online survey in partnership with 
Positive Life NSW, a peak peer organization in Australia, to explore whether PLHIV are 
aware of and/or concerned about HAND, or whether PLHIV were experiencing signs and 
symptoms of cognitive changes and/or observing them in others.  
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While the number of participants in the Phase 1 study was similar to the pilot, the sample 
included a broader and more diverse group of respondents living across Australia and showed 
that overall, these participants were also aware of HAND, and more than half expressed 
concerned about it. As in the preliminary pilot study, PLHIV were experiencing signs and 
symptoms which may be related to HAND and as previously reported by Cohen et al., 
(2015), some PLHIV in this study had begun to experience signs and symptoms of HAND in 
their mid-40’s. A perhaps unsurprising finding was that those who had been living with HIV 
for a longer period were more likely to have knowledge or experience of HAND in 
themselves or others.  
 
A common sign of non-HIV dementia is the decreased ability to organize (Clifford & Ances, 
2013). Results from the online survey revealed a statistically significant association between 
the duration of HIV infection and self-reporting of a decreased ability to organize things. This 
symptom has potential to impact on many self-care activities for PLHIV such as regular 
attendance at medical reviews, personal care and hygiene, medication supply and adherence, 
and activities of daily living (Cody & Vance, 2016). In addition to affecting general health, 
losing the ability to organize may also increase HIV infectivity if, for example, the person is 
not regularly taking cART medication, consequently has a higher HIV viral load, and is 
possibly engaging in high risk sexual behaviour.   
 
8.2.3 Resources for communication 
An unexpected finding of the Phase 1 study was that many of the PLHIV who were 
concerned about HAND also expressed anxiety about discussing this subject with others. 
They expressed fear for the future and loss of mental capacity and independence – despite 
many receiving a positive response when they had raised the subject of HAND. Many 
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respondents had also noticed changes in cognition among peers in their social networks, but 
generally did not feel comfortable to talk to their friends directly about this.  
 
As almost one-third of the 126 respondents in Phase 1 indicated that additional resources 
about HAND would be helpful to facilitate discussions with formal and informal supports, 
this could be one relatively simple and cost-effective solution for reducing fear and 
apprehension and to promote education for the early identification of HAND. Resources that 
offer information about HAND and provide suggestions for how to discuss the condition with 
both formal and informal supports may help alleviate the concerns of PLHIV, as fear about a 
diagnosis of HAND has been associated with a delay in seeking help (Chambers et al., 2015; 
Gagnon, 2015). Additionally, some PLHIV have experienced stigma and discrimination in 
their past and are fearful of stigma in their future (Karamouzian, Akbar, Haghdoost, 
Setayesh, & Zolala, 2014; Skinner & Mfecane, 2004). If PLHIV have concerns about HAND, 
and are fearful of possible stigma and discrimination, they may be less likely to access 
medical care (WHO, 2008). As an additional outcome of this study, two resources were 
developed, and focus tested with PLHIV who have a diagnosis of HAND, and these are 
available online and in print (Appendix Two).  Following focus testing of both resources and 
further discussions with PLHIV, a specific support group for PLHIV with HAND was 
established. The current group is facilitated by social workers.  
 
8.2.4 Contribution of professional caregivers 
Findings from the preliminary pilot and Phase 1 studies have already contributed to 
increasing knowledge and awareness of HAND. In addition to offering further resources for 
communication within and between PLHIV and their caregivers, HIV community teams in 
NSW have also started implementing individual care plans for PLHIV who have noticed that 
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declining organizational skill is affecting their ability to maintain activities of daily living. 
These findings also prompted the candidate to consider the situation of PLHIV who do not 
have the support of an informal caregiver, or those whose informal support is at distance, for 
example, living in another city or state and/or those who live alone.  These considerations 
highlight the advantage of using pragmatism as a paradigm for this thesis, as emerging data 
allowed for further exploration of the phenomenon and influenced the direction of the next 
phase of the study which was to ask whether professional caregivers could act as an alternate 
to an (absent) informal caregiver in identifying cognitive change in PLHIV at risk of HAND?  
 
The proposition, therefore, was that HIV community teams are also uniquely placed to 
identify those PLHIV who are at risk of HAND based on their access to current and past 
medical history, awareness of the persons’ social circumstances and daily functioning, and 
observation of the home environment over time. As PLHIV had indicated in the online 
survey that they were concerned about HAND, the next phase aimed to determine what 
measures HIV community teams were using to identify which PLHIV in their care were at 
risk of developing HAND. HIV community teams record their clinical care and assessments 
in various electronic medical record (eMR) systems and hard copy patient records. Evidence 
for the proposition that professional caregivers could make a contribution to observing for 
cognitive change in PLHIV, and identify other risk factors for HAND, might therefore be 
recorded in these patient records.  
 
However, the results of the Phase 2 study clearly showed that a considerable amount of 
clinical and social information was not documented in the patient’s clinical notes or eMR. 
Information about risk factors for HAND was incomplete in every single patient record 
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audited for the study, and further, was predominantly from a secondary source (often the 
patient) or unconfirmed (by copies of test results or by the patient’s doctor).  
 
This finding calls into question the accuracy of documentation and comprehensive 
assessment by professional caregivers and implies that the signs and symptoms of HAND 
may not be being optimally reviewed or formally investigated, thereby impacting referral for 
early medical review and possible diagnosis. Complete and accurate documentation is 
essential, as PLHIV who have stable HIV health may only be monitored every four to six 
months by their HIV prescriber and a HIV community team member. This is possibly the 
only regular opportunity for professional caregivers to observe for cognitive changes and to 
record evidence of health maintenance or decline.   Further, integrated models of care rely on 
the sharing of patient assessment information, which does not currently appear complete.  
 
8.2.5  Improving risk assessment for HAND 
As the Phase 2 study had shown that HIV community teams were collecting limited and 
incomplete information on PLHIV in their care, the question of how to improve assessment 
to identify those at risk of HAND in the community was a logical next step. Using knowledge 
gained from the previous study phases, it was proposed that improving the awareness of risk 
factors for HAND among both informal and formal caregivers could be achieved through 
better communication and screening for specific clinical and social factors indicative of risk.  
 The expert Delphi panel assembled for the Phase 3 study were easily able to reach consensus 
on essential assessment criteria to identify those at risk of HAND in the community. The 
panel also recommended that assessment criteria be presented as an initial risk assessment 
screening tool to collect baseline medical and social information, with further identification 
of items to include for annual monitoring. The initial assessment tool was proposed as a 
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precursor to formal assessment by medical and nursing staff, while the annual monitoring 
tool was proposed to assist community-based health professionals in their ongoing 
assessment of risk of HAND in PLHIV, facilitating early formal medical review for this 
condition.  
 
Therefore, an initial risk assessment screening tool and an annual monitoring tool were also 
major outcomes from this thesis. These tools were developed using essential assessment 
criteria recommended by the expert panel who collectively contributed their significant 
experience of working in a community setting with PLHIV, and with those who have a 
diagnosis of HAND. The risk assessment tools developed from this study are designed to 
have utility for health professionals with limited knowledge of the risk factors or signs and 
symptoms of HAND and as requested by the expert panel, are accompanied by a flow chart 
to guide clinicians through the assessment process (Appendix Four). 
 
8.3  STRENGTHS AND LIMITATIONS  
 
This work has highlighted the importance of supporting PLHIV and their caregivers to 
identify HAND and each of the study phases has contributed to improving understanding and 
knowledge about the experience of PLHIV and the complexity of diagnosing HAND. A 
background of only 12 identifiable studies published over the past 28 years describing the 
experiences of HAND among PLHIV and their informal and professional caregivers 
determined the need for a pragmatic approach to this thesis. The choice of an explanatory 
sequential design using mixed methods allowed for emerging findings to drive the research 
direction across three study phases but had both strengths and limitations. The first two 
studies required participants to be able to read and speak English. This was a limitation of 
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these studies which failed to represent the views of PLHIV who may not read and write in 
English, or those who are unable to access online resources. Future research would need to 
include translation of written material to other languages (such as for developing resources 
for communication about HAND and online surveys) and access to interpreters.  
 
Fundamental to the development of this thesis was first establishing whether PLHIV and their 
informal caregivers could actually identify some of the signs and symptoms of HAND. In the 
absence of a background literature, it could not be assumed that in asking research questions 
about HAND, people living with HIV and/or their caregivers knew what they were being 
asked about. The preliminary pilot study was completed at three clinical sites, offering the 
initial viewpoints of PLHIV and their informal caregivers from locations across the city of 
Sydney. The clinics were a stand-alone inner-city HIV clinic, an inner-city sexual health 
clinic and a suburban hospital immunology clinic. The preliminary pilot study was designed 
to follow the HIV positive patient through their usual standard of care at the clinic they 
attended. Designed as an observational study, there was no HIV-negative matched 
comparison group. The self-assessment questionnaire (booklet) had been developed 
specifically for the observational study and had not been validated. The researchers relied on 
their own professional judgement and incidental anecdotal evidence from caring for PLHIV 
to nominate which of the four or more signs and symptoms of cognitive decline identified 
from the booklet were to be made aware to medical staff – in other words, the team 
collectively determined their own criteria for referral. Following the usual standard of clinical 
care, a small number of PLHIV were referred for formal neuropsychological testing, with 
four subsequently being diagnosed with HAND.  Further analysis was unable to be completed 
due to the purposive sampling method and small participant numbers. However, the intention 
of this preliminary pilot study was to gain a snapshot of data and foundational knowledge 
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where none previously existed. This pilot study was instrumental in influencing the 
subsequent direction of the thesis to explore the complexity of HAND.  
  
The Phase 1 online survey was able to utilize the broader profile of Positive Life NSW to 
target a wider population of PLHIV to give voice their experiences and concerns about 
HAND.  Limitations of this study were the equity of access to an online survey offered 
through a social media account and the three week timeframe during which the survey was 
open. While this undoubtedly influenced the survey response rate, the candidate was required 
to comply with the schedule of the host of the online platform. The researchers made a 
decision to only recruit via this method as other methods of recruitment would have required 
many ethics submissions to a broad range of organizations possibly yielding only small 
numbers of participant’s through each. Although this sample size was also small, responses 
were received from across Australia. Small numbers within some sub-samples may have 
affected statistical results, however, this was the rationale for also reporting effect sizes. It is 
entirely possible that survey respondents who had a specific interest or concern about HAND 
were over-represented in the sample. Survey questions did not request respondents to 
quantify the period of time related to their experience of signs and symptoms of HAND and 
did not ask about stigma. Additionally, those without access to a computer or computer skills 
were presumably excluded from completing the survey online.  
 
The file audit of records from Phase 2 was completed over a short period of time (one 
month). Other limitations of this study included that each service used different eMR 
systems, which prevented a comparison of how information is uploaded to each system and 
how health professionals access it. However, the formal caregivers (health professionals) 
from the two HIV community teams in Sydney whose file documentation was audited have 
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extensive clinical experience providing clinical care and support to PLHIV and were very 
open to improving their service. Additionally, participation by both teams in the file audit 
allowed for comparison and combination of data. All data were de-identified prior to being 
analysed by the candidate and none were shared with any third party. 
 
The selection of experts who participated in the modified Delphi study were from four HIV 
services and included formal caregivers from Phase 2 who were committed to providing 
further insights and improvements in service delivery to PLHIV. As Delphi participants were 
all from one state of Australia (New South Wales), this could be considered a limitation of 
this study, however, it is equally important to the Delphi method that selected participants 
have relevant experience of the specific health condition and key population. As the State 
with the largest population of PLHIV, and as members of the original services developed 
more than 30 years ago to care for people with HIV in Australia, panel members were drawn 
from the unique statewide (NSW) service (AIDS Dementia and Psychiatric HIV Service). 
This service has more than 20 years of experience in providing care, support and case 
management to PLHIV with cognitive impairment and therefore, panel members were likely 
representative of Australian HIV experts.  
 
Lack of anonymity in the face-to-face Delphi meetings may have limited participant 
contribution, obliged members to conform to the discussion, or allowed some participants to 
dominate the group. Validity may also have been compromised when panel members 
changed their view due to discussion or strong opinions expressed in the face-to-face 
meeting. This was managed by asking other panel members to explicitly consider the 
question from another point of view to illicit further discussion.  Additionally, the candidate 
attempted to minimise bias following the second large group meeting by sending the final 
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drafts of agreed items for the screening and monitoring tools via individual email addresses to 
give each panel member an opportunity to provide further (anonymous) comment.   
 
8.4  SIGNIFICANCE OF FINDINGS  
 
HIV-Associated Neurocognitive Disorder is associated with significant morbidity and 
mortality for people living with HIV and can cause various levels of disability. Because 
HAND is a potentially treatable condition, the early identification of signs and symptoms is 
important for prompt diagnosis and the opportunity to reduce prevalence and severity 
(Skinner et al., 2009). However, the identification and diagnosis of cognitive impairment is 
complex and multifactorial, and as identified in Chapter 2, the diagnosis of HAND is often 
achieved by excluding other conditions (Nabha et al., 2013). Further, as PLHIV age, they are 
similarly at increased risk of developing comorbid conditions. Regular engagement with HIV 
community teams could provide greater opportunity to develop strategies to detect and 
manage co-morbid conditions such as diabetes and cardiovascular disease which may further 
impact their cognitive health. For those diagnosed with HAND, HIV community teams can 
provide case management services. These teams are also beneficial for PLHIV who have 
complex health needs in addition to HAND and can develop individual cognitive 
rehabilitation strategies for the assimilation of health and social support services. 
 
The findings of this thesis strongly support the important role of informal and professional 
caregivers in providing valuable insights into the physical, social and emotional wellbeing of 
PLHIV. As such, these findings support the work of others (McDonald, Elliott, & Saugeres, 
2013), who concluded that informal and professional caregivers can notice changes in 
behaviour or within the home environment of PLHIV which may have otherwise gone 
unnoticed.  Informal caregivers have been shown to have a positive impact on the health of 
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PLHIV (Uchino, 2004). In addition to supporting the management of symptoms of cognitive 
change, informal caregivers assist by arranging and/or escorting the PLHIV to medical and 
clinic appointments and facilitating medication management and adherence, thereby 
contributing to the potential for early review for the diagnosis and treatment of HAND. 
Further, some PLHIV may lack insight into cognitive changes they are experiencing as these 
changes may be subtle or assumed to be due to morbidity associated with ageing. For others, 
informal caregivers may live some distance from the person and so the level of support may 
be limited (Schnall et.al, 2018).  
 
If the PLHIV does not have the regular support of an informal caregiver, professional 
caregivers based in the community setting can act as an alternative in their absence. 
Professional caregivers can observe cognitive risk factors for HAND, however, the results of 
the Phase 2 study clearly show that these health professionals may need further support to 
conduct regular assessment of significant and essential risk criteria. Furthermore, for those 
PLHIV in a relationship, where both are HIV positive and both at risk of developing HAND, 
the support of a professional caregiver could act as a sentinel to any changes. There are 
approximately 26,444 PLHIV in Australia (Kirby, 2017), of whom an estimated 20% are at 
risk of developing HAND. This equates to approximately 5,288 PLHIV in Australia 
developing HAND. Early intervention, diagnosis and treatment are important and can have a 
profound impact on the health and wellbeing of PLHIV and the coordinated delivery of their 
health services. Raising awareness of HAND among PLHIV, and their informal and formal 
caregivers, may improve identification of those PLHIV at risk of developing HAND. 
 
The findings of studies within this thesis have also noted that communication about HAND 
may be an issue; both between PLHIV and their informal and professional caregivers, and 
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between health service professionals. The development of two specific resources about 
HAND was an additional outcome of the thesis. The resources are now in circulation 
(including online) and aim to provide information to the community and open a dialogue 
about cognitive decline in PLHIV. The file audit noted poor documentation in the clinical 
notes of PLHIV which is likely to be impacting integrated care and the possible health 
outcomes of PLHIV. Strategies have been developed locally to improve documentation by 
the HIV community teams involved and communicated more broadly via the publication in 
Chapter Six and in conference presentations as below.  
 
Finally, an initial risk assessment tool and annual monitoring tool have been developed for 
HIV community teams and others to use in community or other settings to identify which 
PLHIV may be at risk of HAND and require referral for early assessment. It is anticipated 
that with development of this form for electronic medical record formats, annual monitoring 
of changes in social circumstances, clinical indicators and cognition can be readily reviewed 
by health professionals to detect early signs and symptoms of cognitive decline. This is 
especially relevant to PLHIV who live alone and do not have the support of an informal 
caregiver who might normally observe daily changes in cognition, or in the situation where 
two PLHIV live together and may both be at risk of developing HAND. 
 
8. 5 CONCLUSION 
This study has provided new knowledge pertaining to PLHIV and their informal and 
professional caregivers’ experiences of identifying and communicating about HAND. The 
practical significance of this study is that as PLHIV age they may experience mild signs and 
symptoms of cognitive impairment that could be HAND. Early identification and diagnosis is 
essential, as HAND is a potentially treatable condition (Skinner et al., 2009).   
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The personal experiences of PLHIV and their informal caregivers should be considered by 
professional caregivers when assessing the person. This is not only a central tenet of person-
centred care, but informal caregivers of PLHIV may have their own experience to share and 
can provide unique insights into the daily social and physical functioning of those they care 
for. Improvements in communication and documentation would provide a more complete 
picture of the circumstances of PLHIV and facilitate better integration (and likely efficiency) 
of care. If the PLHIV does not have the support of an informal caregiver and/or lives alone, 
professional caregivers are also well placed to observe for cognitive changes. A HAND risk 
assessment and annual monitoring tool has been developed by clinical experts to identify 
PLHIV at risk of HAND and enable early referral and diagnosis.  
 
8.6  RECOMMENDATIONS 
 
The following initiatives and strategies arising from the findings of this thesis are 
recommended for future implementation in HIV community services within New South 
Wales: 
 
1. To acknowledge and include the personal experiences of PLHIV and their informal 
caregivers’ in clinical assessment as both can contribute valuable insights to aid in the 
early diagnosis of HAND; 
2. To assess all patients with HIV with an initial risk assessment tool and complete an 
annual follow up using a monitoring tool; 
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3. To make the risk assessment tools developed as part of this thesis freely available on 
the electronic medical record systems of public health services so these become a 
best-practice standard of care for HIV community-based teams; 
4. To increase awareness of cognitive decline in PLHIV by providing a copy of the 
HAND resource from Positive Life NSW to all PLHIV and their informal caregivers 
before or at their initial risk assessment; 
5. To use the risk screening process as an opportunity to support PLHIV with personal 
health strategies to reduce the detrimental effects of co-morbid conditions and provide 
case management to those with HAND if needed; 
6. To provide focused monitoring for PLHIV who do not have support of an informal 
caregiver &/or live alone. 
 
8.7  RECOMMENDATIONS FOR FURTHER RESEARCH 
 
Future research should consider the inclusion of PLHIV and informal caregivers from non-
English speaking backgrounds and invite PLHIV to contribute to the prioritization, design 
and development of future projects as co-researchers. Other recommendations for future 
research include: 
 A longitudinal study to document the prevalence and incidence of HAND as PLHIV 
age in the local population, including common risk factors and signs and symptoms; 
 A longitudinal study of outcomes from using the initial risk assessment tool and 
annual monitoring tool with all patients engaging community-based HIV services to 
develop a streamlined pathway for referral for formal review of cognitive changes 
which may be HAND; 
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 Exploration of stigma and discrimination related to the development and diagnosis of 
HAND and whether this affects future access to health and social care; 
 Exploration of advanced care planning among PLHIV diagnosed with HAND; 
 Design and evaluation of a cognitive rehabilitation program for PLHIV with HAND; 
 Assessment of informal and professional caregiver’s knowledge relating to HAND to 
design specific education for these groups. 
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How can nurses identify the experience of cognitive impairment for people living with HIV, 
leading to early diagnosis? Cummins D, Waters D, Aggar C, O’Connor C, C. 
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18-20 October 2017, Melbourne, Australia (Oral poster presentation)  
Development of assessment tools for HIV community based health care professionals to 
detect people living with HIV who may be at risk of HIV associated neurocognitive disorder 
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6. “Developing Resources to assist PLHIV with HAND.” 2016.  Positive Life NSW.  
 Report from survey data for NSW Ministry of Health available at:  
At the Research Reports/ Submission page 
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APPENDICES 
 
Appendix One:  
Preliminary study: Ethics approval including participant information, participant consent; one 
year follow up participant information.  All related documents: participant questionnaire, 
demographic survey, medication chart and Booklet “HIV associated mild neurocognitive 
disorder” 
 
Appendix Two:  
Phase 1 study- ethics approval; Survey “HIV and the Brain”; written responses; two HAND 
resources available at: http://www.positivelife.org.au/images/PDF/2018/PLNSW-
HAND2018-FriendsFamily.pdf 
http://www.positivelife.org.au/images/PDF/2018/PLNSW-HAND2018.pdf 
 
Appendix Three:  
Phase 2 ethics approval, participant information, participant consent form; copy of file audit 
items. 
 
Appendix Four: 
Phase 3 ethics approval, Delphi information sheet; participant information; participant 
consent (health professional and client); Health professional demographic survey; Likert 
scale (for initial and monitoring tools); Initial risk assessment tool, annual monitoring tool, 
and flow chart for HAND assessment; Pilot survey for health professional 
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